Warning: There are an increasing number of fraudulent websites that impersonate ECCMID. We would like to alert all our members and delegates to possible scams and we strongly advise you to use only the official ECCMID online registration for your bookings.

ePoster Sessions

Here you can find the list of ePoster sessions during ECCMID 2021 and the presenters that will be taking part in them. The ePosters will be available starting 10 days prior to the congress days in July (9-12). We will also schedule some sessions during the congress days and they will remain open until 3 months after the congress (October 17, 2021).

ePoster session list

Abstract NumAbstract titleLast nameFirst name
4666To be or not to beMalhotraSanchi
4760Curious Case of a Car AccidentBangertMadison
4804An Unusual Case of Fusobacterium InfectionOgawaLauren
4998Brucellosis complicated by spondylitis in an Austrian patientWunschStefanie
5000Previously fit and well 38-year-old male with history of dyspnoea, wheeze and productive coughWatsonRebecca
5001Treponema pallidum infection in a 26-year-old patient with HIVDrorDanna
5002Whipple Endocarditis in an Austrian patient after cardiac surgeryWunschStefanie
5003Febrile neutropenia in a 35-year-old woman with acute lymphoblastic leukaemiaAlegre AlbendeaMaría
5004Disseminated histoplasmosis mimicking inflammatory bowel diseaseCobussenMaarten
5005Disseminated Mycobacterium chimaera infection in a 54-year-old patient presenting with a dry cough, subfebrile temperatures, weight loss and nights sweatsKusterSabine
5007Non-tubercular mycobacteria (NTM) infection in a previously healthy 34-year-old maleChiesaAnnacarla
5008Cutaneous lesions in times of COVID-19KrieglLisa
5009Meningoencephalitis in a healthy 25-year-old Tanzanian man, living in Austria, returning from TanzaniaKönigElisabeth
5010Refractory pneumonia in a healthy 64-year old man living in South-East Austria KönigElisabeth
Abstract NumAbstract titleLast nameFirst name
1018A case of cutaneous mucormycosis following a motor vehicle accident (MVA) with a dismal outcomePapadakisEleftherios
118A case of eumycetoma and treatment challenges in a non-endemic regionWeinbergSharon Esther
1243Cryptococcal meningitis complicated by cerebral scedosporium in a non-HIV patient: a case reportQuinivista-YoonJenny Mae
1258The first Latin American bilateral lung transplant after severe SARS-CoV-2 infection LopezAlicia
130Cytomegalovirus meningoencephalitis in a critically ill Filipino elderly female: a case reportSanchezAnna Anjelica
1886Neurotoxoplasmosis: three cases during one yearBondiAlessandro
2195A case series of disseminated cases of histoplasmosis from a tertiary care hospitalKumariRenu
2271Immune reconstitution syndrome with rapidly fatal cerebral oedema after antifungal therapy in Cryptococcus neoformans meningitis in a HAART-naïve HIV patient: a case reportSiripongboonsittiTaweegrit
2569Be conscious of Cryptococcus neoformans: cryptococcal meningoencephalitis and cryptococcaemia with unfavorable outcome in a patient with myasthenia gravisIeronymakiAlexandra
350Severe cryptococcal meningoencephalitis with large vessel vasculopathy and multi-territory cerebral infarctsSunCaitlyn
3630A novel case of cerebral toxoplasmosis secondary to the use of the tumour necrosis factor-α agent, adalimumabKellyAdam
3633Prosthetic valve endocarditis due to Trichosporon inkin: a paediatric caseFudgeSabrina
3896Eosinophilic pneumonia and nasal myiasis by Oestrus ovis: the first case report from Mediterranean areaBozziElena
4009Leishmania spp. and Pneumocystis jirovecii infection in the immunocompromised hostPiresHelena
52Rhizopus infection in an HIV/AIDS patient: first case report in CameroonKuate NgouanomMarius Paulin
622Fungaemia due to Paecilomyces variotii in an immunocompromised hostSonaliChoudhari
729Successfully treated Myceliophthora thermophila invasive sphenoidal sinusitis in an immunocompromised patient: a case reportZambolinGiulia
Abstract NumAbstract titleLast nameFirst name
113An audit on osteoporosis screening, diagnosis and management in aging patients living with HIVNurdinNadra
1211Transduced dendritic cells expressing HIV-1 p24-Nef antigens result in HIV-1 specific cytotoxic T cell inductionRamezaniAmitis
1446Prevalent Candida, Trichomonas vaginalis and bacterial vaginosis are significantly associated with the risk of Human Immunodeficiency Virus infection in South African pregnant women MzimelaNtokozo
153HIV/AIDS-related cerebral disease spectrum encountered in neurosurgical practice in Sri LankaLalDewa
1614The interdependence of the HIV infection epidemic process among drug users in Minsk, Belarus and the incidence of this infection in the Minsk populationShylavaMarharyta
1642Cost-effectiveness of routine CD4 cell count monitoring in a tertiary outpatient HIV centre: a retrospective review of current practice in an Irish tertiary hospitalO'reganRhea
2013Rare case of HIV infection and thrombotic thrombocytopenic purpura with neurological symptomsKöseogluMuhammed Berk
2183Human herpesvirus-8 (HHV-8) and Epstein-Barr virus (EBV) associated extracavitary primary effusion lymphoma presenting as a thoracic wall mass in a HIV patient: a case reportGranadoJoana
2341“I didn’t know what to do or who to call”: a quality improvement project on the experience of long COVID for people living with HIV at a large London tertiary centreChencinerLouisa
2400In vitro antibacterial activity of antiretroviral drugs against representative bacteria of the gut microbiotaRubio GarcíaElisa
2510Distal symmetric polyneuropathy in an HIV-infected manOlivEira E SilvaFernando
3002Comparison of the new HIV VL XC Assay with the established Alinity m in HIV-1 viral load measurementEhretRobert
3033Syphilis among HIV-infected men who have sex with men during COVID-19 era in 2020 in CroatiaVanjaRomih Pintar
3155Cobas® plasma separation card as an alternative sampling method for analysis of HIV and Treponema pallidum antibodiesVanroyeFien
3366Infectious disease, elderly migrant and the French law: a glimpse of international cooperationSeynaeveDamien
3501Castleman disease and Kaposi sarcoma in human immunodeficiency virus infected patients: a single-centre experienceTrindade Figueiredo TorresMargarida
389582 year old patient with aortic mechanical prosthesis and feve: endocarditis relapse? No, HIV infectionGarcia CarúsEnrique
3937It’s not always COVID-19! Or is it? Two cases of new HIV diagnosis in the COVID-19 eraEdwardsFrances
4309Performance evaluation of a novel quantitative HIV-1 assay on the fully automated NeuMoDx™ molecular system CoutureCatherine
4365Distribution of HPV types in HIV-negative and -positive patients in Pakistan: a comparative studyAzizHafsa
4398Psychiatric comorbidities in patient with HIVSinghKomal
4967Evaluation of the Xpert® HIV-1 Viral Load XC RUO: a novel Point-of-Care HIV viral load assayDorwardJienchi
781Eosinophilic granulomatosis with polyangiitis in HIV patient: a case reportArcegonoMarlon
819Diagnostic performance of novel HIV Duo and Anti-HCV II immunoassays, versus commercially available alternativesReichhuberReichhuber
860Performance analysis of three commercial kits designed for RNA quantification of HIV-1 group O variantsAlessandri-GradtElodie
Abstract NumAbstract titleLast nameFirst name
1061Ribavirin for rat hepatitis E virus infection in immunocompromised patientsSridharSiddharth
116Hepatitis C virus transmission from mother to childZnovetsTatyana
1277Epidemiology and distribution of hepatitis B virus genotypes in the East Valladolid health areaCantón BenitoElena
1568Role of plasmatic and urinary tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) concentration in a cohort of hepatits B virus chronic patientsStroffoliniGiacomo
1592Aseptic meningitis as an extrahepatic manifestation of acute hepatitis E: a case reportTvrdáMonika
1684Comparison of birth-cohort and non-birth-cohort hepatitis C virus screening in the emergency departmentFordJames
251Prevalence of hepatitis E in RussiaMikhailovaJulia
2819Blood samples' characteristics and incidence of invalid results of quantitative HIV and HCV NAT from living, heart beating, and after circulatory death tissue donorsRibeiroVictoria Stadler Tasca
31Telemedicine in viral hepatitis care: a well-received transition in a central London patient cohortDavidKate
3118Direct-acting antiviral (DAA) treatment uptake and impact over 2015-2020 in Tuscany, ItalyCeccarelliLuca
3482Molecular epidemiology of hepatitis B virus in EritreaHamidaMohammed Elfatih
3604Changing demography of hepatitis C patients in the Czech RepublicHusaPetr
3611Development and characterisation of oral combination vaccine against hepatitis B and anthraxBhargavaSaurabh
3852Accurate diagnosis of HEV-infected patients by using a new fully automated high-throughput solution.Avellon CalvoAna
4031Impact of rods and rings autoantibodies as a biomarker on non-HCV diseasesYazici OzçelikEda
4810HBV MGB® Kit/InGenius: a new system for the quantification of HBV DNA in plasma and serumOlivoCristina
4920Seroprevalence factors associated with HBsAg carriage in Guinean prisonsSowMamadou Saliou
75Limited value of IgM antibody determination as single screening approach for hepatitis E virusRivero-JuarezAntonio
2021Relationships between IL-1β, TNF-α genetic polymorphisms and HBV infection: a meta-analytical studyWeiYinhao
Abstract NumAbstract titleLast nameFirst name
1299The burden of respiratory syncytial virus (RSV) disease in patients hospitalised in a large tertiary hospital in the United KingdomKnapperFrancesca
1605The cost-effectiveness of expanding vaccination with the cell-based influenza vaccine for low-risk adults aged 50 to 64 years in the United Kingdom (UK)Mould-QuevedoJoaquin
1716Using QIAstat-Dx® Respiratory SARS-CoV-2 Panel as a tool for diagnosis of zoonotic strains and the G4 Eurasian avian-like H1N1 influenza A and for differentiation from the seasonal influenza A virusesPeñarrubiaLuis
1855Neuraminidase inhibitors and single-dose baloxavir are effective and safe in uncomplicated influenza: a meta-analysis of randomised controlled trialsTejada MagranerSofia
2035Influenza season 2020-21: factors conditioning the reduced circulation of influenza viruses in ItalyPennatiBeatrice Marina
2434Distribution and frequency of main respiratory viruses and bacteria causing atypical pneumonia previously and during the COVID-19 pandemicYarci CarriónAyla
2678Striking absence of “usual suspects” during the winter of the COVID-19 pandemic, 2020-2021 SarvepalliSiri S.
2872Analysis of viral pneumonia due to influenza virus in patients admitted from 2012 to 2016 in a tertiary hospital: comparison with severity scalesFullana BarcelóMaria Isabel
3336The Respiratory infection intensity and impact Questionnaire (RiiQ™) shows increased symptom severity in presence of underlying risk factors in adults hospitalised with influenza, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV)Ispasgabriela
3437Monocyte CD169 expression as a biomarker of SARS-CoV-2 infection and recovery: a comparative study with SARS-CoV-2 nucleic acid RT-PCR detectionGattiArianna
3684Respiratory viral pathogens in Bulgaria and their role in co-infection with SARS-CoV-2TrifonovaIvelina
3714Role of the microbiome in coronary patients with influenza virus infectionReigadasElena
3929T cell epitope position at the N-terminal end of an influenza peptide vaccine significantly snhanced induction of immunitySeiClara J.
4668Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological modeling studyWagatsumaKeita
4753Clinical features, outcome and prognosis of human metapneumovirus lower respiratory tract infections in adult inpatients: a multicentric, prospective, observational studyPhilippotQuentin
4931Seasonal influenza in elderly patients: surveillance data from a tertiary care hospital in Romania from 2017/18 to 2019/20DraganescuAnca Cristina
625Protection against H9N2 influenza A virus induced by recombinant NP-HA2 fusion proteinZeinolabedinMaryam


Abstract NumAbstract titleLast nameFirst name
1074Human lactoferrin-derived peptide 1-23 (HLP 1-23) in vitro activity on alphaherpesvirus replicationNadejdeNelu
1281Validation of Simplexa™ HSV 1 & 2 Direct and Simplexa™ VZV Direct kits for herpes simplex virus (HSV) and varicella-zoster virus (VZV) detection in low-volume cerebrospinal fluid samplesBoutolleauDavid
134Encephalitis in immunocompromised patients in France, 2016-2019MaillesAlexandra
1483Clinical evaluation of a fast human cytomegalovirus (HCMV) PCR assay to catalyse analytical practiceGrewingThomas
1600Herpes simplex virus type 2 meningitis in adults: national survey on treatment among infectious disease specialists in DenmarkJakobsenAnna
1632Risk factors and outcomes of refractory and/or resistant cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantationKarantoniEleni
1709Metatranscriptomic characterisation of mild and severe viral encephalitisAiJingwen
177False positive herpes simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM seropositivityVandervoreLaura
1799Congenital human herpesvirus 6 (HHV-6) infection in a full-term neonate: a diagnostic challenge KittasChristos
2869Rhombencephalitis due to Epstein-Barr virus ShinhaTakashi
2982pUL52: a new potential therapeutic target of human cytomegalovirus DNA-packagingMullerClotilde
3355Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: real-life data from ItalyZammarchiLorenzo
4Cytomegalovirus-specific cell-mediated immune monitoring and cytomegalovirus infection in patients with active systemic lupus erythematosus (SLE) receiving immunosuppressantsBruminhentJackrapong
4011Cytomegalovirus glycoprotein B genotype distribution in lung transplant recipientsReyes RuizCarmen Alhena
425Interim report of post-marketing surveillance of letermovir in Japanese allogenic haematopoietic stem cell transplantation recipientsHiraishiItaru
4323Acute vision loss in a patient with HIV-1 infectionPolicarpoSilvia
4342First experience with letermovir for prevention of cytomegalovirus (CMV) reactivation in CMV-seropositive paediatric patients post-allogeneic haematopoietic cell transplantationGrollAndreas H.
725Eczema herpeticum in children with burnsRijalSushil
Abstract NumAbstract titleLast nameFirst name
1136Rational use of ultrasonography with triaging of patients to detect dengue plasma leakage in resource limited settings: a prospective cohort studySigeraPonsuge Chathurani
1143Direct costs of managing hospitalised dengue patients in Sri Lanka: a prospective studySigeraPonsuge Chathurani
1282Clinical presentation of Puumala virus infections in southern Austria in the peak year 2019 compared to the peak year 2012Zollner-SchwetzInes
1496Assessment of the YKL-40 concentration in patients with tick-borne encephalitisMoniuszko-MalinowskaAnna
1699Clinical and laboratory characteristics of febrile illness caused by tick-borne encephalitis (TBE) virusBogovičPetra
1853Serum and cerebrospinal fluid antiviral cytokine profile in tick-borne encephalitisVilibic-CavlekTatjana
2047Preparation of recombinant antigens for the diagnosis of the West Nile feverStukolovaOlga
2576Atypically-imported severe primary dengue presenting with neutrophilic leukocytosis, elevated inflammatory markers, myopericarditis and cardiac tamponadeIacopoVellere
3210Serum TAFI levels and its relation with bleeding and pathogenesis in Crimean-Congo haemorrhagic fever patientsAltinNilgün
3472Serological evidences of circulation of rodent-borne viruses in humans in Northwest ItalyFaolottoGiulia
3596Epidemiological analysis of Zika, dengue and Mayaro viruses in Laranjal do Jari, State of Amapá, BrazilLopes Sanz DuroRodrigo
3944Population screening results of separate regions of the Turkestan region for seroprevalence to the Crimean-Congo haemorrhagic fever virusAbuovaGulzhan
4028Molecular genetic analysis of rabies virus, allocated in AzerbaijanNarimanovVidadi
4815Development of PCR-based next generation sequencing protocols for West Nile virus whole genome sequencingPapa-KonidariAnna
808Genetic diversity of dengue virus serotypes circulating among Aedes mosquitoes in selected regions of NigeriaNdamsIliya
811First autochthonous cases of tick-borne encephalitis in BelgiumStoefsAnke
Abstract NumAbstract titleLast nameFirst name
1538Early prediction of plasma leakage in severe dengue by vascular endothelial released proteinMariappanVignesh
2696Added value of testing for specific serum IgA additionally to IgM in acute secondary dengue virus infectionsDieckmannKersten
2703Development of a novel NS1-based ELISA for the detection of specific IgG antibodies against Japanese encephalitis virusPollmannMarc
3377HPV diagnosis in men from proper specimen collection to reliable resultsStaryAngelika
778Evaluation of GenomEra Norovirus for detection and differentiation of norovirus genogroup I and II in faecal specimensLamHoyin
Abstract NumAbstract titleLast nameFirst name
1146Measles outbreak at the emergency room in a Japanese tertiary hospitalMawatariMokomo
1598Parvovirus B19 infection in immunocompetent adultsPérez JiménezRita Desirée
1902A multi-centre retrospective study of clinical features, laboratory characteristics and outcomes of 325 hospitalised children with COVID-19: a preliminary report from Iranian Network for Research in Viral Diseases (INRVD)JazayeriSeyed Mohammad
3078COVID-19 at nursing homes in Madrid, Spain, during the first wave of the pandemicGuineaJesus
3731Serological screening of infections in pregnant women: forewarned is forearmedPomaresChristelle
4414Linkage of genetic variants of the main envelope glycoproteins as a marker in the development of CMV congenital infectionTaravillo CañeteIrene
4960Measles to be continued?SapaniucCristina
515Prevalence of viral hepatitis in African people with HIV varies by region of ancestryPatelNisha
847Pattern of dengue virus infections in patients and Aedes vectors during outbreak and inter-outbreak seasons in a dengue high risk area of Sri LankaNoorBushran
856Spatio-temporal diffusion pattern of dengue incidence, virus serotypes and vectors in a dengue high-risk area of Sri LankaNoorBushran
Abstract NumAbstract titleLast nameFirst name
2829Antiviral activity of Carica papaya extract against experimental dengue virus (DENV) 1, DENV-2, DENV-3 and DENV-4 infection and cytotoxic effect of Carica papaya extract against C6/36 Aedes albopictus cellsGalappaththiMalshi
2853Impact of co-administration of letermovir on isavuconazole plasma concentration in allogeneic hematopoietic cell transplant (HCT) recipientsSuYiqi
3178Outcome of progressive multifocal leukoencephalopathy treated by rhIL-7: a retrospective cohort studyLajaunieRébecca
3332Intracerebral penetration of aciclovir: a porcine-based model for pharmacokinetics within the brain (pilot study)MariagerTheis
4477Alert for bradycardia with remdesivir use in COVID-19 patients: two case reportsEl HidayHisham
Abstract NumAbstract titleLast nameFirst name
4645Knowledge, attitude and practices (KAP) of physician about adult immunisation: a study from a developing countryKhanumiffat
802Antibiotic treatment ineffectiveness: impact on patients' quality of lifeArquembourgJocelyne
809Analysis of social media to identify the topics of discussion and the users’ level of knowledge about antibiotic resistanceGlaserPhilippe
Abstract NumAbstract titleLast nameFirst name
1054Clinical features and diagnostic approaches in abdominal tuberculosis: 5-year experience from a non-tuberculous-designated hospital in ChinaJinWenting
1055Persistent fever, multiple peritoneal lymphadenopathy and haemorrhagic peritoneal effusion: abdominal tuberculosis, still a big clinical dilemmaJinWenting
1110Frequency of adverse events caused by various preventive therapy regimens within the Zero TB Initiative in Vladimir CitySolovyevaAlexandra
1164Influence of host genetic variation on cytokine response heterogeneity upon BCG vaccination in children from Guinea-BissauBoahenCollins
1305Online interactive case-based education improves competence in diagnosing NTM lung disease and related patient communication Rohani-Montez, PhdChristy
1414Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: a case reportDe VitoAndrea
1430Identifying mechanisms underlying the association between Mycobacterium tuberculosis infection and chronic fatigue syndrome using in silico analysis of canonical pathwaysMaKevin Sheng- Kai
1474Who dies of multi-sensitive tuberculosis in the 21st century in Paris?BeaumontAnne-Lise
1560Mycobacterium gordonae, a non-pathogenic mycobacterium?PocinhoSara
16Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study Codecasaluigi ruffo
169Rapidly-growing non-tuberculous mycobacterial infections among patients with multiple myeloma from a country with high tuberculosis burden: a case series and literature reviewCruzMarie Gene
1742Quality of life and its determinants among pulmonary tuberculosis (TB) patients taking direct observation therapy (DOT) in Kabul, AfghanistanAziziShabnam
1762The hurdles of evaluating a new all-in-one test to diagnose tuberculosis and inform therapeutic regimen: from building an international network to study designBaldanRossella
1787Active case-finding of tuberculosis in general populations and at-risk groups: a systematic review, meta-analysis and meta-regressionBohlbroAnders Solitander
1802Gender differences on the way to a pulmonary tuberculosis diagnosis: observations from Guinea-BissauBohlbroAnders Solitander
1851Evaluation of Xpert MTB/RIF Ultra for diagnosis of extrapulmonary tuberculosis: a retrospective analysis in a low-tuberculosis prevalence settingDel GiudiceAnnalisa
189Infectious endophthalmitis caused by Abiotrophia defectiva after penetrating injury in child:a case report and case reviewJinDeng
1910Comparison of three methods of Mycobacterium tuberculosis complex spoligotype determination for clinical isolates, Lyon, FranceGenestetCharlotte
1948Different purified protein derivative (PPD)-stimulated cytokine responses from patients infected with genetically distinct Mycobacterium tuberculosis complex lineagesRanaivomananaPaulo
1966Detection of the multidrug-resistant phenotype in Mycobacterium tuberculosis clinical isolates, by using GenoType MTBDRplus and whole genome sequencingBakulaZofia
1971Urinary tract infections in Benin: exploring the virulence factors and antibiotic resistance genes and virulence genes among bacteria isolatesDougnonVictorien
2039Diagnostic role of 18F-FDG PET/CT in disseminated Mycobacterium chimaera infections after cardiac surgeryBattagingiuliana
209The influence of rheumatoid factor on the prognosis of patients with tuberculosis and rheumatoid arthritisLaiHongli
2171Tuberculosis in elderly: epidemiological profile, prognosis factors and chronological trends in southern Tunisia, 1995–2016TriguiMaroua
2199Country-specific approaches to latent tuberculosis screening targeting migrants in EuropeIoanaMargineanu
2214The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV-infected adults in Lithuania: a twelve-year analysisMatulyteElzbieta
2270Donor-derived tuberculosis in a lung transplant recipient: an unmet need in donor screeningPascaleRenato
2305Epidemiological dynamics and characterisation of a successful pre-XDR Mycobacterium tuberculosis clone actively transmitted in ItalyMiottoPaolo
2412Efficacy and safety of terizidone used in combination treatment in patients with pulmonary multidrug-resistant tuberculosis (MDR-TB)GigeaAdela
2519Disseminated BCG infection following intravesical instillation for bladder carcinoma: a 3-case seriesGonçalvesInês
2526Incidence and mortality of tuberculosis in people living with HIV in Denmark: a nationwide cohort studyMartin-IguacelRaquel
2545Is T-SPOT.TB a valid test in the diagnosis of lymph node tuberculosis when performed directly on lymphnode specimens?: report of a first experienceTunesiSimone
2548Susceptibility profile of Rapidly-Growing Mycobacteria (RGM): a single-centre retrospective study of 524 isolates: an Indian experienceMohammedIrfana
2674ß-lactams against Mycobacterium kansasiiMuñoz MuñozLara
2686Emergency hospitalisation among tuberculosis patients in IrelandO' ConnellJames
2722Disseminated tuberculosis complicated with haemophagocytic lymphohistiocytosisCaldasJoão Paulo
2757Evaluation of two Mycobacterium tuberculosis proteins as novel diagnostic biomarkers for latent tuberculosisPapakonstantinouDanai
2862Feasibility study of MIC panel in the QDST system for Mycobacterium tuberculosisKimHaeun
2922pncA mutations of Mycobacterium tuberculosis and outcomes of pulmonary tuberculosis in UkraineKonstantynovskaOlha
2969Analytical performance data of FluoroType® mycobacteria direct: an assay for identification of clinically relevant mycobacterial species directly from specimenKuespertKatharina
2994Identifying gaps in diagnosis and treatment for latent tuberculosis infection: a tertiary hospital experience, 2010-2020Grijota-CaminoMaria D.
301Xpert MTB/RIF Ultra with trace results on pulmonary specimens: results from repeat specimens for Xpert MTB/RIF Ultra and TB cultureBlackMarianne
3052Bone marrow tuberculosis in an immunocompetent patientRossiBenedetta
3158Bedaquiline resistance: looking for the submerged part of the icebergFournier Le RayLaure
3191Clinical experience with tuberculosis and immune reconstitution-inflammatory syndrome in patients treated with anti-tumour necrosis factor-αArenas Mirasmaria del mar
3202Tuberculous aortic pseudoaneurysm: a case reportAlves BrancoElsa
3259MDR Mycobacterium abscessus skin and soft tissue infection following autologous fat grafting in a cosmetic tourist to Kurdistan treated with an antibiotic combination including imipenem-relebactam and rifabutinBeechAlison
3291Dysglycaemia among tuberculosis patients without known diabetes in DenmarkJørgensenAnja
3296Mycobacterium tuberculosis urinary LAM antigen in patients with CD4 count above 200 cells/μLDambulaFelix
3302Multi-country validation of RISK6, a 6-gene transcriptomic signature, for tuberculosis diagnosis and treatment outcome monitoringBayaaRim
3379Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysisGentileValeria
3431Polymorphisms in antibiotic resistance genes between Mycobacterium bovis and Mycobacterium bovis bacillus Calmette-GuérinFlorouZoi
365Combined delamanid-bedaquiline regimen for 12 months in patients with pre-XDR-TB: safety and efficacy in a limited cohortPrivolnevVladislav
3693Modern solutions for an ancient pathogen: whole-genome sequencing for diagnosis of lepromatous leprosyYoungBernadette
3747Dual RNA sequencing of Mycobacterium avium-infected human macrophages identifies characteristic host-pathogen interactionsSchildkrautJodie
3837Evaluation of the new Xpert® MTB/RIF Ultra assay for detecting tuberculosis in extra-pulmonary specimensReina RodríguezMaría José
3847Breast tuberculosis in North West London: a case series over 10 yearsBarnacleJames
3972Complications of Mycobacterium chimaera infectionEdwardsFrances
3979Thyroid tuberculosis: an unusual locationLopes FigueiredoCarlos
3983Tuberculous otitis media: a treatable cause of irreversible hearing lossLopes FigueiredoCarlos
3997Congenital tuberculosis after in vitro fertilisation: first two cases in Spain and review of the literatureLagarejos GonzalezEduardo
4003Case report: same-day identification and genotypic antibiotic susceptibility testing of Mycobacterium avium from positive blood culture bottleCamaggiAnna
4007A curious case of multidrug-resistant tuberculosisGranadoJoana
4024Association of cyclin-dependent kinase 6 (CDK6) and its upstream miRNAs with tuberculosis susceptibility in a Chinese populationBaiHao
4043Change in the epidemiology of mycobacteria: focused on Mycobacterium abscessusFraile TorresArturo Manuel
4058Seasonality of pulmonary tuberculosis in a tertiary university hospital in MadridEstebanJaime
4064Can we improve case finding of  MDR-TB in South Kivu in Democratic Republic of the Congo?MoranConor
4085Diagnostic accuracy of stool among adults with pulmonary tuberculosis: a systematic review  Lomholt LaursenLine
4166Mutations in genes implicated in antibiotic resistance in Mycobacterium africanum could be phylogenetic and are not associated with adverse clinical outcomesWestonnatasha
4178Neutrophil-dependent secretion of the biomarker LRG1 in tuberculosisKutschenreuterJulia
4195Evaluation of patients diagnosed with multiple sclerosis in whom ocrelizumab treatment was initiated in terms of latent tuberculosis reactivation PullukcuHusnu
423Urogenital tuberculosis in married females with recurrent UTINagiNazia
4272Features of pathogens of bloodstream infections in HIV-positive patientsPanovaAnna
4359Tuberculous pericarditis: a case reportGavaldà MansoMeritxell
4413Prevalence of latent Mycobacterium tuberculosis infection in haematopoietic stem cell transplant candidates, comparing tuberculin skin test and fourth generation interferon-gamma release assayCastro-LimaVictor
4425Impact of COVID-19 pandemic on finding of new cases of pulmonary tuberculosis in Kharkiv, UkraineKonstantynovskaOlha
4433Case report of Tuberculous Meningitis in an immunocompetent patient: a diagnostic challengeAlves SilvaPedro Gonçalo
4462An “innovative” use of a commonly and widely available diagnostic test QuantiIFERON® to help clinicians in the diagnosis of haemophagocytic lymphohistiocytosisRussoCristina
4489Non-tuberculos mycobacteria as emerging infectious disease in patients with common variable immunodeficiencyRussoCristina
4521An “innovative” use of a commonly and widely available diagnostic test QuantiFERON to help clinicians in the diagnosis of haemophagocytic lymphohistiocytosis (HLH)RussoCristina
4690Discordance between molecular and culture-based susceptibility test in MDR-TB: a challenge in clinical practiceCruz-CalderónStefania
4829Diabetes mellitus with pulmonary tuberculosis is characterised by a pro-inflammatory response, up-regulated matrix metalloproteinases and dysregulated angiogenic factors: data from a cellular model and human cohortThongPei Min
4876The susceptibility to Mycobacterium tubercolosis: immunological and nutritional profiles in a paediatric cohort De LucaMaia
4934Matrix metalloproteinase and neutrophil extracellular trap upregulation in human and murine central nervous system tuberculosis: targets for host-directed therapy to improve immunopathologyPohXuan Ying
537Prevalence of diabetes mellitus in patients with tuberculosis: a prospective cohort studyBuasroungPanyachot
650Clinical aspects of tuberculosis in sickle cell disease patients: a retrospective comparative studyHouistAnne-Laure
796Diagnosis of Coxiella burnetii infection via metagenomic next-generation sequencing: a case report ZhangJingjia
804Diagnosis of tuberculosis by interferon-gamma releasing assay (IGRA): new chemiluminiscence immunoassay (CLIA) versus enzyme-linked immunospot assay (ELISPOT)Mendoza CedielPablo
830Predictors of all-cause mortality in tuberculosis in a Malaysian university tertiary hospitalChooSarah Qian Rou
866Liposomal amikacin (ALIS) efficiency against intracellular Mycobacterium abscessusVincentLe Moigne
906Rifabutin is active against clinical isolates of Mycobacterium abscessus LiBing
910In silico and in vitro screening of PafA inhibitors as antimycobacterial agentsKanHung-Lin
913MAB_2355c confers macrolide resistance in Mycobacterium abscessus by ribosome protectionGuoQi
927Antibacterial Peptide RP557 increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formationChuHaiqing
938The relationship between mental health and risk of active tuberculosis: a systematic reviewHaywardSally E
942Genotypes and associated factors of non-tuberculous mycobacteria among adult human immunodeficiency virus positive patients with presumptive pulmonary tuberculosis at National Tuberculosis and Leprosy Training Centre, Zaria, NigeriaMohammedZakariya
99Comparative evaluation of Standard E TB-Feron ELISA and QuantiFERON-TB Gold Plus assays in patients with tuberculosis and healthcare workersYooIn Young
Abstract NumAbstract titleLast nameFirst name
1020Ceftazidime-avibactam for the treatment of infections by Klebsiella pneumoniae carbapenemase (KPC)-producing Gram-negative bacilli in severely immunosuppressed patientsRearteAndres Nicolas
1022Short treatments for Gram-negative bacilli bacteraemia in neutropenic patients: towards the new paradigmRearteAndres Nicolas
1060Long-term mortality and cause of death following Gram-negative bloodstream infection: a propensity matched 5-year observational linkage studyMcnamaraJohn F
1166Prospective evaluation of septic shock patients in a tertiary care educational university hospital: a series of 1088 casesAkyolDeniz
127A case series on melioidosis in Cardinal Santos Medical Center, PhilippinesAlbayChristessa Emille
1333A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of sepsisD'onofrioValentino
1436Predictors of mortality in Staphylococcus aureus infective endocarditis (SAIE): a continuous challengeNacinovichFrancisco Manuel
1466Splenic macrophages as the source of bacteraemia during pneumococcal pneumoniaOggioniMarco Rinaldo
1476Epidemiological and clinical features of invasive extraintestinal pathogenic Escherichia coli disease in patients admitted in tertiary care hospitals: a retrospective, multi-centre, observational cohort studyDouaJoachim
1486Gut barrier dysfunction and the risk of ICU-acquired bacteraemiaVarkilaMeri
1502Retrospective multi-centre study on Campylobacter spp. bacteraemia in 34 French hospitals : the campylobacteraemia studyTinévezClaire
1599Eosinophilia as a marker of prosthetic valve endocarditis and aortic root abscess due to Trichosporon mucoidesBoodmanCarl
1603Estimation of the sepsis burden in France between 2015 and 2019 based on the French national hospital discharge databasePandolfiFanny
1625HEMOFAST randomised controlled clinical trial evaluating the benefit of rapid multiplex PCR for the management of sepsis: results of intermediate analysisCasparYvan
1670Sepsis awareness at the hospital level: a survey-based cross-sectional studyMeylanSylvain
1914Mitral endocarditis by Abiotrophia defectiva: an unusual two-case series in MajorcaOlmos TorresAlexandre
1988Stroke-like presentation of pneumococcal meningitis: a case seriesPaglianoPasquale
2025Diarrhoeagenic enteroaggregative extended-spectrum β-lactamase Escherichia coli causing bacteraemia in BelgiumVanstokstraetenRobin
2137Impact of type of antibiotic treatment on the outcomes of Enterococcus faecium bloodstream infectionsBartolettiMichele
2172Clinical and genomic characterisation of invasive Salmonella infections in patients with haemoglobinopathyAl-HamadArif M.
2233Individualising the use of [18F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteraemia: experiences from a tertiary care centreKouijzerIlse
231Antistaphylococcal penicillins versus cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentric studyLefèvreBenjamin
2349Uncomplicated Staphylococcus aureus bacteraemia: partial oral treatment is comparable to fully parenteral treatmentMooneyHannah
2360C-reactive protein to exclude complicated pneumococcal disease manifestations in adultsSerbéeMilou
2364Bacteraemia in pediatric acute leukemia patientsBechirAchour
2435Bacteraemia in adult acute myeloid leukemia patientsBechirAchour
2538Characterisation of sepsis inflammatory endotypes using circulatory proteins in sepsisRicaño-PonceIsis
2539Relationship between Streptococcus gallolyticus subsp. gallolyticus, Enterococcus faecalis and colorectal neoplasms in recurrent endocarditis: a historical case seriesMiró MedaJosé M.
2585Implementation of blood cultures in the Ebola Virus Disease (EVD)-care response in North Kivu, Democratic Republic of the Congo: results of a pilot studyKalemaJocelyne
2643Polymicrobial bacteraemia at a tertiary care hospital in Northen SpainFayosMarina
2665Group A streptococci invasive disease in Portuguese children: a nationwide retrospective study between 2010 and 2019RomanaAndreia
2669Clinical outcome and predictors of mortality of infections caused by MDR Acinetobacter baumannii in intensive care unit: an observational studyD'avinoAlessandro
267Infective endocarditis: evaluation of 178 casesAkyolDeniz
2683A review of the epidemiology, risk factors and control measures for single cases and outbreaks of invasive group A streptococcal infection (iGAS) in care homes and nursing homes for the elderly in the east of England: January 2010 to January 2020KapadiaSmita
2755Staphylococcal endocarditis: Staphylococcus aureus versus coagulase-negative staphylococciBonnetEric
2801Trends in invasive group A streptococci in Serbia over a ten-year periodGajicIna
2861Predictors of re-hospitalisation following discharge of patients with Gram-negative bacteraemia: a retrospective cohort studyPoratYanay
2934Impact of neutropenia on clinical manifestations and outcome of Staphylococcus aureus bloodstream infection: a propensity score-based overlap weights analysis in two large, prospectively evaluated cohortsCampJohannes
295Loss of miRNA-132/-212 function does not influence the clinical course of severe Escherichia coli sepsis in miceSchützeSandra
3013Bacterial and patient risk factors for adverse outcomes with Escherichia coli causing bloodstream infections in North West London: a prospective studyJauneikaiteElita
3120Comparing procalcitonin with C-reactive protein as adjunct biomarkers for diagnosis of bacterial infections in the emergency departmentSørensenMorten Børge
3151Time to blood culture positivity as an independent predictor of mortality in patients with Pseudomonas aeruginosa bacteraemiaRoloMarta
3171Non-HACEK Gram-negative Bacillus endocarditis: a multi-centre retrospective case-control studySebillotteMarine
3319A systematic review of infective endocarditis by Enterobacter cloacaeIoannouPetros
3374Retrospective study of the clinical and microbiological outcomes of the management of Pseudomonas aeruginosa bacteraemia with the standard doses of piperacillin/tazobactam and ciprofloxacin based on EUCAST susceptibility testing criteria of 2019PatelDipti
3450Streptococcus anginosus group: bacteraemia epidemiology in a Spanish tertiary hospitalPascual Del Riquelme BabéAlfonso José
3453Bloodstream infections caused by extended-spectrum ß-lactamase-producing Klebsiella pneumoniaeSeija ScaroniVeronica
3508Differences between infectious and inflammatory aortitis: a multi-centre retrospective regional studyCarrerMathilde
3512Using causal inference to identify potential biomarkers of sepsisCoutoBráulio
3549Assessment of a cellular host response test in risk stratification of patients presenting to the emergency department suspected of COVID-19 or other respiratory infectionsSheybaniRoya
3564Multi-centre antimicrobial susceptibility testing of EBL-1003 (apramycin) in clinical isolates from paediatric and adult sepsis patients in South-East AsiaGysinMarina
359Anaerobic bacteraemia: aetiology and antibiotic susceptibility profile during a 6-year periodAguirre QuinoneroAmaia 
3615Klebsiella pneumoniae invasive syndrom: case reportHusaPetr
3670“Fishbone” Vibrio vulnificus induced septic shock in a chronic lymphocytic leukemia with autoimmune haemolytic anemia patientTandocGayle Francez Monique Yao
3706Current analysis of fatal left-sided infective endocarditis in adults: a 10-year single centre experienceBlanco ArévaloAlejandro
3744A qualitative study exploring pre-hospital patients delays in seeking care for symptoms of bloodstream infectionsRuffinFelicia
3780Prospective evaluation of septic shock patients with bacteraemia in a tertiary care educational university hospital: a series of 165 bacteriological culture-confirmed casesAkyolDeniz
3790A case report: native-valve endocarditis caused by Achromobacter xylosoxidans. Failure of meropenem treatmentVelíškováZuzana
3800Significance of single positive blood cultures for Enterococcus species in a university hospital in East of EnglandAbiriOyekola
3897Daptomycin-induced eosinophilic pneumonia, a case reportPacePier Giorgio
3918Is analysis of procalcitonin levels useful in Gram-negative bacteraemia?MullaneNiamh
3920Short- and long-term mortality by vancomycin‐resistant enterococci infections in fragile and non-fragile population: a meta‐analysis Pezzanimaria diletta
3949An unusual case of Aerococcus urinae infective endocarditis complicated by beta-lactam induced neutropenia and a bleeding cerebral mycotic aneurysmBeechAlison
3995A descriptive study of patients included in Code SepsisGranero SalasMaría Teresa
407Serotype distribution, clinical presentation and resistance phenotype of group B streptococcus causing invasive infection in Lleida, SpainMuñozAlba
4071Direct linkage between the prevalence of known common ExPEc Escherichia coli sequence types in UK sewage to those causing Escherichia coli UTI and sepsisTolemanMark Alexander
4086Bloodstream infections caused by multidrug-resistant Gram-negative bacilli: results from a nationwide study in Italy (ALARICO Study)FalconeMarco
4150How much does empirical treatment cover infectious agent(s) of septic shock in a tertiary care educational university hospital? An analysis of 486 culture-confirmed casesAkyolDeniz
4183Host biomarkers performance for distinguishing bacterial from non-bacterial infections in febrile non-severe patients from LMICsFernandez CarballoBlanca Leticia
4289Community-acquired bacteraemia in very elderly patients: a prospective single-centre studyVoutsinasPantazis-Michael
4353The prevalence and clinical characteristics of Moraxella spp. bacteraemia in adults and children from a regional UK laboratoryTomlinsJennifer
4356The potential impact on clinical decision making times of direct identification of bacteria in positive blood cultures using a FilmArray™ panel compared to conventional automated identification and antimicrobial susceptibility testing: a pilot studyRathishBalram
4393Changing epidemiology of bacteraemia in the COVID-19 pandemicDe CarloChiara
4422Septic shock diagnosed in the emergency room versus septic shock diagnosed inside hospital wards or intensive care units: an analysis of 1088 casesAkyolDeniz
4430The relationship between the new taxonomy of Streptococcus bovis and pathology of colon cancer, endocarditis, and biliary diseaseGarcía ColladoYolanda
4446Complement deposition on extracellular vesicles in plasma of septic patients as a potential novel biomarker for sepsisHuberSilke
4504Development and validation of the BLOOMY prediction scores for 14-day and 6-month mortality for bloodstream infections: a multi-centre, prospective, cohort studyTacconelliEvelina
467Procalcitonin-guided antimicrobial therapy in sepsis as a mechanism to preserve gut barrier function: results of the PROGRESS randomised clinical trialKyriazopoulouEvdoxia
502How representative is a Point-of-Care randomised trial? Clinical outcomes of patients excluded from a Point-of-Care randomised controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multi-centre prospective observational cohort studyRosselAnne
4713High levels of monocytic myeloid-derived suppressor cells are beneficial in sepsis patients with MODSSchrijverIrene T.
54Variability in size and volume of red blood cell and platelet: a pragmatic diagnostic biomarker to neonatal sepsisKhadkaPriyatam
612Aerococcus urinae: a rare cause of aortic root abscessTiongChong Wei
664Evaluating the impact of the Accelerate PhenoTest® BC Kit on patients with bloodstream infections receiving ineffective empirical antibiotic treatment: IOAS study experience of 4 hospitalsMacvaneShawn
682Molecular characterisation of group A streptococcus causing invasive infectionMuñozAlba
684Staphylococcus aureus bacteraemia (SAB): an ounce of intervention leads to tonnes of improvement in clinical outcomesAlburMahableshwar
745Bacteriological profile of central line-associated blood stream infections (CLABSI), with specific reference to biofilm formation and resistance pattern, and their correlation with response and outcomeArunanBharathi
813Mortality in patients with Escherichia coli bacteraemia and presentation as sepsis/septic shock: contribution of microbiological factorsMaldonadoNatalia
840Microbiology data from a global multi-centre prospective observational cohort of sepsis in hospitalised neonates: the NeoOBS studyKostyanevTomislav
932Monocyte distribution width for the diagnosis of sepsis and infection in the emergency departmentCusinatoMartina
986Early signaling of kidney injury in septic patients by using urinary neutrophil gelatinase-associated lipocalinLevinsonTal
Abstract NumAbstract titleLast nameFirst name
1161Predictors of long-term outcomes in older adults with community-acquired pneumoniaSaltogluNese
1193Bacterial epidemiology changes on cystic fibrosis patients between 2009 and 2019 in a tertiary hospital in MadridNavarro LaraEva
1301Descriptive study of Legionella pneumonia in a tertiary hospitalGonzález BoresPaula
1317Evolution and distribution of pneumococcal serotypes in adults hospitalised with community-acquired pneumonia (CAP) in Spain from 2011 to 2018 using the UAD1/2 test: the CAPA studyTorresAntoni
1338Incidence and aetiology of ventilator-associated tracheobronchitis: a prospective study in ICUs of two tertiary care hospitalsMukherjeeDip Narayan
135Community-acquired pneumonia secondary to Dermacoccus nishinomiyaensis infection: a case reportOgbacMartin Kristoffer
1381In vitro activity of lefamulin against Staphylococcus aureus and Haemophilus influenzae, common pathogens in cystic fibrosis (CF), collected from non-CF paediatric patients (SENTRY Surveillance 2015-2019)PauknerSusanne
1462Estimating the incidence of acute lower respiratory tract disease including pneumonia and lower respiratory tract infection in Bristol, EnglandHyamsCatherine
1463Use of urinary pneumococcal antigen test to improve antibiotic prescribing in community-acquired pneumoniaPečavarBlaž
1570Severe community-acquired pneumonia in the Czech RepublicBartosHynek
1686Invasive pulmonary aspergillosis-mimicking Legionnaires` disease in transplant recipientsKimJinyeong
1767The most prevalent pneumococcal serotypes causing community-acquired pneumonia in adults in Greece using urinary antigen detection test: the EGNATIA study, 2017-2019LiapikouAdamantia
1898Outpatient pneumonia treatment in a setting with and without an infectious disease doctorKusuljaMarija
1945The clinical impact of ultra-low-dose CT versus chest X-ray in patients suspected of community-acquired pneumonia at the emergency departmentVan EngelenTjitske S.R.
1951Differences in pneumococcal serotype distribution in hospitalised adults with community-acquired pneumonia between Spain and Greece (CAPA & EGNATIA studies), 2017-2019: Could different PCV13 vaccination policies account?LiapikouAdamantia
2076External validation of automated chest radiography algorithm for diagnosing pneumoniaZhangLufang
2281Is pertussis associated with worsened health condition in adult patients with chronic obstructive pulmonary disease (COPD)?Van Den SteenPeter
2283Impact of universal pneumococcal conjugated vaccine and SARS-CoV-2 pandemic in adult invasive pneumococcal disease in SpainGonzález DíazAida
2781Prevalence of atypical pathogens in SARS-CoV-2 co-infection in Argentina: finding what we were not looking forFavierPatricio
2800Clinical outcomes in SARS-CoV-2 and Mycoplasma pneumoniae co-infected inpatients: is this co-infection a new challenge?FavierPatricio
3009Pneumococcal serotype distribution in adult population in Russia: results of the SPECTRUM studyKozlovRoman
3016Oxygen consumption by cellular aerobic respiration in sputum from patients with acute lower respiratory tract infectionKolpenMette
3068Latent class analysis-based subgroups of patients with community-acquired pneumonia and differential response to adjunctive corticosteroid treatmentWittermansEsther
315Sepsis in relation to lymphopenia in community-acquired pneumoniaCilloniz CamposCatia
3246Pneumonia outcomes in obese and non-obese patients treated with ertapenemWardlowLynn
3278Enhanced surveillance of Legionella species and Legionella pneumophila infections in patients through qPCR testing in response to COVID-19 in EnglandStaffordEleanor
3321Incidence rate of community-acquired pneumonia in adults: a 5-years population-based prospective active surveillance study in ArgentinaCisnerosVeronica
3356Comparison of body composition, physical capacity, and immuno-metabolic profile of hospitalised patients with community-acquired pneumonia caused by COVID-19, influenza and bacteriaRyrsøCamilla Koch
3464Pneumococcal disease in Ecuador: clinical characteristics, serotype distribution and antimicrobial resistance patternsSalazar TamayoGrace Johanna
3531Significant increase in healthcare resource utilisation and associated costs of pertussis infections in adults with asthma: a retrospective database study in EnglandBhavsarAmit
3547Applicability of direct antimicrobial susceptibility testing of respiratory samples in patients with severe lower respiratory tract infectionRomero HerreroDANIEL
3601From a Legionnaires’ disease-missed diagnosis to a Saprochaete clavata disseminated fulminate diseaseCaldasJoão Paulo
3634Incidence of all-cause and pneumococcal pneumonia in Tennessee and Georgia, USA, 2018-2020: results from the PNEUMO StudySelfWesley
3665Epidemiology of pneumococcal infections in chronic obstructive pulmonary disease patients (2017-2019)Fernández-DelgadoLucía
3811Evaluation of 16 urinary antigens tests for the detection of Legionella pneumophila serogroup 1 lipopolysaccharide subgroupsAllamCamille
4132Characterisation of the lung virome in patients with Legionnaires’ diseaseIbranosyanMarine
4247Genotypical similarity of Staphylococcus aureus isolates from patients with chronic sinusitisGibalaAgnieszka
4249Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care databaseHamiltonFergus
4260Association of prior lymphopaenia with mortality in pneumonia: a cohort study in UK primary careHamiltonFergus
4417Severe сommunity-acquired pneumonia in real-world practice in RussiaRachinaSvetlana
461Invasive pneumococcal disease among adults in Germany: impact of infant vaccination and COVID-19 pandemicVan Der LindenMark
527Chest CT presentation of Coxiella burnetii community-acquired pneumonia compared to Streptococcus pneumoniae pneumoniaDe La PorteClémentine
615Burden of sick leaves associated to all-cause community-acquired pneumonia in working adult population in Spain: age, risk of pneumonia and setting as drivers of costRejas-GutiérrezJavier
616Economic healthcare burden of all-cause community-acquired pneumonia in adults by age, risk and setting in real-world data in SpainRejas-GutiérrezJavier
720Clinical effectiveness of amoxicillin dose and duration in childhood community-acquired pneumonia in the United Kingdom and Ireland: a pragmatic randomised controlled trial (CAP-IT)BielickiJulia Anna
934Ceftaroline fosamil real-world use patterns and treatment outcomes in adult patients hospitalised with community-acquired pneumonia: a multinational, retrospective studyAnsariWajeeha
Abstract NumAbstract titleLast nameFirst name
1091Evaluation of nanobiosensor based on Surface Plasmon Resonance (SPR) of gold nanorods for rapid detection of Vibrio cholerae genome in water samplesBakhshiBita
1491Faecal microbiota transplantation is effective for post-colectomy recurrent Clostridioides difficile infectionChoJanice
1494Individualised autovaccine immunisation reduces recurrences and improve quality of life in women with recurrent urinary tract infections (rUTI)Diaz Brito FernandezVicens
1569C1q but not TLR4 gene polymorphism is associated with asymptomatic bacteriuria in patients with type 2 diabetes mellitusIoannouPetros
1663Liver perfusion with enhanced antibiotics reduce donor-derived infection after liver transplantationLiuJianrong
1678Treatment efficacy of narrow-spectrum antibiotics in patients with community-acquired urinary tract infections in a secondary hospitalTanYao Xiang
1680Syphilis diagnosis and linkage to care following implementation of an emergency department-based screening programFordJames
1730Recurrent mild Salmonella infections are a potential environmental risk factor for colon cancerDuiijsterJanneke
1737Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracyTer HorstLiora
1738Influence of prophylactic treatment on the quality of life and symptoms control in women with recurrent urinary tract infectionsArenas Mirasmaria del mar
1935Clinical specificities and outcome of enterococcal liver abscesses: analysis of 68 cases among a French cohort of 359 pyogenic liver abscessesOliosiEmma
2100Urinary levels of IP-10 and CRP are elevated in urinary tract infections in children: a prospective cohort studyAshkenazi-HoffnungLiat
2167Chlamydia trachomatis and Neisseria gonorrhoae reinfections in France: retrospective study between 2017 and 2021Trombert PaolantoniSabine
2253A direct from urine specimen lipid-based MALDI-TOF MS diagnostic for Gram-negative pathogensYangHyojik
23Corynebacterium coyleae in urine, a contaminant: yes or no?BravoRiquelme
2304Sexually transmitted infections prevalence, co-infections analysis and patients follow-up through a multiplex PCRMunoz DavilaMaria José
2390The role of cephalexin in the treatment of recurrent urinary tract infectionsRico CaballeroVeronica
2404A retrospective analysis of Aeromonas gastrointestinal infection and its influence in inflammatory bowel diseaseBarbosa NevesSara
241Risk factors and birth outcomes associated to congenital syphilis in a single hospital from Buenos Aries, ArgentinaBrizuelaMartin
2496Considerations that underlie non-adherence to guidelines for managing urinary tract infections in nursing homes: a qualitative interview studyKuilSacha Danielle
2805Antibiogram profile of Escherichia coli isolated from urine cultures in a tertiary care hospital in IslamabadUmairMasab
2913Predictors and incidence of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in patients with sterile pyuriaAggarwalAnivita
2921Gonococcic urethritis: a review of cases diagnosed over 10 years at a tertiary care hospital in Zaragoza, SpainCondadoHector
3026Aetiological diagnosis of Genital Ulcer Disease in the Health Department of Valencia La Fe (Spain)García HitaMarta
3097Detection and association between Mycoplasma hominis and bacterial vaginosis in patients from the health area of ​​Hospital La Fe (Valencia, Spain)García HitaMarta
3167Evaluation of the prevalence of Aeromonas spp. and Clostridium difficile in children with diarrhoea associated with immunodeficiencyShamsSaeed
3182Virulence characteristics and cell death alteration of hypervirulent Klebsiella pneumoniae in Korean isolatesKimHyun Ah
3248Arcobacter butzleri associated with gastroenteritis: experience of a teriary centre in BarcelonaNadal-BarónPatricia
327Female lower genital tract infections due to Neisseria meningitidis in Athens, Greece, over the last two yearsTsakalosAnastasios
3320Chlamydia trachomatis in outpatients in North Rhine-Westphalia, Germany: a five-year retrospective study (2015-2019)GriegoMarcena
3663Evaluation of the new FluoroType® STI for detection of pathogens causing sexually-transmitted infectionsBogaJose A
3674Are current PCR methods sensitive enough to detect Streptococcus agalactiae in vaginal and rectal swabs?Brzychczy-WlochMonika
3789Acidic urine pH effect in the kidney infection by uropathogenic Escherichia coli strains in a murine urinary tract infection model.Herrera EspejoSoraya
3845Empirical treatment of uncomplicated urine infection in womenBenavides LanzasAna Maria
3856No Lockdown for sexually transmitted infectionsUrrutikoetxea-GutierrezMikel
3865Prevalence of STIs among asymptomatic users attending to Drassanes Exprés screening programmeNadal-BarónPatricia
3869Prevalence of chlamydia and gonorrhea by anatomical site of detection among asymptomatic patientsNadal-BarónPatricia
3879High azithromycin resistance rate in Mycoplasma genitalium anorectitisBertiValentine
3967Synergistic effect of phages with doxycycline for the treatment of Escherichia coli causing a genitourinary tract infectionCestaNovella
3991Syphilis: not only genital chancresUrrutikoetxea-GutierrezMikel
4245Campylobacter spp: a two-year review in a northern Portugal hospitalSouaaSara
4354Genome-based epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Spain: a prospective multi-centre studySalmerónPaula
4360Low prevalence of enteroaggregative Escherichia coli and verocytotoxigenic E. coli in asymptomatic schoolchildren in Madrid (Spain) but evidence of school transmissionSánchez-PrietoSergio
4455Higher gonococcal bacterial load in Mycoplasma genitalium co-infectionVan DijckChristophe
4470Epidemiology of infectious anorectitis in a French cohort of men who have sex with men in 2020GündüzGuillaume-Azad
4605Assessment of bacterial ecology in emphysematous pyelonephritisSaadiMohamed
4612Assessment of medical and surgical management of acute obstructive pyelonephritis caused by extensively drug-resistant enterobacteriaSaadiMohamed
4699Detection of macrolid-resistant Mycoplasma genitalium in sexually transmitted infections screening programme in Tarragona, SpainGutiérrez-FornésCristina
483British Infection Association Guideline for clinical management of enteric fever in EnglandMccannNaina
4857Sexual genotypes of Chlamydia trachomatis in university students from four large cities in the Brazilian Amazon regionBrasilienseDanielle
4862High prevalence of sexual infection and distribution of Chlamydia trachomatis genotypes in young women from Marajó Island, in the Brazilian AmazonBrasilienseDanielle
4885Acute pyelonephritis of pregnancyLarbi AmmariFatma
4897Prospective study of macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Murcia, SpainTrueba ArgamasillaAndrea Amparo
494Trends in the incidence of syphilis between 2014 and 2019 in our health area and its association with HIVPérez JiménezRita Desirée
513Epidemiology of pyogenic liver abscesses in GermanyZimmermannLisa
529Associations of Yersinia enterocolitica infection with autoimmune thyroid diseases: a systematic review and meta-analysisZangiabadianMoein
597Sexually transmitted diseases during the COVID-19 pandemic in MálagaMartinez PerezRocio
677Epidemiological study and antimicrobial sensitivity of isolated Neisseria gonorrhoeae in the East healthcare area of Valladolid: Period 2016-2020Cantón BenitoElena
8Trends in antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in Greek women, 2015-2020VassalosConstantine M.
845Mycoplasma genitalium: evidences and figures in a tertiary hospital in SpainGarcía-LechuzJuan Manuel
908Microbial infections and Parkinson’s disease: a systematic review and meta-analysisSharmaAkash
930Fosfomycin non-inferior to ciprofloxacin as oral stepdown treatment for Escherichia coli febrile urinary tract infection in women: a randomised, placebo-controlled, double-blind, multi-centre trialTen DoesschateThijs
952Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors for multidrug resistanceGarcia-BustosVictor
988Epidemiological and clinical characteristics of patients with Campylobacter bloodstream infection: a retrospective case-control studyTauS140


Abstract NumAbstract titleLast nameFirst name
1019C-reactive protein kinetics differentiate viral from bacterial aetiologies of central nervous system infectionsLevinsonTal
1182Management of intracerebral abscess: it is a “no brainer”!AlburMahableshwar
1225Pseudomonas guariconencis isolation from necrotic trauma: the emergence of a new human pathogen?SpyridopoulouKalliopi
1639Ventriculitis: a severe complication of central nervous system infectionsLuque PazDavid
2049Retrospective effectiveness study of dalbavancin and other standards of care of the same class (IV lipo- and glyco-peptides) in patients with acute bacterial skin and skin structure infections (ABSSSI): preliminary data analysisRuggieriAlessandro
2406Adult gonococcal conjunctivitis: prevalence, clinical features and complicationsCuesta ChascoGenoveva
2445Polycaprolactone nanofibrous mats incorporated with cefazolin-containing niosome nanoparticles: synergistic infection therapy and wound healingZafariMahdi
2448Campylobacter fetus cellulitis: a case reportPocinhoSara
2578Hyperbaric oxygen therapy (HBOT): Avoiding side effects with multidisiplinary evaluationTasbakanMeltem
2579Phenotypic and genotypic characterisation of Staphylococcus aureus strains isolated from bone and joint infectionsUnaliIlaria
269Nosocomial meningitis in a tertiary care educational hospital in Turkey: a perspective between 2006 and 2021AkyolDeniz
2693Comparative analysis between brucellar and pyogenic spondylodiscitisSmaouiFatma
2718Susceptibility profile of Nocardia species: A single-centre retrospective study of 124 patients: an Indian experienceMohammedIrfana
2743Primary cutaneous Nocardiabrasiliensis;infection: a case studySpiliopoulouAnastasia
286Does the amputation level influence the infectious outcome in diabetic toe osteitis? Comparing the transarticular (cartilage level) versus the transosseous amputation levels (bone level)UçkayIlker Hasan
2941Staphylococcus aureus from skin and soft tissue infections: molecular characterisation of isolates and clinical profiles of patients from the United Arab EmiratesSenokAbiola
313Carbapenem-resistant Klebsiella pneumoniae nosocomial meningitis in a tertiary care educational hospital in Turkey: a series of 14 casesAkyolDeniz
341Endotoxins: the uninvited guest in dental implants: an in vivo studyMoura TelesAna
3518Preliminary clinical sensitivity analysis of the QIAstat-Dx Meningitis/Encephalitis PanelSalaEster
4100Disseminated Nocardia farcinica infection: a reasonable suspicion, a challenging treatmentTomasoniDaniele
4135Impact of Staphylococcus aureus nasal carriage on staphylococcal infections in type 2 diabetes IoannouPetros
4177Not as rare pneumococcal focal intracranial suppuration GuillemLluïsa
4297Epiduritis in infectious spondylodiscitis: epidemiological and microbiological featuresAbdeljelilMeriam
4380Deep neck infections in paediatrics: a single-centre retrospective 6-year experienceMarianiMarcello
4423Microbiological profile’s study of diabetic foot infectionsAbidMaha
4427Cellulitis caused by Gram-negative bacteria: a retrospective study of 44 casesMudrovčićMonika
4552Diagnostic tools for neurosyphilis: a systematic reviewBoogGustavo
4689Infection with low pathogenic bacteria is associated with a higher diabetic foot amputation risk in the TOOL cohortGrambergMeryl
475Intravenous (IV) fosfomycin for treatment of severely infected patients (FORTRESS): an update from a European, multi-centre, non-interventional and prospective clinical studyLittyFelix-Alexander
4755Validation study of a methicillin-resistant Staphylococcus aureus (MRSA) risk assessment tool for skin and soft tissue infections (SSTIs) at St. Luke’s Medical Center, Quezon City, Philippines: a cross-sectional studySuacoJane
4756The association of amoxicillin and ceftriaxone is synergistic in vitro against Listeria monocytogenesMorettoFlorian
4930Treatment of primary brain abscessesJawadSarah
88Prevalence and predictors of Pseudomonas aeruginosa among hospitalised patients with diabetic foot infections: a multi-centre evaluationVeveMichael
9Swiss interprofessional guidance of good practice of acute and complicated diabetic foot infections and syndromes: a national projectUçkayIlker Hasan
Abstract NumAbstract titleLast nameFirst name
1088A pilot study revealing host-associated genetic signatures for source attribution and stress resistance of sporadic Campylobacter jejuni infection in EgyptSaifNehal Aasem
1152Tularemia outbreak in the South Moravia Region of the Czech RepublicHusaPetr
1208A case of atypical cat scratch disease in an Italian girlGardiniGiulia
1260Epidemiological, clinical and laboratory features of acute Q fever in a cohort of hospitalised patients in a regional hospital in Israel, 2012-2018FinnTalya
1386Salmonella Ball: a new player in Germany?FischerJennie
1445LIAISON®LymeDetect®: a new solution for the early diagnosis of Lyme borreliosis  GrassiBeatrice
1453Coxiella burnetii DNA in raw milk and raw milk products from sheep and goats in Apulia and Basilicata regions, South ItalyLa SalandraGiovanna
1464Evidence of cat-to-human transmission of Staphylococcus felisBroensEls M.
1574High incidence of phase I IgG seroconversion after an acute Q fever episode: implications for chronic Q fever diagnosisMerchante GutiérrezNicolás
162Does environmental water support the survival of Francisella tularensis, the aetiological agent of tularemia?HennebiqueAurélie
1862Changes in the epidemiology of leptospirosis in the UK in the era of COVID-19DuganChristopher
211How seasonality affects Leptospira spp. dissemination among freshwaters? A study from two districts of mainland PortugalOliveira FernandesMaria do Rosario
213No increased risk for non-Hodgkin`s lymphoma after Q fever: results from a 16 year retrospective population-based analysis incorporating 2007-2010 Q fever outbreak in the NetherlandsWeehuizenJesper
2229Listeriosis epidemiology in Gipuzkoa, Northern Spain: 2012-2020Vallejo RecunaPedro
2363First detection of Bartonella henselae and Bartonella clarridgeiae, and prevalence of Rickettsia felis, in cat and dog fleas from the Canary Islands (Spain)Abreu YanesEstefanía
2407Resistome analysis of manure-amended grasslandTyrrellCiara
274Group B streptococcus bacteraemia rates in Nakhon Phanom, Thailand, are 2-3 fold greater than in the United Kingdom and Singapore; the excess is due to ST283BarkhamTimothy
276Human pathogenic potential of ESBL-producing Escherichia coli from swine microbiomes in Cameroon and South AfricaFounouLuria Leslie
3073Intracellular Raman micro-spectroscopic characterisation of the morphoforms of Coxiella burnetii in a cell culture modelUngerNancy
3093Diversity of yersiniabactin in Klebsiella ornithinolytica from clinical and non-clinical settingsCoutoNatacha
3354Persistence of the biothreat agent Francisella tularensis in aquatic environment through a viable but non culturable (VBNC) stateBrunetCamille D.
3373Recurrent Campylobacter jejuni enteritis in a patient with common variable immunodeficiency over the course of eight years, 2010-2018IlktaçMehmet
3560Clinical manifestations and long-term outcome in adult patients with early Lyme neuroborreliosis: a retrospective cohort studyStupicaDasa
3686Whole-genome sequencing of verocytotoxin-producing Escherichia coli isolated in 2019 and 2020 in SloveniaTrkovMarija
3727Molecular epidemiology of Helicobacter pylori among residents and their environments in areas with high gastric cancer morbidity in JapanHoriuchiSaori
3756Staphylococcus pseudintermedius recovered from human infectious diseases: a summary of casesBlondeauLeah
3772Recovery of Staphylococcus kloosii from an ankle lesion of an 84 year old female patientBlondeauLeah
3778Diagnostic dilemma of leptospirosis in COVID-19 pandemicBatraPriyam
4113Preliminary bactericidal evaluation of a 10L transparent jerry can for solar disinfection of contaminated drinking waterSawantBhairavi
4222Early European Lyme neuroborreliosis: comparison between different clinical manifestationsOgrincKatarina
4232Differences in the frequency of the main clinical manifestations of early European Lyme neuroborreliosisOgrincKatarina
4275A multiplex qPCR to detect respiratory Chlamydiaand evaluate testingBesleyMatthew
4535Is the new automate VirClia® effective in screening in cat scratch disease?BarbryAlexia
4543Detection of Enterococcus spp. isolates from poultry origin with anti-Clostridium perfringens activityTorresCarmen
4683Lyme borreliosis: comparison of 4 IgG screening kitsTrombert PaolantoniSabine
4747A paediatric case of Acute Respiratory Distress Syndrome (ARDS) resembling COVID-19: don’t forget about the differential diagnosisRindiLorenzo
480Characterisation of internalin genes in Listeria monocytogenes food strains, and their association with the invasiveness in vitroIskraMateusz
4840Evidence for food-associated human infection: dissection of Klebsiella pneumoniae high-risk clone ST307 isolates from human and retail meatGarcía-MeniñoIsidro
4940A renal calculus acting as a nidus of infection for brucellosisBeechAlison
507Pasteurella multocida endocarditis with septic arthritis: a case report and review of the literatureCarterEmma
553Outbreak of Brucella melitensis traced to unregulated, commercialised camel milk with whole genome sequencingYagelYael
561The diagnostic significance of immunoglobulins class A in the diagnosis of Astrakhan rickettsial feverSmirnovaNina
569Treatment of erythema migrans with doxycycline for 7 days versus 14 days: a noninferiority randomised open-label studyStupicaDasa
570Association of statin use and microbiological and clinical characteristics of early Lyme borreliosisStupicaDasa
713Serogroup classification of Legionella pneumophila using transmission infrared spectroscopy and machine learningHalabiMilad
936Increased awareness and knowledge of Lyme borreliosis and tick bite prevention among the general population in France: 2016 and 2019 health barometer surveySeptfonsAlexandra
Abstract NumAbstract titleLast nameFirst name
1079Occurrence of Bartonella species and haemotropic Mycoplasma in pets and their associated fleas from East and Southeast AsiaZareaAya Attia Koraney
1159Neural injury and repair in a new neonatal mouse model of Listeria monocytogenes meningitis and meningoencephalitisSeeleJana
1816Treatment strategies for generalised tetanus: a retrospective study in a Chinese hospitalAnYuling
204Evaluation of three years implementation of CXCL13 for diagnosis of Lyme neuroborreliosis at the national reference centre for Lyme borreliosis in BelgiumDepypereMelissa
207Nocardiosis in children in GipuzkoaErcibengoaMaria
2118Identification of immunodominant Bartonella bacilliformis proteins for serodiagnostics and vaccine developmentDichterAlexander A.
2168Mycoplasma hominis isolates in respiratory samples: a retrospective observational study in a tertiary level hospital between 2006-2020Rojas DíazAdriana Carolina
2399Cytokine profile response of human peripheral blood mononuclear cells stimulated by Bartonella bacilliformisYmañaBarbara
2556Nocardiosis in immunocompromised patients: 2007-2020VempatiSwati M.
2912Characterisation of complete genome and transcriptome of capnophilic small colony variants in Escherichia coli ST131NguyenLe Phuong
3057The diagnostic challenge of abdominal actinomycosis: a review of five casesSequeira PintoAna Raquel
3380Combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysisChanjamlongNaphatsawan
349Post-transplant outcomes of Burkholderia-colonised patients among cystic fibrosis patients undergoing lung transplantation: a single-centre Canadian studyGauvreauAndrea
4435Azorhizobium caulinodans: first reports of human infectionPalop BorrasPurificacion Begoña
45Thyroglossal duct cyst infection due to Nocardia farcinica in a kidney and pancreas transplant recipientMinjaresRamon O.
4662Cranial neuropathy versus Bannwarth syndrome: a post hoc analysis of a retrospective cohort study of adult patients with early Lyme neuroborreliosis in EuropeStupicaDasa
469Almost fatal relationshipsDekelMichal
4727Disseminated Ureaplasma parvum in a hypogammaglobulinemic host BharathanBinutha
733Evaluation of early markers for the direct diagnosis of Lyme diseaseDolangeVictoria
985Epidemiology of  Lyme borreliosis and tick-borne encephalitis in Belarus (2000-2020)KniazevaVolha
Abstract NumAbstract titleLast nameFirst name
1028In vitro activity of dalbavancin and other anti-staphylococcal agents against infecting isolates of methicillin-resistant coagulase-negative staphylococciPapadimitriou OlivgerisMatthaios
1213Surveillance of antibiotic resistance among Clostridioides difficile in a Greek university hospitalStafylakiDimitra
1410The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in outpatients and inpatients in Slovakia: emergence of USA300, a pandemic community-associated MRSA (CA-MRSA) cloneTkadlecJan
1444Does antiseptic treatment select for daptomycin-resistant Staphylococcus aureusWendelAndreas Friedrich
1529In vitro evaluation of delafloxacin activity when tested against contemporary European acute skin and skin structure infections: results from the SENTRY antimicrobial surveillance programme (2018-2020)ShortridgeDee
160Vancomycin-resistant enterococci in the community: a prospective cohort study to determine prevalence, transmission and molecular epidemiologyGutherJulia
1616Activity of oritavancin and comparators against a contemporary collection of Enterococcus spp. clinical isolates from Europe (2015-2019)CarvalhaesCecilia G.
1626Oritavancin activity against Gram-positive pathogens causing bone and joint infections in European medical centres (2015-2019)CarvalhaesCecilia G.
1782In vitro antimicrobial susceptibility profiles of Gram-positive anaerobic cocci responsible for invasive human infectionsCattoirVincent
184Reduced susceptibility to chlorhexidine among Staphylococcus aureus isolates in Israel: phenotypic and genotypic tolerancePeretzAvi
1843Rifampicin resistance as a marker of multidrug-resistance in Staphylococcus epidermidis responsible for late-onset sepsis in neonatal intensive care unitsBourgeois NicolaosNadège
1854Absolute DNA counting by digital PCR can provide direct quantification of drug resistance genes relative to genomic targets to identify methicillin resistance in Staphylococcus spp. from clinical samplesBusbyEloise
186Mother-to-neonate transmission of antibiotic-resistant bacteria: a cross-sectional studyPeretzAvi
2139In vitro activities of ceftaroline and comparator agents against bacterial pathogens frequently causing community-acquired respiratory tract infections in patients from Latin America: ATLAS surveillance programme 2016-2019HackelMeredith
2163European regional analysis of the in vitro activities of ceftaroline and comparator agents against bacterial pathogens frequently isolated from patients with community-acquired respiratory tract infections: ATLAS surveillance programme 2015-2019HackelMeredith
2186In vitro activities of ceftaroline and comparator agents against bacterial pathogens collected from patients with skin and soft tissue infections in Europe: a regional analysis of results from the ATLAS surveillance program 2015-2019HackelMeredith
225Is MRSA/MSSA a contamination risk on surfaces of the dental equipment?PinaCristina
227Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: a population-level study, Japan, 2015-2018TsuzukiShinya
2336Characterisation of methicillin-resistant Staphylococcus aureus wound isolates in a tertiary care hospital in HungarySonnevendAgnes Maria
2440In vitro activity of ceftobiprole and dalbavancin against a collection of daptomycin-, linezolid-, vancomycin- and/or teicoplanin-resistant coagulase-negative staphylococci isolates from clinical samplesVeLasco De La FuenteSilvia
2495Dynamics of resistance in microorganisms isolated from patients in multidisciplinary hospitals during the COVID-19 pandemicZaytsev Andrey
252Antimicrobial resistance among Streptococcus pneumoniae clinical isolates during a 10-year period, in a tertiary hospital in Athens, Greece: a retrospective studyTsakalosAnastasios
264Five years of analysis of the in Vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programmeCarvalhaesCecilia G.
2828Changing profile of invasive disease-causing Staphylococcus aureus in AustraliaBainesSarah L
2856Livestock-associated methicillin-resistant Staphylococcus aureus isolated from the patients of an Italian hospitalMerlaCristina
3184Community-onset impetigo by methicillin-resistant Staphylococcus aureus: an unusual outbreak with resistance to fusidic acid and exfoliative toxin genesVendrikKaruna
3196In-host emergence of linezolide resistance in a complex pattern of methicillin-resistant Staphylococcus aureus colonisation in siblings with cystic fibrosisBoudetAgathe
3221Nine years of genomic surveillance of Staphylococcus aureus from blood cultures in a single hospitalPostiglioneUmberto
3225Clonal MRSA ST239 identification in a single neonatal unit: uses of whole-genome sequencing in the NeoOBS StudyVilkenTuba
3274Significant genetic relationship between Staphylococcus aureus isolates from hemodialysis patients and their household contacts: example of spread between hospital and communityMontoya UrregoDaniela
3395Clonal lineages of Staphylococcus pseudintermedius associated with skin and soft tissue infections in pets, PortugalMoraisCatarina
3478Antimicrobial susceptibility of staphylococci at the Department of Orthopaedic Surgery compared to cumulative University Medical Centre susceptibility data (Ljubljana, Slovenia)Maver VodicarPolona J
3592In vitro ceftobiprole combinations against Staphylococcus aureus and Enterococcus faecium with different resistance phenotypesRuedas LópezAlba
3650Methicillin-resistant Staphylococcus aureus (MRSA) invasive infections: epidemiology and risk-factors for mortality in bacteraemic patients in Porto Alegre, BrazilWürdig RicheCezar Vinícius
3729Detection of Staphylococcus aureus CC398-t1451, both MRSA and MSSA, in chicken-derived food samplesFernández FernándezRosa
3807In vitro susceptibility of fosfomycin in Aerococcus spp. isolated from urine samplesAngulo LópezItziar
4000Molecular characterisation of Staphylococcus aureus harboring Panton-Valentine leukocidin in community-acquired skin and soft tissue infections of Ecuadorian patientsPaz Y MiñoAriane
4040Continuous predominance of Clostridioides difficile ribotype 027 in MexicoGarza GonzalezElvira
4329Linezolid-resistant enterococci: findings from a large tertiary care centre in AustriaVan Den NestMiriam
4347Dissemination of the novel vancomycin-resistant Enterococcus faecium strain type ST117/CT71 in Germany: trends and challengesWeberRobert E.
4385Determination of a dalbavancin epidemiological cut-off value (ECOFF) for Enterococcus faeciumWernerGuido
4391Genomic and phenotypic analysis of linezolid-resistant Staphylococcus epidermidis in a tertiary hospital in Innsbruck, AustriaHuberSilke
4581A rapid and reproducible MALDI-TOF-based method for vancomycin resistance detection in Enterococcus faecium isolatesRodriguez-SanchezBelen
4606Emergence of methicillin-susceptible Staphylococcus aureus with decreased sensitivity to vancomycinDuarteFelipe Crepaldi
4718Spread of vancomycin-resistant Enterococcus faecium ST133 in flowing surface waters in SwitzerlandBiggelMichael
4896Whole-genome sequencing analysis of invasive Streptococcus pyogenes isolates from patients in Hunter New England Health District, New South Wales, AustraliaGreenEmily
51Epidemiology and molecular characterisation of linezolid non-susceptible Enterococcus spp. clinical isolates from the SENTRY antimicrobial surveillance program, 2017-2019CarvalhaesCecilia G.
586Susceptibility of Gram-positive clinical isolates collected in Europe during 2019 to ceftobiprole and comparators: analysis by region and countryHawserStephen
620Sensitivity of Mycobacterium tuberculosis in the basic health zone of Lleida (Spain) over a period of four yearsMuñoz SantaAlba
692Complicated carriage with methicillin-resistant Staphylococcus aureus (MRSA): evaluation of the effectiveness of decolonisation regimens advised in the national guidelineWestgeestAnnette
714Clonal lineages of Staphylococcus aureus isolated from wild rodents: first report of mecC-MRSA in PortugalSilvaVanessa
788Correlation of risk factors with the clinical presentation, microbiology and genetic profile of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin and soft tissue infections among patients attending a tertiary care hospital, Sri LankaPiyasiriDammalage Lasanthi Bhagya
970Characterisation and molecular analysis of a chimeric multiresistant Staphylococcusaureus strain with temperent and inducible bacteriophagesBurgold-VoigtSindy
Abstract NumAbstract titleLast nameFirst name
10Detection of extended spectrum beta-lactamase (ESBL) and carbapenem-resistant Klebsiella pneumoniae isolated from hospitalised patientsCarvalhoIsabel
1037In Vitro Activities of Ceftazidime-avibactam and Comparator Agents against Gram-negative isolates from China as Part of the ATLAS Global Surveillance Program 2019HackelMeredith
1041In Vitro activity of aztreonam/avibactam and comparator agents against Enterobacterales from Europe collected during the ATLAS Global Surveillance Program, 2015-2019KazmierczakKrystyna
1044In Vitro activities of aztreonam/avibactam and comparator agents against carbapenemase-producing Enterobacterales collected during the ATLAS Global Surveillance Program, 2015-2019KazmierczakKrystyna
1047Activity of meropenem-vaborbactam and comparators against European carbapenem-resistant Enterobacterales isolates without a carbapenemaseShortridgeDee
1048Activity of meropenem-vaborbactam and comparators against Pseudomonas aeruginosa isolates from patients with pneumonia in European hospitalsShortridgeDee
1087Association of combination therapy of tetracycline and colistin with lower mortality rates in patients with difficult-to-treat resistant Acinetobacter baumannii bacteraemiaKimSi-Ho
1137Surveillance report (ATLAS) on antimicrobial activity of β-lactam/β-lactamase inhibitors (BL/BLIs) and its comparator agents against Gram-negative bacteria from India, 2018-2019RoutrayAbhisek
1144Exposure to non-antimicrobial drugs and risk of urinary tract infection with drug-resistant EnterobacteriaceaeElbazmeital
1177Characterisation and evolution of resistance to ceftazidime/avibactam and aztreonam/avibactam in Enterobacter cloacae complex during 2018-2020 at the Hospital Universitario 12 de OctubreMartín-HigueraCarmen
1189Significantly higher antibiotic susceptibility and invasiveness of Klebsiella variicola in comparison to Klebsiella pneumoniae suggest species identification provides valuable information to cliniciansVoellmyIrene
1201Stenotrophomonas maltophilia and antibiotic use: a 10-year retrospective, laboratory-based surveillance study in a Hungarian tertiary care hospitalGajdácsMárió
1212Ceftazidime-avibactam: in vitro activity against Enterobacteriales and Pseudomonasaeruginosa in a cancer clinicGrigoryevskayaZlata V.
1228Rethinking optimisation of empiric Gram-negative therapy for pneumonia in intensive care units: we can do betterKlattMegan
1234VIM-2-producing Pseudomonas chlororaphis causing bloodstream infection in an infant patient in Brazil: a case reportCamargoCarlos Henrique
124The occurrence of hypervirulent Klebsiella pneumoniae strains harboring blaNDM/OXA-48 and CTX-M-15 in a clinical settingEl-BastawisieMaha
1241Comparison of the transmission and evolution pattern of ST11 and ST15 carbapenem-resistant Klebsiella pneumoniae infection in a surgery ward from 2016-2018ZhangYi
1255Prevalence and molecular characterisation of extended-spectrum-β-lactamase-producing Escherichia coli isolated from faecal samples of healthy individuals in JapanKaiSaito
1308First detection of CTX-M-27-producing Escherichia coli from humans in South AmericaBoncompagniSelene Rebecca
1328ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among Dutch veterinary healthcare workersMeijsAnouk
1365Rifampicin resistance associated with rpoB mutations in Neisseria gonorrhoeae strains isolated in Austria, 2017-2020SchaefferJustine
1370Genomic characterisation of high-level macrolide resistance in Campylobacter isolated in Austria, 2016-2020SchaefferJustine
1385Programming issues in automated resistance testing devices can falsely increase carbapenem-nonsusceptibility rates in MorganellaceaeVoellmyIrene
1492In vitroactivity of meropenem/vaborbactam compared to that of ceftazidime/avibactam against carbapenemase-producing Enterobacterales from SwitzerlandNordmannPatrice
1540Susceptibility of extended-spectrum β-lactamases (ESBL) and carbapenemase-producing Enterobacterales (CPE) to nitroxoline: a new candidate for difficult-to-treat uropathogens in ArgentinaPasteranFernando
1552Phylogenetic and bispecific mAb target analysis of Pseudomonas aeruginosa strains isolated from patients during the EVADE studyTaborDavid E
1563Activity of cefiderocol and comparators against European Enterobacterales including carbapenem-resistant isolatesShortridgeDee
1582Extended-spectrum cephalosporin resistance among wild bird isolates in GreeceZoiAthanasakopoulou
1588In Vitro activities of aztreonam/avibactam and comparator agents against metallo-β-lactamase-producing Enterobacterales collected during the ATLAS Global Surveillance Program, 2016-2019KazmierczakKrystyna
1590Relebactam increases susceptibility of Enterobacterales and Pseudomonas aeruginosa to imipenem in both imipenem-susceptible and imipenem-non-susceptible Gram-negative bacteria: Global SMART 2017-2019HilbertDavid
1591Activity of cefiderocol and comparators against US Enterobacterales including carbapenem-resistant isolatesShortridgeDee
1606Activity of cefiderocol and comparators against US isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia, including carbapenem-resistant isolatesShortridgeDee
1610Effect of carbonyl cyanide m-chlorophenylhydrazone on ciprofloxacin resistance and biofilm formation in Escherichia coli and Klebsiella pneumoniae causing hospital-acquired urinary tract infectionsEl-MahdyRasha
1622Dissemination of the mcr-1 gene among multidrug-resistant Escherichia coli from pigs and pork, Portugal, 2016–2019LeaoCelia
1644In vitro activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Pseudomonas aeruginosa and Enterobacterales collected from haematology and oncology patients in a nationwide study in SpainCercenadoEmilia
1666Azithromycin-resistant Neisseria gonorrhoeae: is bacterial culture-based AMR surveillance missing anything?AlharbiBushra
1723Therapeutical characterisation and functionality of a novel antibacterial endolysin, Lys1140, against multidrug-resistant priority pathogensNachimuthuRamesh
1729In vitro susceptibility of cefiderocol and comparators against resistant Gram-negative bacteria collected from Europe in the SIDERO-WT 2014-2019 surveillance programmeLongshawChristopher
1751Association of carbapenemase and 16S rRNA methylase in Enterobacterales clinical isolates from Switzerland between 2017 and 2020FournierClaudine
1754Diverse genomic background of both carbapenem- and colistin-resistant Klebsiella pneumoniae isolates in HungaryTothAkos
1779Contribution of RND efflux pump regulatory system AdeRS in susceptibility to chlorhexidine digluconate and glucoprotamin-based Incidin™ Plus in Acinetobacter baumanniiMeyerChristina
18Surveillance of ceftriaxone-resistant Salmonella enterica serotype Typhi across Pakistan and evaluation of healthcare worker knowledge and practicesNizamuddinSummiya
1804Natural course of colonisation with ESBL-producing Enterobacterales among hospitalised patients: a retrospective cohort studyStadlerRahel Noemi
1844Emergence and spread of XDR Providencia stuartii in UMHATEM “N.I. Pirogov”MalchevaMariya
187Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infectionsQuanfengLiao
1890Emergence of ST39 clone among KPC-producing Klebsiella pneumoniae isolates in GreeceGalaniIrene
1916Biological and genetic analysis of Pseudomonas aeruginosa international high-risk clone ST274Chichón De La FuenteGabriela
1956The change of Gram-negative microorganisms isolated from bacteraemias in febrile neutropenic attacks in patients with haematological malignancies by years: experience from a single centre, 15 yearAksoyFirdevs
2088Clonal expansion of colistin- and carbapenem-resistant Acinetobacterbaumannii belonging to the international clone II in SerbiaKabicJovana
2116Characterisation of the T156M amino acid substitution in the RND efflux pump regulator AdeS of AcinetobacterbaumanniiLucassenKai
2122In vitro activity of gepotidacin and comparators against a collection of Escherichia coli and Staphylococcus saprophyticus urine isolates collected from Europe during 2019-2020MendesRodrigo E.
2131Susceptibility of Burkholderia cepacia complex to ceftazidime/avibactam and standard drugs for treatment in cystic fibrosis (CF) patientsKahlBarbara
2193Antibiotic resistance profiles of clinical Acinetobacter species other than A. baumannii in animalsAttiliAnna-Rita
2279In vitro activity of ceftolozane/tazobactam against Enterobacterales and Pseudomonas aeruginosa from patients in intensive care units (ICU) in Asia: SMART 2017-2019KazmierczakKrystyna
2300Activity of ceftolozane/tazobactam against piperacillin/tazobactam-resistant and carbapenem co-resistant Pseudomonas aeruginosa: SMART Asia 2017-2019KazmierczakKrystyna
2325Characterisation of genetic determinants of plasmid encoding CTX-M β-lactamases and AmpC cephalosporinase among multidrug-resistant Salmonella spp. in BrazilCamargoCarlos Henrique
2350In vitro activity of ceftazidim/avibactam against 200 carbapenemase-producing Enterobacterales harbouring 36 different carbapenemasesAndersAgnes
2373Activity of ceftolozane/tazobactam against piperacillin/tazobactam-resistant and carbapenem co-resistant Pseudomonas aeruginosa from patients with respiratory tract infections in 6 Western European countries: SMART 2016-2019KazmierczakKrystyna
2378Predominance of OXA-48 carbapenemase and clonal relatedness in Klebsiellapneumoniae community isolates in Belgrade, SerbiaCirkovicIvana
2408Antimicrobial susceptibility to ceftolozane/tazobactam and comparators amongst Pseudomonas aeruginosa isolates collected from patients in hospitals in the Middle East & Africa: SMART 2017-2019KazmierczakKrystyna
2453Antimicrobial susceptibility to ceftolozane/tazobactam and comparators among Gram-negative isolates collected from patients in Morocco: SMART 2016-2019KazmierczakKrystyna
248Nationwide antimicrobial susceptibility surveillance of pathogenic Escherichia coli and Klebsiella pneumoniae isolated from infected inpatients against three carbapenems, tigecycline, and colistin in Vietnam from June to December 2019PhamHung Van
2480Emergence of Enterobacterales with co-expression of two carbapenemases during COVID-19 pandemic in Argentina: KPC+NDM, NDM+OXA-48 and KPC+IMPPasteranFernando
2482Emergence and dissemination of multidrug-resistant organisms in marine wildlife: a 3-year surveyM'zaliFatima
2485Susceptibility of ceftolozane/tazobactam among respiratory pathogens isolated in Latin America from 2017 to 2019: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)CardinalLeandro
2493Antimicrobial susceptibility to ceftolozane/tazobactam and comparators among Gram-negative isolates collected from patients in South Africa: SMART 2017-2019KazmierczakKrystyna
2498Antimicrobial susceptibility to imipenem and imipenem/relebactam among non-Morganellaceae Enterobacterales (NME) isolates encoding OXA-48-like enzymes collected globally from SMART 2017-2019YoungKatherine
2513Susceptibility testing of sulbactam/durlobactam and comparators against a representative national collection of Acinetobacter baumannii isolates from GreecePournarasSpyros
2529Antimicrobial susceptibility to ceftolozane/tazobactam, imipenem/relebactam and comparators among Gram-negative isolates collected from patients in the Balkan region: SMART 2016-2019KazmierczakKrystyna
256Prevalence of carbapenemase-producing Enterobacterales (CPE) isolates recovered from urine cultures in a tertiary hospital in Athens, Greece, over a five-year periodKontotezaIfigeneia-Vasiliki
2564Antimicrobial activity of cefepime in combination with taniborbactam (formerly VNRX-5133) against a european 2018-2020 surveillance collection of Pseudomonas aeruginosaHackelMeredith
2581Antimicrobial activity of cefepime in combination with taniborbactam (formerly VNRX-5133) against clinical isolates of Enterobacterales from Europe collected from 2018-2020 surveillanceHackelMeredith
2608Susceptibility of Pseudomonas aeruginosa to empiric therapy and alternative treatments in adult patients with respiratory tract infections in Canadian intensive care units: SMART surveillance (2016-2019)El AliRadwan
2653Comparative in vitro activity of ceftolozane/tazobactam, ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, and cefiderocol against Pseudomonas aeruginosa, including drug-resistant isolates at an academic medical centerKlattMegan
2733Sensitivity of selective agar plates for detecting carbapenem-resistant Pseudomonas aeruginosaShahabSelvi Nafisa
2734Synergistic bacterial killing elicited by simultaneous inactivation of Penicillin-Binding Proteins 2 and 3 (PBP2 and PBP3) in a resistance-deprived Acinetobacter baumannii (AB)WerkmanCarolin
2767Resistance profile of Bacteroides fragilis group isolated from clinical samples in Quito, Ecuador. Do they harbor the nim gene?ZuritaJeannete
2790Early-life exposures associated with children’s risk of ESBL-producing Enterobacteriaceae gut colonisation in an urban informal settlement of Lima, PeruNadimpalliMaya L.
2812In vitro activity of eravacycline against extensively drug-resistant (XDR) Acinetobacter baumannii and Stenotrophomonas maltophiliaTeoJocelyn Q
2888Detection of carbapenemase-producing organisms directly from rectal swabs by a multiplex lateral flow immunoassayPournarasSpyros
2908One Health drivers of extended spectrum ß-lactamase (ESBL) resistance in Malawian householdsCockerDerek
2937In vitro activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and/or meropenem/vaborbactamGaibaniPaolo
2945Surveillance of multidrug-resistant Enterobacterales is affected by the new EUCAST definitionFriedliOlivier
2946Susceptibility profiles and resistance mechanisms of Pseudomonas aeruginosa isolates from European intensive care unitsTorrens RibotGabriel
2947Know the enemy!: The molecular characterisation of 102 pathogenic porcine Escherichia coli isolatesBernreiter-HoferTanja
297Using informatics tools to facilitate data engineering and visualisation to analyse antibiotic resistance data: Antibiotic Resistance Laboratory Network, United StatesHuangYuh Jyuan Jennifer
2984Decreased susceptibility to didecyldimethylammonium chloride among clinical strains of Pseudomonas aeruginosa, a ten-year retrospective study in a university hospital of Caen, FrancePottierMarine
2995A genomic snapshot of antimicrobial resistance in Campylobacter fetusDuimBirgitta
3005Association of antimicrobial resistance of urinary bacteria between primary care and hospitals in the NetherlandsMartinez LopezEvelyn Pamela
3030In vitro activity of sulbactam-durlobactam against carbapenemase-producing Acinetobacter baumannii isolates from BrazilGalesAna C.
306The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluationVan De garDeEwoudt
3111Detection of CTX-M-15 harbouring Escherichia coli isolated from poultry faecesIbrahimagićAmir
3116Haemophilus influenzae population structure in invasive disease based on clade-related classificationCarrera-SalinasAnna
3123Temporal and geographical trends in third-generation cephalosporin resistance in Escherichia coli in urinary tract infections (UTI) in primary care, France, 2015-2019LemenandOlivier
3142Genetic characteristics and transferability of resistance genes in carbapenemase-producing Acinetobacter spp. isolated from hospital sewage and river waterSuzukiYuki
3169The emergence of GIM-1 and SIM-1 carbapenemases in clinical isolates of Enterobacteriaceae strainsHamidOmnia
3175The CARBAR part 1 study: a pooled analysis of the epidemiology data for UK, France and SpainGoldenbergSimon
3198Evaluation of the in vitro activity of cefepime-taniborbactam against carbapenemase-producing Enterobacterales recovered in SpainHernández-GarcíaMarta
3209Characterisation of a GES-5 carbapenemase-producing Pseudomonas aeruginosa outbreak in a tertiary hospital in Madrid, SpainLucas FernándezJesús
3251Global disease burden of Klebsiella pneumoniae bloodstream infections in infants aged under 6 months: systematic review and meta-analysesO'sullivanColleen
3256Phenotypic characterisation of resistance emergence to cefiderocol in extensively drug-resistant (XDR) Acinetobacter baumannii bacteraemic isolatesLeonildiAlessandro
3304Genome analysis of cephalosporin non-wild type Enterobacteriales recovered from healthy and diseased food-producing animals in EuropeEl GarchFarid
3316Antimicrobial susceptibility of Neisseria gonorrhoeae in Málaga during a period of nine yearsMartinez PerezRocio
3341Antimicrobial resistance of Escherichia coli isolated from diseased animals trends of the last four years with attention to the human critical antibioticsBotteldoornNadine
3349Characterisation of Neisseria gonorrhoeae isolates using a core-genome multilocus sequence typing (MLST) schemeHigginsPaul G
3358Genomic characterisation of carbapenem-resistant Escherichia coli from multiple hospitals in Nanjing, China: focusing on frequent co-occurrence of blaNDM and blaKPC-2CaoXiaoli
3369Etiology and antibiotic susceptibility of bacterial infections in Indonesian hospitals: a multi-centre point prevalence surveyDe BrabanderJustin
3391Emergence of new multi-resistant Brachyspira hyodysenteriae strains in Belgium, revealed by phenotypic agar dilution and whole-genome sequencingVereeckeNick
3396Patients with confirmed or suspected carbapenem non-susceptible Gram-negative infections from the CARBAR part 2 study: UK, France and SpainGoldenbergSimon
3440Cephalosporin and azithromycin susceptibilities in Neisseria gonorrhoeae in Austria: evaluation from 2015 to 2020FuernkranzUrsula
3498Prevalence of colistin resistance carriage within a large cohort of ICU patients in Nouvelle-Aquitaine (France) and efficiency of laboratory’s susceptibility testing methodsToirotAudrey
3514Compartive activity of imipenem/relebactam against Klebsiella pneumoniae KPC-3 producersDelgado-ValverdeMercedes
3528Underestimated detection of IMP-13-producing Pseudomonas aeruginosa led to a silent outbreak in a haematology unitBientzLéa
3538Molecular characterisation of KPC-producing Enterobacterales from Czech hospitals: evidence of an epidemic spreadKraftovaLucie
3540Antimicrobial resistance, ESBL detection, integron characterisation and molecular typing of environmental Escherichia coli isolates of a broiler farm Martínez ÁlvarezSandra
3580Antimicrobial susceptibility of Pseudomonas aeruginosa bacteremia in Málaga, Spain: a nine-year studyMartinez PerezRocio
3635Genetic landscape of third-generation cephalosporin-resistant and carbapenem-resistant Klebsiella pneumoniae complex upon hospital admission in GermanyXanthopoulouKyriaki
3645Multi-species carriage of carbapenemase-producing Klebsiella pneumoniae: an outbreak related to the mobilomeXanthopoulouKyriaki
3690Plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from urine clinical samples with quinolone low-resistance levelsRodriguez-IglesiasManuel Antonio
377Five-year susceptibility trends of cefiderocol against Gram-negative bacteria collected in North America and five European countries between 2014 and 2019: SIDERO-WT-2014-2019 studies TakemuraMiki
3802Molecular characterisation of colistin-resistant carbapenemase-producing Klebsiella pneumoniae isolates from intensive care unit patientsTürkAyşe Hande
3809Emergence of carbapenemase-producing Serratia marcescens: resistome, mobilome and phylogeny analysed by whole-genome sequencingReyes RuizCarmen Alhena
3813Intestinal carriage of colistin-resistant Enterobacteriaceae in healthy volunteers in an Indian metropolitan cityAbdulGhafur K
3816The phantom menace: silent spread of a colistin resistance gene in a neonatal intensive care unit in Northern ItalyGaiarsaStefano
3907Resistance to expanded-spectrum β-lactams, aminoglycosides and quinolones in multidrug-resistant Enterobacterales (MDRE) isolated in patients receiving an allogeneic hematopoietic stem cell transplantation (Allo-SCT): the ENTHERE-SCT StudyFernández-MartínezMarta
3909Resistance patterns and incidence of nosocomial Pseudomonas aeruginosa bacteraemia in a tertiary care educational hospital in Turkey: a perspective between 2001 and 2019AkyolDeniz
3915In vitro activity of mecillinam against OXA-48 carbapenemase-producing EnterobacteralesKoumakiVasiliki
3928Risk factors associated with persistent carbapenem-resistant Enterobacterales gut colonisationOlallaLima Rodriguez
395In vitro activity of ceftolozane/tazobactam against Enterobacterales and Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia in GermanyKreskenMichael
3966Complex transmission of carbapenem resistance for various Enterobacterales species in a vascular chirurgical department of a French hospitalDuboisVéronique
3982Antimicrobial resistance, inappropriate empirical treatment, and outcomes of Gram-negative bacilli bloodstream infection in haematological febrile neutropenic patients in Spain: a multi-centre studyChumbitaMariana
3989Evolution of the non-carbapenemase-producing ertapenem-resistant Enterobacterales isolates from 2016 to 2020Lagarejos GonzalezEduardo
4012Antimicrobial resistance of Salmonella from poultry meat in Brazil: results of a nationwide surveyBatista RauRenata
4019Surveillance of Escherichia coli, Klebsiella peumoniae and Proteus mirabilis antimicrobial resistance rates from paediatric urinary tract infections in Greece (2015-2020)BanouKirkira
4042Genotyping of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from patients with haematological malignancies by multilocus sequence typingKlyasovaGalina
4066Clonal diversity, distribution of virulence genes and capsule types in carbapenemase-producing Klebsiella pneumoniae isolated from haematological patientsKlyasovaGalina
4070Distribution of virulence genes and capsule types in Klebsiella pneumoniae isolated from blood culture in patients with haematological malignanciesKlyasovaGalina
4072VIM type metallo-beta-lactamase (MBL)-producing Klebsiella oxytoca group in Poland, 2009-2019UrbanowiczPaweł
4092OXA-48-producing Enterobacterales in Poland, 2013-2019UrbanowiczPaweł
4114Distribution of minimum inhibitory concentration of ceftriaxone to gonococcal strains in a reference sexually transmitted disease clinic in Madrid (Spain)LejarragaClara
4119Multidrug-resistant ESKAPE pathogens in bloodstream infections in burn patients, Saint-Louis Hospital, ParisPetitHeloise
4129Specific and common features of VIM/IMP-like metallo-beta-lactamase-producing Pseudomonas aeruginosa genotypes spreading in PolandUrbanowiczPaweł
4153Prospective matched case-control study on the epidemiology of colistin-resistant Enterobacterales in the Netherlands VendrikKaruna
4157Antimicrobial resistance and genetic relatedness of environmental bacteria across the animal-human wildlife interface in AustriaCabal RoselAdriana
4167Phenotypic characterisation of high-level aminoglycosides-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolatesLibergeMathilde
4174Correlation between antibiotic resistance in Pseudomonas æruginosa and antibiotic consumption in an intensive care burn department in TunisiaThabetLamia
4179Neisseria meningitidis: resistance surveillance in the Republic of Belarus (2012 – 2020)KharkhalHanna
4180Genome typing and in silico analysis of diverse sequence types of extremely drug-resistant (XDR) carbapenemase-producing Klebsiella pneumoniae (CP-KP)MaatallahMakaoui
4208Regional distribution of carbapenemase-producing Acinetobacter baumannii in Southern SpainLopez CereroLorena
422Prevalence of CC131 and the emergence of other sequence types among Escherichia coli isolates causing urinary tract infections from Asia-Pacific, Europe, and Latin AmericaMendesRodrigo E.
4253Molecular characterisation of faecal Escherichia coli isolates of diarrhoeic children in an Algerian hospital: detection of CTX-M-15-ST1845 and ST131-MDR isolatesTorresCarmen
430Increasing third-generation cephalosporin resistance in Klebsiella pneumoniae in Swiss hospitals (2009 – 2019) is biased by the frequency of screening culturesGasserMichael
4305Successful dissemination of KPC-3 and OXA-181 carbapenemases in different genetic backgrounds of Klebsiella pneumoniae from Portuguese hospitalsFariaNuno Alexandre
443Multidrug resistance in Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa and susceptibility to four last resort antimicrobials, GermanyKreskenMichael
4464Transmission of Escherichia coli and blaCTX-M/blaCMY in feedlot lambs in consecutive years: the role of the environment at wholeCasellaTiago
4482Longitudinal study detects the co-carriage of mcr-1, -4 and blaCTX- M genes in Escherichia coli strains in a Portuguese farrow-to-finish swine herdLimaTiago
4487Distribution of carbapenemase-producing Gram-negative microorganism causing colonisation/infection in the setting of SARS-CoV-2 pandemicMartín-HigueraCarmen
4493Changing landscape of carbapenamases in Chennai, IndiaRohitAnusha
4523Dissemination of MBL-producing Enterobacter cloacae complex isolates in Poland (2013-2019)UrbanowiczPaweł
4591The emergence of high-level colistin resistance during treatment against heteroresistant Acinetobacter baumannii: a silent cause of treatment failureMachadoDiana
4619Colonisation by multidrug-resistant Gram-negative bacteria after haematopoietic stem cell transplantationRogachevaYuliya
462Prevalence and molecular characterisation of rectal carbapenem-resistant Enterobacteriaceae (CRE) isolates from food handlers and infected hospitalised patients in KuwaitMoghniaOla
4642Resistance surveillance and epidemiology of Neisseria gonorrhoeae in KwaZulu-Natal, South AfricaMitchevNireshni
4654Molecular epidemiology and mechanisms of resistance to carbapenem in Enterobacterales collected during a multi-centre studyPelosoPedro F. D.
4680High prevalence of imipemem heteroresistance in Enterobacter cloacaeJiaXiaojiong
4696The emergence of carbapenemase-producing Gram-negative bacilli isolates in Jazan region, Saudi ArabiaBrekThamer
473High prevalence of infections with extended-spectrum beta-lactamase producing Escherichia coli in adults with HIV presenting with urinary tract infections to primary care clinics in ZimbabweOlaruIoana Diana
4744Emergence of NDM-producing Klebsiella pneumoniae high-risk clones ST11 and ST15 in hospitals in the Brazilian Amazon regionBrasilienseDanielle
4809High prevalence of extended-spectrum ß-lactamases in Escherichia coli strains collected from strictly-defined community-acquired urinary tract infections in adults in China: a multi-centre prospective clinical microbiological and molecular studyJiaPeiyao
588Susceptibility of Gram-negative clinical isolates collected in Europe during 2019 to ceftobiprole and comparators: analysis by region and countryHawserStephen
641VIM-4 and mcr-9 producing Enterobacter asburiae causing bloodstream infections in the Clinical Centre of University of Pécs, HungarySonnevendAgnes Maria
651In vitro activities of ceftazidime-avibactam and comparator agents against Enterobacterales from Europe stratified by region, ATLAS global surveillance programme, 2018-2019KazmierczakKrystyna
656In vitro activities of ceftazidime-avibactam and comparator agents against Enterobacterales and Pseudomonas aeruginosa from Israel, collected through the ATLAS global surveillance program, 2013-2019HackelMeredith
675Whole genome sequence analysis of ST1851 NDM-1-producing Acinetobacter baumanni isolates from TurkeySarı KaygısızAyşe Nur
695Dynamics of Escherichia coli populations in the human gut after colonisation with extended-spectrum ß-lactamase (ESBL)-producing strainsSchweitzerMichael
728Phylum barrier and Escherichia coli intra-species phylogeny drive the acquisition of resistome in Escherichia coli PetitjeanMarie
741The first nationwide surveillance of carbapenem-resistant Enterobacteriaceae in the United Arab EmiratesPálTibor
750In vitro activity of ceftazidime-avibactam and comparators against isolates of Enterobacterales and Pseudomonas aeruginosa collected from paediatric patients as part of the ATLAS global surveillance programme, 2013-2019KazmierczakKrystyna
751In vitro activities of ceftazidime-avibactam and comparator agents against Enterobacterales isolates collected in Europe stratified by infection type , from the ATLAS global surveillance programme, 2016-2019KazmierczakKrystyna
752In vitro activities of ceftazidime-avibactam and comparators against Pseudomonas aeruginosa from Europe stratified by infection type, ATLAS global surveillance programme, 2016-2019KazmierczakKrystyna
761Non‑fermentative Gram‑negative rods bactaeremia in adult patients with haematological malignanciesCarenaAlberto
764Development of a clinical score to stratify the risk for carbapenem-resistant Enterobacteriaceae bacteraemia in cancer patientsCarenaAlberto
780Phenotypic and molecular investigation of ST11 NDM-1-producing Klebsiella pneumoniae isolates persisting between 2015 and 2018 in a Bulgarian hospitalKostyanevTomislav
834Molecular genetic characterisation of extensively drug-resistant Klebsiella pneumoniae isolated in the children`s hospital in MoscowNovikovaIrina
836Characteristics of antibiotic resistance of Klebsiella pneumoniae strains isolated from blood and cerebrospinal fluid of childrenNovikovaIrina
887The management of patients with colonisation and infection with extended-spectrum β-lactamase-producing Enterobacterales and associated patient characteristics, risk factors and clinical outcomes in the Mercy University Hospital (MUH), Cork: a retrospective, cross-sectional observational studyKelliherStjohn
943Antimicrobial activity of ceftazidime/avibactam and comparators against Pseudomonas aeruginosa and Enterobacterales collected in Croatia, Czech Republic, Hungary, Poland, Latvia and Lithuania: ATLAS surveillance programme, 2019AdámkováVáclava
957The intestinal carriage of mcr-9 among Enterobacteriaceae with inducible colistin resistance in hospitalised patients and a whole genome sequence analysis of mcr-9-positive isolatesSmelikovaEva
959Report of the national reference centre for multidrug-resistant Gram-negative bacteria on carbapenemases in Germany in 2020PfennigwerthNiels
Abstract NumAbstract titleLast nameFirst name
1145Evaluation of multiple methods for determining the linezolid minimum inhibitory concentration in clinical isolates of methicillin-resistant Staphylococcus aureusSasakijunpei
1153Development of E-tests with substances in vitro potentiate the effect of antimicrobial drugs for multidrug-resistant Klebsiella pneumoniae strainsSamoilovaAnna
1194Multi-centre inter-laboratory analysis of routine susceptibility testing with a challenge panel of resistant Gram-negativesDeckersCorentin
1470Evaluation of CHROMID Colistin R for the detection of colistin resistance in Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae complexGatermannSören
1722Predicting the effects of imipenem/relebactam and doripenem/relebactam combinations against KPC-producing Klebsiella pneumoniae in time-kill experiments: MIC determined by traditional method versus using pharmacokinetically based concentration ratioFilimonovaAlla
19False amoxicillin/clavulanic acid susceptibility in Bacteroides fragilis using gradient strip testsRentenaarRobert Jan
1907In vitro susceptibility of mecillinam and temocillin in multidru-resistant EnterobacteralesPlambeckLars
1950Detectability of carbapenemase-producing strains using mass spectrometry-based MBT STAR-BL and disk diffusion methodsMitsuruMatsumura
1985Evaluation of ComASP oritavancin test for rapid antibiotic susceptibility testing of Gram-positive clinical isolatesLazzaroLorenzo M.
1990ETEST® Fosfomycin for antimicrobial susceptibility testing of Enterobacteriaceae, Serratia marcescens and Enterococcus faecalis: performance results from a multi-centre studyBlanchardLaurine
2050Antimicrobial susceptibility testing of Eggerthella lenta using disk diffusion methodDeclerckBaptist
2106New MBT Sepsityper IVD kit increases the viability of bacterial blood pellets for nanomotion based antibiotic susceptibility testingSturmAlexander
2117Systematic interaction screening of ceftazidime/avibactam and fosfomycin against eight isogenic Escherichia coli strainsKroemerNiklas
2125Development of a high-throughput method to predict antimicrobial susceptibility of Pseudomonas aeruginosa biofilms De BleeckereAmber
215Updated EUCAST ertapenem breakpoints for MicroScan® Dried Gram-Negative MIC Panels from a multi-centre assessment of EnterobacteralesChauJennifer
216Multicenter Evaluation of Cefazolin MIC Results for Enterobacterales Using EUCAST Breakpoints on MicroScan Dried Gram Negative MIC PanelsChauJennifer
2264In vitro anti-biofilm activity of bacteriophage K ATCC 19685-B1 and daptomycin against staphylococciPlotaMaria
2277Detection of carbapenem resistance by the Reveal™ rapid phenotypic AST assay in strains from the CDC and FDA antimicrobial resistant isolate bankSinghPragya
2369In vitro susceptibility of cefiderocol against Acinetobacter baumannii: disk diffusion compared to the reference broth microdilution testRomanelliFederica
2370In vitro activity of cefiderocol in combination with colistin, fosfomycin and tigecycline against Acinetobacter baumanniiStolfaStefania
2385Meropenem/vaborbactam against ESBLs and GES carbapenemase-producing Enterobacter cloacae complexPablo MarcosDaniel
2394Differences in drug-susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare-chimaeraFernandez PittolMariana
2459Evaluation of the MICRONAUT-S system for Legionella pneumophila antimicrobial susceptibility testingAllamCamille
2471The use of the Reveal™ system to detect and characterise heteroresistant bacterial populations in blood samplesSinghPragya
2501ETEST® amoxicillin/clavulanic acid for antimicrobial susceptibility testing of Enterobacterales, Haemophilus influenzae and anaerobes: clinical trial performance results MorierasAngeline
2609The use of the Reveal™ system to quantitatively determine the efficacy of bacteriophageSinghPragya
2707Stability of four carbapenem antibiotics in discs used for antimicrobial susceptibility testingShahabSelvi Nafisa
2724Evaluation of early reading of broth microdilution technique for polymyxin BCarneiroMaiara
2793Antibiogram of slowly growing mycobacteria in the United StatesHunkinsJosh
2873Rapid antimicrobial susceptibility testing by MALDI-TOF MS of lipids determines MICsMoyFrancesca
3072Higher gentamicin resistance in Proteus spp. and Providencia spp. as measured by the Phoenix compared to the VITEK 2 automated antibiotic susceptibility test systemAltorf - Van Der KuilWieke
3074Performance of the EUCAST disc diffusion method and gradient tests in detection of linezolid susceptibility in Enterococcus faecalis and Enterococcus faeciumHaldorsenBjörg C.
3148Comparison of three methods to detect the in vitro activity of ceftazidime-avibactam against carbapenem-resistant Klebsiella pneumoniae and Escherichia coli blood isolatesKirbasEkin
3176New method of antibiotic selection reveals diversity and reduces bacterial load in sputum of children with cystic fibrosisVecherkovskayaMaria
3192Evaluation of a rapid MALDI-TOF MS assay for antimicrobial susceptibility testingIdelevichEvgeny A.
3310Evaluation of analytical performance of QMAC- dRASTTM system for direct and rapid antimicrobial susceptibility testing on Gram-negative and Gram-positive organisms from positive blood culturesDescyJulie
3378Validation of a rapid predifussion disk assay to determine aztreonam plus avibactam (ATM-AVI) susceptibility for carbapenemase-producing Enterobacterales (CPE)PasteranFernando
3401Colistin susceptibility testing of Acinetobacter baumannii isolates: verifying accuracy and reliability among two methodsSamarasKonstantinos
3541Performance of MIC methods in susceptibility testing of Neisseria gonorrhoeaeMittereggerDieter
3553Area of technical uncertainty for piperacillin/tazobactam in Enterobacterales: MIC re-evaluation using two-gradient diffusion strips in relation to the new EUCAST breakpointsMauriCarola
3578Activity of cefepime/taniborbactam (formerly cefepime/VNRX-5133) and comparators against NDM-producing Enterobacterales from a regional outbreakNiccolaiClaudia
3885Determination of fosfomycin susceptibility in extended-spectrum beta-lactamases-producing and carbapenem-resistant Enterobacterales isolates by agar dilution and comparison with automated systemKaracanEyyüb
4073Implementing EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) method for Gram-negative sepsis in a resource limited settingGuptaAyush
4151Comparison of Etest, disk diffusion, and broth microdilution for in vitro susceptibility testing of Stenotrophomonas maltophilia between 2015-2018KirbasEkin
4188Comparison of in vitro susceptibility of fosfomycin against drug-resistant uropathogens by various susceptibility testing methodsBirRaunak
4238Variable susceptibility of Klebsiella pneumoniae to UVC lightLoiodiceMichele
453A comparison of Escherichia coli susceptibility for amoxicillin/clavulanic acid according to EUCAST and CLSI guidelinesVanstokstraetenRobin
4807Evaluation of the QuickMIC rapid AST assay for blood cultures in a clinical settingMalmbergChrister
4834Clinical impact of a direct Rapid Antimicrobial Susceptibility Testing (dRAST™) in administration of optimal therapy in patients with bloodstream infectionFontaineCorentin
661Antimicrobial use in patients with bloodstream infections from 4 hospitals in the improving outcomes and antibiotic stewardship (IOAS) study: a quasi-experimental multi-centre study of the Accelerate PhenoTest® BC KitMacvaneShawn
715Accuracy of the Sensititre™, Micronaut-S™ and of the disk diffusion methods for antimicrobial susceptibility testing of the Bacteroides fragilis group: a comparative study on 55 European resistant isolatesLangloisBénédicte
758Impact of the Accelerate PhenoTest® BC Kit on time to results for pathogens from bloodstream infections: IOAS (Improving Outcomes and Antibiotic Stewardship) study experience of 4 hospitalsBhalodiAmira
993Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanismsAlbertos TorresDiana
Abstract NumAbstract titleLast nameFirst name
1075New variants of AbaR-like islands among genome of Tigecycline resistant Acinetobacter baumannii clinical isolates belong to different International Clones show a regressive processSavariMohammad
11Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in GermanyStinguCatalina Suzana
1126Siginificant contribution of an resistance nodulation cell division type efflux to 23S rRNA alteration in erythromycin resistance of Campylobacter spp. OncelBeyza
1292Gene expression analysis on alternative carbapenem resistance mechanisms in Acinetobacter baumanniiHöfkenLisa-Marie
1298MgrB W20S mutation is responsible for colistin-resistance in ST258 KPC-producing Klebsiella pneumoniaeRochMélanie
1334Stable mutants are involved in heteroresistance to colistin in clinical isolates of Klebsiella pneumoniae producing OXA-48Sánchez LeónIrene
1336In-depth genomic characterisation of a clinical daptomycin-resistant and vancomycin-intermediate community-acquired MRSA superbugCafisoViviana
1441Molecular characterisation of in vivo acquisition of ceftolozane/tazobactam and ceftazidime/avibactam resistances in a patient treated for a Pseudomonas aeruginosa infectionDerocheLuc
1499Assessment of resistance development to KBP-7072 by serial passage and single-step mutational selectionHubandMichael D.
1641Genetic characterisation of ESBL-producing Klebsiella pneumoniae from humans and poultry in NigeriaJesumirheweChristiana
1674Methicillin resistance in Staphylococcus aureus: be aware that it is not a stable resistance!Dupieux-ChabertCéline
1675Biofilm formation in cefiderocol-resistant Acinetobacter baumanniiGhaziIslam
1786Comparative study of the microbiological activity of imipenem/relebactam with respect to ceftazidime/avibactam against KPC-2 and KPC-3-producing Klebsiella pneumoniae: mutant preventive concentrations (MPC) and dynamics of appearance of resistanceArca-SuárezJorge
1884Emergence of multidrug-resistant Acinetobacter bereziniae in Hungary: first description of OXA-58 and VIM-4 co-producing isolatesTothAkos
1924Multiclonal outbreak caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam and meropenem/vaborbactam in Northern Italy: epidemiological and genomic investigationDi PilatoVincenzo
2004Ceftobiprole exerts synergism against Enterococcus faecalis clinical isolates despite their β-lactam resistanceCampanileFloriana
2132Identifying the two-component signal transduction network (TCS) controlling the resistance to corbomycin and complestatin in Staphylococcus aureusGómez ArrebolaCarmen
2146Evaluation of pleuromutillins resistance mechanisms among surveillance clinical isolates: results from the worldwide surveillance programme for lefamulin in 2019MendesRodrigo E.
2220Calcium channels: proposed involvement in the antimicrobial effect of a natural product formulation against vancomycin-resistant Enterococcus faeciumAlharethZakia
2235High prevalence of tetracycline resistance genes among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis clinical isolates causing infections in Europe (2019)MendesRodrigo E.
2237Collateral sensitivity-informed antibiotic combinations for the treatment of Streptococcus pneumoniae infectionsAulinLinda Brita Sofia
2308Selective landscape of drug resistance in experimentally-evolved biofilms adapted to a large panel of diverse antimicrobialsWickhamGregory
2319Assessment of an immunochromatography assay for carbapenemase detection (NG-Test CARBA 5) compared to a PCR methodEvrardSeverine
2328Clinical characteristics, antimicrobial resistance profile and resistance mechanisms of carbapenem-resistant bacteria from patients admitted to hospital in rural coastal KenyaAmuleleAnne V.
2329Successive emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae harbouring blaKPC-76 or blaKPC-79 sequence type 11 clinical isolatesShiQingyu
2533A novel class 1 integron (In1992) carrying blaGES-16 in an extensively drug-resistant Pseudomonas aeruginosa (XDR-PSA) clinical strain in BrazilGalesAna
2599blaIMP-18 is carried by a new class 1 integron (In2030) in an extensively drug-resistant Pseudomonas aeruginosa (XDR-PSA) strain in BrazilGalesAna
28Assessment of in vitro synergy of fosfomycin with meropenem, amikacin and tigecycline in whole-genome sequenced extended and pan drug-resistant Klebsiella pneumoniae: exploring a colistin sparing protocolAl QurainiMunawer
2837Co-existence of mcr-1 and mcr-9 genes in an ESBL-producing Escherichia coli isolated from broiler carcass in Quito-EcuadorOrtega ParedesDavid
3064SHV-1-producing Klebsiella pneumoniae: inpatient evolution towards carbapenem resistanceNaasThierry
3112Colistin heteroresistance in Pseudomonas aeruginosa blood isolatesKirbasEkin
3168Imported case of pandemic ST147 Klebsiella pneumoniae, blaNDM-5 and blaOXA-181 producer, and resistant to Colistin, in South Tyrol, ItalyBianconiIrene
3200Exploring the in vitro activity of cefepime/taniborbactam combination against metallo-ß-lactamase producing Klebsiella pneumoniae and Pseudomonas aeruginosa isolatesParanosPaschalis
3217Occurrence of acquired and chromosomal antibiotic resistance genes in K. pneumoniae isolate from long-term care facilities in Northern Italy: molecular analysis by next-generation sequencingPiccirilliAlessandra
3254Rapid detection of VanA/B-producing vancomycin-resistant enterococci using lateral flow immunoassay from colonies and blood cultureNaasThierry
3318Phenotypic and molecular characterisation of a multidrug-resistant Bacteroides vulgatus isolate that also has imipenem resistanceMahmoodBakhtiyar
3398Molecular and in vivo assessment of virulence factors in colistin-resistant Pseudomonas aeruginosa ST235 high-risk cloneVatanseverCansel
3586Macrolide resistance among Streptococcus spp. of animal originLópez De Egea VegasGuillem
3736Genetic characterisation of multidrug-resistant Bacteroides fragilis clinical isolates in the NetherlandsBoitenKathleen
3746Intraspecies transformation of msrD gene conferring high-level macrolide resistance in Neisseria subflavaAbdellatiSaïd
40IS26 is responsible for the evolution and transmission of blaNDM-harbouring plasmids in Escherichia coli of poultry origin in ChinaZhaoQiu-Yun
4234Rapid detection of ESBL in Enterobacterales group II by flow cytometry: a two-site validation studyPina-VazCidália
4262Rapid detection of plasmid AmpC by flow cytometry: a two-site validation studyPina-VazCidália
4293Genomic characterisation of colistin-resistant Enterobacter spp. isolated from the water environment of high-risk hospital unitsFleresGiuseppe
4311Triple carbapenemase detected in clinical Klebsiella pneumoniae isolateEisfeldJessica
4320Eravacycline and tigecycline susceptibility in XDR and MDR Acinetobacter baumannii: molecular detection of RND efflux pump resistance mechanism and effect of efflux pump inhibitorGautamHitender
4400The active role of acrB-mediated efflux pump in tigecycline resistance of invasive Klebsiella pneumoniae isolatesKaracanBurak
4599Characterisation of carbapenem-resistant Enterobacter cloacae complex isolates: diversity of virulence genes and plasmids harboring blaKPC-2NogueiraMara
4634Resistance and virulence characteristics of carbapenem-resistant Klebsiella pneumoniae in bloodstream infection in a tertiary hospital in HenanYanWenjuan
4674Emergence of ceftazidime-avibactam resistance during an outbreak by the ST307 Klebsiella pneumoniae high-risk clone harbouring blaKPC-3 variants after ceftazidime-avibactam treatmentHernández-GarcíaMarta
472Identification of RND efflux pump AdeABC-independent tigecycline resistance mechanism in Acinetobacter baumanniiWangZhiren
4811Suboptimal ceftolozane/tazobactam (C/T) concentrations in continuous infusion could lead to the emergence of C/T resistance against Pseudomonas aeruginosa in an in vitro hollow fiber infection model MonteroMilagroMaria
4914First report of the co-existence of blaOXA-23  and blaOXA-72 carbapenemases in Acinetobacter baumannii strains from the North of SpainAranzamendi ZaldumbideMaitane
511Identification of novel plasmid-mediated tigecycline resistance gene tet(Y) in clinical Acinetobacter baumannii isolateWangZhiren
634Emergence of novel Campylobacter coli erythromycin resistance methylase (Erm)-positive strains in FranceJehanneQuentin
670Whole-genome sequencing analysis of uropathogenic Escherichia coli for determination of stepwise fluoroquinolone-resistance developmentMasakoKaido
679Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureusGostevVladimir
835Characterisation of heteroresistance to imipenem in Bacteroides fragilis strainsBaaityZain
868Role of inorganic phosphate concentration in fosfomycin activity against Escherichia coliOrtiz PadillaMiriam
907Colistin resistance-regulating two-component system alters growth of Klebsiella pneumoniaeKim SunJu
951SOS response suppression as a strategy to reverse heteroresistance phenomenom in clinical isolates of Escherichia coliDiaz-DiazSara
953Phenotypic heterogeneity of SOS response expression in Escherichia coli clinical isolates under ciprofloxacin pressureDiaz-Diaz


Abstract NumAbstract titleLast nameFirst name
1158Detection of colistin resistance in Pseudomonas aeruginosa using MALDIxin test on the routine MALDI Biotyper Sirius mass spectrometerLarrouy-MaumusGerald
1286Accurate detection of PBP2a-expressing MRSA directly from blood culture with AcrionTM SystemViirtolaMarjaana
1291Detection of extended-spectrum β-lactamase in diarrheagenic Escherichia coli by flow cytometrySinghTaru
1347In vitro synergistic activity of colistin, vancomycin, rifampicin and ampicillin/sulbactam combinations against pandrug-resistant (PDR) Acinetobacter baumannii strains, in a Greek tertiary hospitalOrfanidouMaria
1364In vitro synergistic activity of ceftolozane/tazobactam and fosfomycin combination against VIM-producing strains of Pseudomonas aeruginosa (VIM-PA), in a Greek tertiary hospitalOrfanidouMaria
1750Rapid antimicrobial susceptibility testing from positive blood cultures using VITEK®2 systemZambardiGilles
1777Rifaximin prophylaxis against travellers’ diarrhoea does not increase acquisition of extended-spectrum ß-lactamase producing (ESBL) Enterobacteriaceae in a UK military population travelling to KenyaTrothTom
1815Rapid ResaImipenem/Acinetobacter NP test for detection of carbapenem susceptibility/resistance in Acinetobacter baumanniiNordmannPatrice
1832Comparison of the CARBA PAcE carbapenemase test with modified carbapenemase inactivation method (mCIM) and carbapenemase Nordmann-Poirel (Carba NP) methods based on an assorted Hungarian strain collectionTothAkos
190A Retrospective study examining the clinical impact of implementing Rapid Antimicrobial Susceptibility Testing in two UK tertiary centresBeckleyGeorgina
1982Plasmid detection and plasmid-mediated antimicrobial gene prediction in Norwegian clinical isolates AhmadRafi
1997Comparison of different methods for detecting antimicrobial resistance genes from metagenomic data obtained from a wastewater treatment plantBosiljMartin
2152Evaluation of critical steps of sequencing workflows for optimal detection of antimicrobial resistance genesMaboniGrazieli
2223Mutations in intergenic ampC region and mexY frequently found with ceftolozane/tazobactam resistance in Pseudomonas aeruginosa by whole genome sequence in 303 clinical UK isolatesPlancheTimothy David
2250Mechanisms of carbapenem heteroresistance in Klebsiella pneumoniae and Escherichia coli isolatesSancakBanu
2259Evolutionary plasticity, drug resistance and virulence of Klebsiella pneumoniae in the Pisa University Hospital during 9 years of investigationsGiordanoCesira
2312Phylogenomic analysis of multidrug-resistant Escherichia coli strains from hospitals in BeninYehouenouCarine
2536Interpretation of phenotypic susceptibility pattern to predict the exclusion of blaNDM in carbapenem resistant Klebsiella pneumoniae: a retrospective analytical study in a resource-limited settingAgrawalUmang
2720Whole genome sequencing analysis of diversity and antimicrobial resistance in Klebsiella pneumoniaeChoiHosoon
2927Genomics insights of Escherichia coli isolated from an intensive pig farming in South Africa using the farm-to-fork approachAbdallaShima
3040Short- and long-term effects of hospitalisation and oral trimethoprim-sulfadiazine administration on the faecal microbiota and resistome in horsesTheelenMathijs J.P.
3397Colistin-induced tolerant cell formation and antibiotic tolerance in Klebsiella pneumoniae OzcanGulin
3415Mycoplasma genitalium and mutations associated with macrolide and fluorochinolone resistanceOggioniMassimo
3448Could be used preliminary readings of MicroScan panels to detect results of antimicrobial susceptibility in ESBL-producing strains?Cuesta UrbanoNerea
3486Metagenomic analysis of the impact of the precision antibiotic ridinilazole, compared to vancomycin, on the gut resistome in a Phase 2 studyDuperchyEsther
3588Whole-genome sequencing to detect antimicrobial resistance-associated determinants in Staphylococcus epidermidisColeKevin
3696Complete genome sequencing and transcriptome analysis of extended-spectrum-beta-lactamase (ESBL)-producing Escherichia coli exposed to flavophospholipolKudoHayami
3794Are quaternary ammonium surfactants good prophylactic options for Neisseria gonorrhoeae "superbug"?CaladoRita
3848Exploring the resistome and virulome in aquacultureManageiroVera
3864Differential detection of closely related CTX-M group 1 variants from Escherichia coli isolates using a real-time internally controlled multiplex loop-primer endonuclease cleavage loop-mediated isothermal amplification (LEC-LAMP) assayHigginsOwen
3866Optimisation of a cost-effective method for the simultaneous detection of carbapenemases and efflux activity in EnterobacteriaceaeCerqueira Da SilvaCarla Marisa
3888Antimicrobial resistance and genomic characterisation of Salmonella Typhimurium and Salmonella I 4,[5],12:i:- isolates from animals in the United StatesSrednikMariela
3950Molecular dynamics as a tool to study the passive diffusion of a series of Pseudomonas quorum sensing inhibitorsSousaCarla F.
3953Evaluation of the Phoenix™ CPO Detect Test for detection and Ambler classification of carbapenemase-producing EnterobacteralesCruzHugo
406Mycoplasma genitalium: analysis of mutations associated with macrolide resistance in Lleida, SpainMuñozAlba
4711Detecting of colistin resistance via different methods in multi-drug resistant Gram-negative bacilli isolated from blood culturesAl HamwiRama
611The predictive value of direct disc diffusion assay results for resistance in Gram-negative bacteraemia: a large NHS trust experienceSwaineThomas
689Detection of extended-spectrum β-lactamase-producing Enterobacterales by the VITEK®2 Advanced Expert System TM system version 9.02 with European standard and extended AST panelsPages MonteiroLaurence
749Empirical antibiotic therapy: a probabilistic approachFreireJúnior Adelino
894Detection by whole genome sequencing of a novel metallo-β-lactamase produced by Wautersiella falsenii causing urinary tract infection in TunisiaChouchaniChedly
Abstract NumAbstract titleLast nameFirst name
4757Pneumococcal brain infection in zebrafish larvae causes vibrational-motor behavior that recapitulates sensorimotor responses in meningitisLe NgocDung
4827Rapid identification of pathogens associated with ventilator-associated pneumonia by nanopore sequencingWuNan
4879Obese patients are being undertreated with antibiotics in the emergency departmentKorenSondre Flaegstad
4939Correlation of treponemal chemiluminescent microparticle immunoassay screening test signal strength values with reactivity of confirmatory testingDemirCuha Mervenur
1400Solving weak points in the therapeutic approach in multidrug-resistant Pseudomonas aeruginosa (MDR-PSA): a 22-point risk score as a clinical toolHernandez JimenezMaria Del Pilar
1643Giannella risk score usefulness in mix carbapenemase settings: are we talking about the same?FavierPatricio
1877Insights from the cefiderocol early access programme for patients with Gram-negative infection and limited treatment options in EuropeKarasAndreas
2293Is there any risk factor in terms of mortality in patients with nosocomial colistin-resistant Klebsiella pneumonia infection?Ataman HatipogluCigdem
2464Travelling bacteria: a case report of a New Delhi metallo-β-lactamase-producing Escherichia coli moving from India to Italy in a gestating womanFumarolaBenedetta
2476Risk factors and outcomes for resistant compared to susceptible Pseudomonas aeruginosa infection in four European health centersPuzniakLaura
2517Cefiderocol-based combination therapy as a “rescue” treatment for severe XDR Gram-negative infections in immunocompromised or critically ill patients: a retrospective case seriesBelatiAlessandra
2528Quantifying the clinical and economic burden of serious carbapenem-resistant Enterobacterales infections: a case-case-control studySaundersMelody
2845Infections due to multidrug-resistant bacteria in patients with hematologic malignancyBechirAchour
3585Systematic review of published cases of cefiderocol use in clinicVialePierluigi
3602Acinetobacter baumannii infections in hospitalised patients, treatement outcomesGhaziIslam
3795Ceftazidime/abivactam for the treatment of infections due to multidrug-resistant Pseudomas aeruginosaBoán-PerezJorge
4322Carbapenemase-producing Klebsiella pneumoniae belonging to sequence type 23 is a predictor of poor outcome in haematological patients TandilovaKristina
4349Therapy outcome of infections caused by carbapenemase-producing Enterobacterales in patients with haematological disordersTandilovaKristina
4375Outcome predictors of infections caused by carbapenemase-producing Enterobacterales in patients with haematological disordersTandilovaKristina
4468Real-life experience with ceftazidime/avibactam-fosfomycin combination use at Florence University Hospital (Italy)Di LauriaNicoletta
4702Combination antimicrobial therapy versus monotherapy for multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections  HolgerDana
4966Extensively drug-resistant Pseudomonas aeruginosa: the experience of a large Portuguese university hospitalMendesPedro Diogo
509Ceftobiprole demonstrates efficacy, safety, and tolerability in older patients: a post-hoc analysis of three randomized trialsHamedKamal
864Attributable deaths and disability-adjusted life-years (DALYs) caused by infections with antibiotic-resistant bacteria in Switzerland from 2010 to 2019GasserMichael
Abstract NumAbstract titleLast nameFirst name
1138Distribution and molecular characterisation of CTX-M β-lactamase-producing Escherichia coli isolated from wild deer inhabiting tourist sites in JapanWatanabeMako
1191The spread of plasmid-borne tet(M/L) and erm(B) genes from chicken litter to the litter-amended soil in South AfricaFatobaDorcas Oladayo
1202Detection of mcr-1 transmission between co-habiting dog and human in the communityMenezesJuliana
1320Genomic characteristics of carbapenemase-producing Enterobacteriaceae isolates from wastewater in northeast JapanKanamoriHajime
1408Genetic diversity of antimicrobial resistance found in Escherichia coli colonising travellers to LaosSnaithAnn
1962Investigation of carbapenemase-producing Enterobacterales in black-headed gulls (Chroicocephalus ridibundus) and the River Danube NagyJózsefBálint
1999Detection and characterisation of ST167 NDM-5-producing Escherichia coli strain from a cat in ItalyAbu-AlshaarAseel
2044The missing link in MDR enterococci spread: detection of vanA, optrA, poxtA, cfrD and hospital-associated strains in European industrial dog foodFreitasAna Raquel
2164Genome-based characterisation of colistin-resistant Escherichia coli isolates from human patients and livestock products in GermanyPfeiferYvonne
2206Study of Legionella community interaction with temperature and disinfection treatment during hospital environmental surveillanceGirolaminiLuna
258An interdisciplinary approach to reveal the dynamics of generalised transduction of antimicrobial resistance genesLeclercQuentin
2637Diversity of plasmids in a large collection of Klebsiella spp. strains from clinical and non-clinical settingsCoutoNatacha
2803Owned dogs as a source of multidrug-resistant Enterobacteriaceae in Mexico CityAquino-AndradeAlejandra
2988Impact of organic and inorganic copper feed formulations in the selection of copper-tolerant and multidrug-resistant Enterococcus faecium from poultry farms and meat available to consumersRebeloAndreia
3017Tracking down multidrug-resistant Acinetobacter baumannii isolates from hospital to the aquatic environment via the wastewater networkGheorgheIrina
3157Mobile genetic elements containing lnuB and lsaE in Streptococcus dysgalactiae subsp. equisimilisBerbel PalauDàmaris
3179Multidrug-resistant bacteria carrying chromosomally- and plasmid-encoded fos operon for utilisation of short-chain fructooligosaccharidesNohejlTomas
334Prevalence of multiresistant Enterobacteriaceae in rivers and wastewater treatment plants in Osona, Barcelona: a threat to humans?Díez De Los RíosJavier
3388First report of BKC-1 production in a Pseudomonas putida group (PpG) clinical isolate from BrazilGalesAna
3422Characterisation of mobile genetic elements harboring metallo-beta-lactamases-encoding genes in carbapenem-resistant Pseudomonas putida group isolates from BrazilGalesAna
3465GES-5-producing Pseudomonas aeruginosa ST235 clone: molecular and genetic analysisSaenzYolanda
3470Comparing dairy heifer fecal microbiome between extended-spectrum β-lactamase-producing Enterobacterales carriers and non-carriers in IsraelCraddockHillary
3606Effects of the herbicide glyphosate on bacterial persistenceMakarovaOlga
3660Genetic characterisation of faecal Escherichia coli isolates of bovine farms of Northern Algeria. ESBL detection, integron characterisation and genetic lineagesTorresCarmen
3683Wild boars as sentinels for environmental spread of ESBLs-producing Escherichia coli>/em>MercatoAlessandra
3705The mef(A)/msr(D)-carrying prophage φ1207.3 encodes an SOS-like system induced by UV-C light and responsible for increased survival and antibiotic resistance mutation rates in Streptococcus pneumoniaeFoxValeria
371Interspecies recombination between Haemophilus species leading to Haemophilus influenzae broad-spectrum resistance to beta-lactamsMichelCharlotte
3760Emergence of the hybrid resistance and virulence plasmids harboring New Delhi metallo-beta-lactamase in Klebsiella pneumonia in RussiaStarkovaPolina
3810Characterisation of chromosomal and plasmid diversity of carbapenemase-producing Klebsiella pneumoniae clinical isolates from the United Kingdom ElementSarahJane
3857Carbapenem resistance genes uncovered by nanopore sequencing in wastewater canalisations from GhanaDelgado-BlasJose F.
3857Carbapenem resistance genes uncovered by nanopore sequencing in wastewater canalisations from GhanaDelgado-BlasJose F.
3868Bacterial diversity and antibiotic susceptibility in Crassostrea gigas, Mytilus spp. and Ruditapes decussatus from aquacultureSalgueiroVanessa
4050Resistance and virulence determinants of ESBL-producing Klebsiella species from process and wastewater of livestock slaughterhousesHammerlJens Andre
4051Clostridioides difficile as a reservoir for dissemination of antimicrobial resistance determinantsKartalidisPhilippos
4060First report of carbapenemase OXA-181-producing Serratia marcescensMansourWejdene
4081A national survey of the epidemiology of predominant capsule serotypes using whole-genome sequencing of Klebsiella pneumoniae clinical isolates reveals recent occurance of K1 and K2 serotypes in tertiary care hospital in OmanAljabriZaaima
4105Resistance surveillance of Vibrio parahaemolyticus from imported seafood in Germany and further dissection of ESBL and NDM-1-producing isolatesHammerlJens Andre
4242Whole-genome sequencing and comparative genomic characterisation of Staphylococcus aureus sequence type 398 isolates from different reservoirsSalgueiroVanessa
4301Genetic variability of blaNDM-5-harbouring mosaic plasmids in the Escherichia coli ST167 high-risk clone from canine clinical infection, ItalyAlbaPatricia
4386IncR plasmid as reservoir of armA methyltransferase gene in a veterinary clinical setting during a decadeSernaCarlos
4560Ecological impact indicators of general practitioners antibiotic prescriptions based on reimbursement data at the department level in FranceAriasPauline
4569First report of the acquired 16S rRNA methyltransferase armA in an Enterobacter hormachei ST171 isolated from a horse R.MatamorosBosco
4611Faecal colonisation of a dog with Enterobacter cloacae harboring a blaNDM-7 carbapenemase geneColeStephen D.
4614Isolation of KPC-producing Enterobacterales from rectal surveillance swabs of two dogsColeStephen D.
4772Genetic and phenotypic characterisation of a novel metallo-β-lactamase, NDM-29 from a clinical isolated Escherichia coli strainZhuYing
48Rapid assessment on the implementation status of antimicrobial resistance prevention and containment strategy and plan of action 2015-2020: across the human, agriculture, and environmental sectorsAlemkereGetachew
613A novel blaNDM-1- and armA-carrying plasmid from an extensively drug-resistant Proteus vulgaris isolateEndimianiAndrea
633Genomic analysis of Escherichia coli ST354 and ST349 carrying qnrE1 and blaOXA-244 from birds of preyTarabaiHassan
717Last Multidrug-resistant Escherichia coli strains from people, poultry and chicken meat in Laos: comparison with those isolated from the gut of travellers visiting the countryEndimianiAndrea
859Klebsiella grimontii isolates possessing blaVIM-1 and mcr-9 in Switzerland and their clonality in EuropeEndimianiAndrea
954ICEPmiChnXH1653, a novel SXT/R391 cross-genus transferrable integrative conjugative element, carrying tandem copies of blaNDM-1 gene in Proteus mirabilisYuYunsong
4651Almost complete lack of relevant antibiotic trials for common infections in low-income country settings impairs evidence base for empiric guidance and optimal patient managementLoebNathalie
4767title Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, and Pseudomonas aeruginosaYangQiwen
4790Chemical interactions between microorganisms can be exploited to counter antimicrobial resistance and rescue our existing arsenal of antibioticsAnand-PoopalarajahRahgavi
Abstract NumAbstract titleLast nameFirst name
1036Epidemiology of osteoarticular infections according to bacterial growth times brings useful data to delineate antibiotic stewardship VidalPauline
1109Can we improve blood culture collection practice? A point prevalence study combined with a survey about knowledge and attitudes among physicians regarding blood culture collection at a tertiary care hospital in SwitzerlandDrägerSarah
1149Impact of a reduced blood culture incubation time on the recovery of anaerobic or microaerophilic bacteriaLe GuernRémi
1220Molecular assay or conventional methods for diagnosis of bacterial vaginosis and vulvovaginal candidiasis?Mantecón VallejoMª Ángeles
1288Multi-resistant Enterobacteriaceae antibiotic susceptibility testing on positive blood culture in less than 8 hoursRuimyRaymond
1358Microbiology of preservation fluids of transplanted kidney collected in blood culture bottles: a time to positivity below 20 hours can help to distinguish pathogenic from colonisation microorganismsDauwalderOlivier
1366Evaluation of the use of artificial intelligence (AI) for the detection of VRE using two different agar typesJazmatiNathalie
1535Prevalence of potential pathogenic and opportunistic bacteria in breastmilk and saliva from mother-child pairs: a pilot studyFernandesMariana
1719Incidence and antimicrobial pattern of extended-spectrum β-Lactamase (ESBL) -producing Enterobacteriaceae isolates among septicaemic neonates at a tertiary healthcare hospital Kabul, AfghanistanAziziShabnam
1820MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extrapulmonary specimens to detect mycobacteriaBisogninFrancesco
1889Pochitis due to Prevotella disiens and Morganella morganii co-infectionBattikhHajer
193Impact of quality improvement measures in reducing blood culture transport time NakraniMalti
1934Identification at subspecies level of clinical isolates of Mycobacterium abscessus using GenoType NTM-DR assayBroncanoAntonio
2169A unique pre-analytical workflow to achieve identification and AST from positive blood culture with Sepsityper® kit on VITEK MS and VITEK2 instrumentsDauwalderOlivier
2191Evaluation of the VITEK 2 AST-N397 Card and the ETEST for antimicrobial susceptibility testing of Enterobacterales and Pseudomonas aeruginosa isolates CortazzoVenere
2210Evaluation of the Fast-Prep™ PBC system for accelerated species identification and antimicrobial susceptibility testing from positive blood culture bottles using MALDI-TOF and VITEK 2Narvaez EncaladaMarco
2226Chemiluminescence treponemal assay signal strength cut-off to predict syphilis infection using the reverse algorithmGarcía MartínMiguel Ángel
2276A blood culture system adapted to field laboratories in Ebola Virus Disease (EVD) outbreaks: design and pilot testing in the Democratic Republic of the Congo KalemaJocelyne
2315A new rapid and simple direct antibody immunofluorescence assay (DAIA) for Q fever diagnosticsKondratevAlexey
232Use of morphokinetic cellular analysis for rapid antimicrobial sensitivity testing in clinical practice: a retrospective studyOldTim
2321The effect of -80°C long-term storage on the viability of multidrug-resistant pathogens and yeasts in biobanking of human stoolsTimbermontLeen
2628Development and evaluation of a benchtop tool to standardise and speed up workflows for convenient MALDI-TOF MS sample preparation in routine laboratoriesPeerMarkus
2940Performances of the FAST-Prep PBC™ system enabling speeded-up positive blood culture ID/AST results using Bruker MALDI-TOF MS, BD Phoenix and disk diffusionVerrokenAlexia
2963Comparison of UF5000+UD10 and UF1000 instruments for urinary cytology: a good technological evolution but not a revolutionDauwalderOlivier
3061An immunochemical approach for Staphylococcus aureus infections targeting quorum-sensing autoinducersFerrero RuedasCarla
3071First comparison of 3 syphilis antibodies confirmation tools: two automated immunoblot and one ELISA spot testSanséauGuilhem
3085Rapid screening of urine samples with no or insignificant bacterial growth without need of culturing by using UF-5000 mass spectrometryIshakThikra
3386Homogenisation improves microorganism recovery and reduces time to detection in diagnosis of deep tissue infectionsSaeediBaharak
3402Application of a specimen collection protocol for the diagnosis of non-viral infectious keratitis SeijaVerónica
3425Development of a 15-minute assay using glycan-functionalised latex nanoparticles for rapid identification of Gram-negative uropathogensPreeceJames
3455New immunofluorescence unitary test for diagnosis of Clostridioides infection diseaseLalandeValerie
3522Validation of LIM broths inoculation methods for prenatal screening of group B Streptococci (GBS) using the WASP® automated inoculation systemHerensSophie
3525Direct identification and antimicrobial susceptibility of Gram-negative bacteria from positive blood culture bottlesAbdel-HamidDalia
3552Evaluation of FAST-Prep™ PBC: an automated and rapid system for isolating microbial cells from positive blood cultureBonaiutoChiara
3713Evaluation of the performance of treponemal and nontreponemal tests used in the diagnosis of syphilisYazici OzçelikEda
3752Impact of the SARS-CoV-2 pandemic on blood culture utilisation and bacteraemia in a tertiary hospital in Northern SpainAguirre QuinoneroAmaia 
3773Rapid susceptibility testing on Mueller-Hinton Rapid-SIR (MHR-SIR) agar directly from bloodstream infectionsNguyen VanJean-Claude
3841Evaluation of two automated systems in rapid screening for urinary tract infectionsTychalaAreti
3890Clinical laboratory data management barriers to antibiotic resistance surveillance: Georgia, India, Kenya, Pakistan, 2017-18BollingerSusan
3958Bacteriological study of kidney stonesCruzHugo
4229Increased sensitivity and specificity and reduced turnaround time culturing orthopaedic and heart valve tissues in blood culture bottle Alcolea MedinaAdela
440False immunological detection of CTX-M enzymes in Klebsiella oxytocaOrtiz De La RosaJose Manuel
4432Microbial D-lactate production: a promising pathogen-specific biomarker for the diagnosis of infection?MorovicPaula
4467Evaluation of the RAPIDEC® CARBA NP for rapid detection of carbapenemase-producing EnterobacteriaceaeBaoRong
451Raman spectroscopy as a tool for diagnosis of  Acinetobacter baumanniiEmbekkat KaviyilJyothi
4559Use of a novel selective medium to detect carbapenem-resistant Enterobacterales and to faster differentiate carbapenemases of isolates from colonized patients of intensive care unitsPerezLeandro
4579Use of a novel selective medium to detect carbapenem-resistant Enterobacterales and to faster differentiate carbapenemases of isolates from colonized patients of intensive care unitsPerezLeandro
4590The impact of 16S rRNA PCR performed on resected heart valves on antimicrobial treatment of blood culture negative infective endocarditisSmithHolly C
460Evaluation of the MicroScan NMDRM1 panel for antibiotic susceptibility testing on multidrug-resistant Gram-negativesPoirelLaurent
466Performance assessment of a new digestion-decontamination kit for the detection of Mycobacteria on respiratory tract specimensBourgeois NicolaosNadège
4774Carbapenemase detection by NG-Test® CARBA 5: a rapid immunochromatographic assay in carbapenem-resistant Enterobacterales diagnosisZhuYing
4792Rapid identification of Streptococcus pneumoniae serotypes by cpsB gene-based sequetyping combined with multiplex PCRZhouMenglan
61Evaluation of the added value of glutamate dehydrogenase testing in the detection of Clostridioides difficile in stool samplesHeiremanLaura
636Rapid detection of trimethoprim resistance directly from urine of patients with urinary tract infectionsSomorinYinka
816Evaluation of an automated rapid plasma reagin assay on the AIX1000 analyzer Van Den BosscheDorien
820Evaluation of a new automated fluorescence flow cytometry analyser for screening of urinary tract infection Mendoza CedielPablo
Abstract NumAbstract titleLast nameFirst name
1103How does blood volume cultured in Europe complies with guidelines? Results of a 125-centre ESGBIES/CTCB survey on the bloodstream infection diagnosticLamyBrigitte
1278Introduction of automated blood culture in a resource-limited setting in West AfricaGroeschnerKarin
1284Quality assurance in identification and antimicrobial susceptibility testing of microorganisms derived from blood culture in a resource-limited setting in West AfricaGroeschnerKarin
1418Easy-to-use microarray recomDot for serological diagnostics of Borrelia, Epstein-Barr virus and TreponemaMeyerChristian
1629Accuracy and precision of automated and manual inoculation of urine culturesWitherspoonBryonna
1903A look back of 50 years in UK National External Quality Assessment Service for MicrobiologyHendersonJennifer
194Quality improvement initiative: reducing unnecessary stool testing and related laboratory costsNakraniMalti
2134Optimisation of the stool testing workflow in a microbiology laboratory by using the BioFire® FilmArray® Gastrointestinal (GI) PanelLlaneza VelascoEugenia
2330The ongoing impact of COVID-19 on the clinical microbiology laboratory at a university medical centreBlondeauJoseph M.
2740Introducing artificial intelligence for early vancomycin-resistant enterococci culture reads with APAS®GiglioSteven
2782Comparison of MRSA plate-reading methods: APAS® Independence (artificial intelligence), plate-in-hand and Kiestra™ (digital reads)GiglioSteven
2915Internal quality controls in full automatised clinical microbiology lab: the “complete workflow” conceptDauwalderOlivier
3429Molecular imaging in diagnostic microbiology: quality control for fluorescence in situ hybridisation (FISH)KikhneyJudith
3432Improving pre-analytical turnaround times for heart valve processing following laboratory merger at Manchester Foundation TrustPriceFiona
3576Evaluation of UF-4000 body fluid mode for automated ascitic fluid cell countingBoyerSophie
366AMRcloud: a new web platform for analysis and sharing of antimicrobial surveillance dataKuzmenkovAlexey Y.
4139Evaluation of an automated culture plate reading instrument for MRSA culture screeningWilliamsAlan
4512An automated COVID-19 dashboard to improve laboratory managementMauryEmma
740The impact of modular laboratory automation on the standardisation of microbiology practices, staff hands-on time and walkaway time PeisachNicole
94Managing and documenting biomaterial samples in multi-centre studies with the DZIF LIMS tool HEnRYHeinenStephanie
Abstract NumAbstract titleLast nameFirst name
1156Comparison of two MALDI-TOF MS for identification of Neisseria spp.IshigakiShinobu
1257First reported case of Bacillus fordii bacteraemia in an 11-month-old female infant with a rhabdoid brain tumourMikaMalamati
1380Rapid identification of bloodstream pathogens and methicillin-resistant Staphylococcus aureus directly from positive blood cultures using AcrionTM systemLiottiFlora Marzia
1460New lean preparation method for identification of mycobacteria by MALDI Biotyper®KostrzewaMarkus
1601Use of mass spectrometry to identify colistin-resistant Enterobacter via lipid A modificationSmithRichard
1913Application of MALDI-TOF technology for microbial identification in laboratory environmental monitoringPeradottoMarco
1981Characterisation of the ocular microbial flora in patients undergoing cataract surgeryBottinoPaolo
2091Direct detection of PBP2a in Staphylococcus aureus from bacterial colonies with AcrionTM high resolution mass spectrometry systemHolmaTanja
2093Discrimination of theEnterobacter cloacae complex with AcrionTM System in clinical laboratoriesGurungSoniya
2111Revisiting identification within the Enterobacter cloacae complex by MALDI-TOF MSGodmerAlexandre
2121Perfomance of MALDI-TOF MS for identification of feces Aeromonas isolates at species levelRuiz De Alegría PuigCarlos
2124Direct MALDI-TOF MS testing from positive blood cultures for rapid identification of bloodstream infection-causing anaerobic bacteriaLiottiFlora Marzia
2514Identification performance of the new VITEK® MS PRIME MALDI-TOF system on a broad range of speciesGirardVictoria
2769Reduction of MALDI-TOF mass spectrometry plate well size improves limit of detection of microbial lipids 10-fold NilssonErik
2772Evaluation of Bruker MS, VITEK MS, Clin-ToF-II MS, Autof MS 1000, M-Discover 100, and VITEK 2 ANC card for identification of anaerobic bacteriaYuShu-Ying
2779Impact of organism identification from positive blood cultures by direct MALDI-TOF MS on antibiotic prescribing patterns in patients with bacteraemiaStokesWilliam
2970Direct identification and antibiotic susceptibility testing of microorganisms present in blood cultures using MALDI-TOF and the rapidBACpro® II kitRodriguez-SanchezBelen
3145MALDI-TOF mass spectrometry utility for the discrimination of the ST175 Pseudomonas aeruginosa high risk clone in a hospital outbreakRodriguez-SanchezBelen
3170Discrimination of Klebsiella oxytoca and Klebsiella michiganensis in clinics using AcrionTM systemGurungSoniya
3197The modified in-house method for direct identification of positive blood cultures by MALDI-TOF MS technologyHtoutou SedlakovaMiroslava
357Implementation of the direct identification and resistance detection from urine in routine diagnostic procedureZboromyrskaYuliya
3792Discrimination between Escherichia coli and Shigella spp. using liquid chromatography high-resolution mass spectrometry-based AcrionTM SystemViirtolaMarjaana
3930Validation of an in-house database for the identification of fungal isolates using MALDI-TOF mass spectrometryRodriguez-SanchezBelen
3948Evaluation of the VITEK® MS system for the identification of filamentous fungiRodriguez-SanchezBelen
3985Comparison between two rapid methods for identification and antimicrobial susceptibility testing from positive blood cultures using MALDI-TOF mass spectrometry and VITEK 2AsencioMaria Angeles
3988Evaluation of the MBT Sepsityper® IVD Kit for rapid Mycobacteria detection from positive blood culture bottlesCamaggiAnna
419Identification of Cutibacterium acnes from deep tissue cultures in clean primary implant shoulder surgerySallesMauro Jose Costa
4285The value of MALDI-TOF failure to provide an identification of staphylococcal species direct from blood cultures and  rule out of Staphylococcus aureus bacteraemia: a post-hoc analysis of the RAPIDO trialHamiltonFergus
4335Comparison of MALDI-TOF with genotype CM/AS hybridisation assay for the identification of non-tuberculous mycobacteria in a north-eastern setting hospitalSaccardoGiorgia
4447Comparison of two preparation methods for direct identification of bacteria from blood cultures by MALDI-TOF MSVelimirovićIvana
4639Rapid detection by MALDI-TOF MS of isolates from cystic fibrosis patients belonging to the epidemic clones A. xylosoxidans ST137 or A. ruhlandii DESGarrigosThomas
4952Improved time-to-result of microorganism identification on positive blood culture using AcrionTM systemFreekeJoanna
601Comparison of MALDI-TOF identification rates for the modified procedure of the cationic polymer technology, before and after protein extraction, with and without the Sepsityper® module analysisCaruanaGiorgia
921The clinical impact of rapid microbiological identification information using VITEK® MS in patients with infection by Gram-positive bacteriaUzuriaga MartinMiriam
Abstract NumAbstract titleLast nameFirst name
4839Vaccinated kidney transplant recipients remain at risk for severe COVID-19 infectionNesherLior
4978Case report: a 90-year-old lady infected with two CoVID-19 VoCs: 20I/501Y.V1 and 20H/501Y.V2VankeerberghenAnne
1014Effect of the FilmArray® Pneumonia Panel on antimicrobial treatment in community-acquired pneumoniaPaternotteNienke
1353GeneXpert MTB/RIF Ultra validation and performance on respiratory and non-respiratory clinical samples for rapid detection of Mycobacterium tuberculosis and its sensitivity to rifampicinTormo PalopNuria
1456Pathogens detected using a syndromic molecular diagnostic platform in patients hospitalised with severe respiratory illness in South Africa in 2017MolelekiMalefu
1586Careful interpretation of the detection of the single nucleotide deletion at position 117 in tcdC from commercial molecular assays in Clostridioides difficileAnantharajahAhalieyah
1636Trending of Lyme disease, anaplasmosis, ehrlichiosis and babesiosis in the Upper Midwest USA (2013-2020) based upon laboratory diagnostics in a rural healthcare systemFritscheThomas R.
1689What about prosthetic joint infections (PJI) diagnosis and bbFISH-ing in the sonication fluid?BirlutiuRares-Mircea
1833SMARTDIAGNOS: next-generation molecular sepsis diagnosis technology for whole blood samplesEnrothHelena
2041Comparison of laboratory methods for Streptococcus pneumoniae nasopharyngeal carriage detection in children and in adults MielletWillem
2056High agreement between Streptococcus pneumoniae serotypes detected by conventional culture and by qPCR in nasopharyngeal samples from carriersMielletWillem
2142Evaluation of the FILMARRAY® Pneumonia Plus panel assay for rapid detection of microorganism isolates versus conventional culture to detect lower respiratory tract infections in critical care patientsFernandez TorresMarina
218The usefulness of the FilmArray® BCID panel in the detection of bacteraemia: results of the first multi-centre study in Latin AmericaSoloagaRolando
2213Clinical performance of broad-range 16S and 18S rRNA gene PCR/real-time PCR and sequencing compared to culture diagnosis: a systematic review and meta-analysisLustigMichael
2290A Point-of-Care (POC) device for Pseudomonas aeruginosa infectionsMarco ColásM.-Pilar
2354Rapid identification of antibiotic resistance in respiratory samples using the automated BIOFIRE® FILMARRAY® and Curetis Unyvero rapid PCR-based pneumonia panelsEnneVirve Irene
2374Evaluating RNA preservation and recovery of SARS-CoV-2 from a collection and transport system for rapid point-of-care diagnostic testsBrazeauDaniel
2463Impact of the FILMARRAY®-based detection of microbial pathogens from positive blood culture vials on the time to optimal antimicrobial regimen in intensive care units of the Helios University Clinic Wuppertal, GermanySchumannJannik
25Usefulness of the BCID2 FILMARRAY® panel: an Argentinian multi-centre studySoloagaRolando
2542Evaluation of the Alinity m STI assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in oropharyngeal and rectal swab specimensNelsonKevin
2694Respiratory multiplex PCR panel: extraction of cycle thresholds and what can be learnt from themDumontYann
27Diagnostic yield of the BIOFIRE® FILMARRAY® gastrointestinal panel in haematology inpatients with hospital-onset diarrhoea in a tertiary hospital in SingaporeSngEdwin Chong Yu
2942Follow up of respiratory samples with the BioFire® FilmArray®: no more one per week?DauwalderOlivier
2956Impact of rapid molecular detection of sepsis on time to optimal antimicrobial therapy in paediatric cancer patientsKhedrReham
2959Evaluation of the MAX™ MDR-TB real-time PCR assay for detection of Mycobacterium tuberculosis complex DNA and resistance conferring mutations and as a screening test for targeted next-generation sequencingKetelsenHannah
2980Detection of Neisseria gonorrhoeae in genital and extragenital sites in men who have sex with men (MSM) in IndiaBhattacharyaAakashneel
3063Preliminary findings show that the QIAstat-Dx Gastrointestinal Panel 2 differentiates Shiga-like toxin genes (stx1 and stx2) from diarrhoeagenic Shiga toxin-producing Escherichia coli (EHEC/STEC) to aid diagnosing typical Hemolytic Uremic Syndrome (HUS)BoherPau
3201Contribution of multiplex PCR syndromic panel in diagnosis of pneumonia in intensive care unitBourgeois NicolaosNadège
348Carbapenemase and 16S RNA genes in the increment to the conventional diagnosis of sepsis in adult critical care patients in Rio de Janeiro: a single-centre cohort studyZenaide Ribeiro GomesMarisa
3492Rapid methicillin-resistant Staphylococcus Aureus (MRSA) detection using Panther Fusion® MRSA assayHenderikxMonique
3709When multiplexing makes a difference: clinical evaluation of a novel multiplex real-time PCR assay for the diagnosis of sexually-transmitted infectionsEscolarCristina
3835Implementation of multiplex PCR stool pathogen testing at a Canadian tertiary care centreHamulaCamille
3919Diagnostic accuracy of Point-of-Care tests in lower community-acquired acute respiratory tract infections: a systematic review and meta-analysisDe NardoPasquale
4075Validation of FluoroType® Enteric multiplex assayGreenJulie
410Clinical performance of four multiplex real-time PCR kits for the detection of seven urogenital and sexually transmitted pathogensPereyreSabine
4128Evaluating inactivation media for BioFire® RP2.1+ testing for biosafety cabinet-free processingRanganathanNisha
4261Aerococcus, Bartonella, Corynebacterium, Coxiella, Cutibacterium, Tropheryma whipplei, Rothia:  recent insights into rare causes for infective endocarditisMoterAnnette
4263Performance of FilmArray® Pneumonia Panel in patients hospitalised in ICUCamélénaFrançois
4382FilmArray® ME Panel: a two-year experience feedbackDauwalderOlivier
4457Diagnostic real-time PCR for detection and quantification of Lactobacillus crispatus in cytolytic vaginosisGasparCarlos
4500Clinical validation of the FluoroType® Mycobacteria assay for the rapid detection and identification of tubercular and non-tubercular mycobacteriaNiccolaiClaudia
4540Evaluation of Filmarray Pneumonia Plus pannel on Intensive Care Unit (ICU) patients with respiratory infectionsGarcía-LechuzJuan Manuel
4546Evaluation of loop-mediated isothermal amplification assay for detection of Clostridioides difficile infection: a prospective diagnostic performance studyGirãoEvelyne
4596Screening of sexually transmitted infections in pooled samples versus single-site testing by Nucleic acid amplification tests in men who have sex with menToscanoCristina
470Dual-priming isothermal amplification (DAMP) for highly sensitive and specific molecular detection with ultralow nonspecific signalsSfeirMaroun
485Evaluation of the Roche cobas MTB and MTB-RIF/INH assays in samples from Germany and Sierra LeoneNadarajanDarshaalini
4957Xpert® MTB/RIF Ultra for rapid diagnosis of extrapulmonary tuberculosis in a limited resource settingTafaHolta
540Evaluation of the BioFire FilmArray Pneumonia Panel for detection of bacterial pathogens in lower respiratory tract specimens in the setting of a tertiary care hospital ZarrasCharalampos
541Evaluation of FilmArray system for rapid identification of positive blood culturesZarrasCharalampos
548T2Bacteria Panel: clinical impact and comparison with blood culture and multiplex real-time PCRPaggiRiccardo
610LAMP point-of-care testing to guide antimicrobial choice for the treatment of canine pyodermaPiroloMattia
614Fast and sensitive multiplex PCR to detect Cutibacterium periprosthetic joint infectionsPrinzJulia
667Detection of bacteria in body fluids using a commercial blood culture identification PCR panel (BCID)TanThean Yen
69816S rRNA sequencing: comparison of the two next-generation sequencing (NGS) platformsSalamonDominika
731An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of low respiratory infections: a multi-centre prospective study on intensive care unit (ICU) patientsSunLingxiao
755Evaluation and correlation of broad-range bacterial 16S-rRNA gene-PCR with species-specific PCR and culture results: experience of a London teaching hospitalDe SarioValentina
773Advantage of the PCR test in aetiological diagnosis of infective endocarditisKotovaElizaveta
807Direct detection of sepsis pathogens using a commercial microarray, in comparison with commercial multiplex PCR and blood cultureSchmidtDirk
857Multi-site evaluation of reproducibility of the BD COR™ system with the BD CTGCTV2 assayGabrielaUribe
883Evaluation of an immunochromatographic assay for the identification of Mycobacterium tuberculosis complex in a low prevalence settingThompsonAmeeka
983Utility of polymerase chain reaction in nasopharyngeal swabs for identifying respiratory bacteria causing community-acquired lower respiratory tract infections (sUsPENSE)DemarsYoris
Abstract NumAbstract titleLast nameFirst name
4675Ozenoxacin antibacterial activity against worldwide Staphylococcus aureus and Streptococcus pyogenes isolates causing skin and soft tissue infectionsHernández-GarcíaMarta
4682NAD kinase: an original bacterial target for antibiotic developmentLeseigneurClarisse
4725Overview of susceptibility and clinical outcomes for isolates from cefiderocol global compassionate use programmeLongshawChristopher
4736Model-Based Dose Selection for the Phase 3 Evaluation of Molnupiravir in the Treatment of COVID-19 in AdultsGaoWei
4743Tribasic silver bisperiodate: a stable dual hypervalent complex with antimicrobial and antibiofilm activitySpinaCarla
4918In vitro cytotoxicity assessment of a novel formulation of polymyxin B (VRP-034)ChaudharySaransh
4944Cefiderocol Susceptibility in hypervirulent Klebsiella pneumoniae is dependent on Fur-mediated regulationStantonTom
4949Cefiderocol susceptibility in Klebsiella pneumoniae is dependent on expression of the iron transporters, CirA and FiuStantonTom
1117Discrimination of non-typhoidal and (para-)typhoidal Salmonella populations by Fourier-Transform Infrared (FTIR) spectroscopyDekkerDenise
1434Comparison and characterisation of Bacillus cereus isolates from industrial and clinical samplesSchmidPaul Jakob
181Characterisation of Clostridium difficile strains, the disease severity and the microbiome changes they causePeretzAvi
1870Haemophilus influenzae serotype distribution in Piedmont (Italy): results of 8 years of surveillanceBondiAlessandro
2626Detection of Legionella spp. and Legionella pneumophila in environmental samples using culture and live/dead-qPCRZamfirMihai
3350Molecular typing of NDM-producing Enterobacterales isolated from surveillance rectal swabs in a neonatal surgery unitAgostaMarilena
3495Prevalence and molecular typing of carbapenem-resistant Enterobacterales among pediatric patients in ItalyBencardinoDaniela
3711Characterisation of Haemophilus influenzae from healthy children attending day-care centres in the Lisbon region, 2015-2019Bajanca-LavadoMaria Paula
396A selective culture medium for screening carbapenem resistance in Pseudomonas spp. FournierClaudine
3974A cluster of wound infections due to Panton-Valentine leukocidin positive conmunity-acquired Staphylococcsus aureus in El Hierro islandGarcía Martínez De ArtolaDiego
4900Clinical and microbiological characteristics of ST11 Klebsiella pneumoniaeYangPing
785Risks posed by car washes: detection of Legionella in water and air samples using culture method and qPCRRedwitzJohannes
Abstract NumAbstract titleLast nameFirst name
4636Cerebrospinal fluid and plasma pharmacokinetics of ceftazidime, avibactam and ceftaroline in healthy volunteersWölfl-DuchekMichael
4832Intrathecal synthesis index of specific anti-treponema IgG: a new tool for the diagnosis of neurosyphilisAlbertoChloe
4899Delafloxacin clinical response by causative pathogen of surgical site infections: a microbiologically enriched and difficult to treat acute bacterial skin and skin structure infection (DRESS study)NutiAlessandra
1813Comparisons of bioinformatics pipelines for whole genome sequence diagnostics of Staphylococcus aureusPernestigAnna-Karin
1863Molecular characterisation of carbapenemase-producing Enterobacterales colonising elderly people discharged from hospital in Italy: focus on persistent carriageTinelliMarco
2003Spoligotyping of Mycobacterium tuberculosis: comparing in vitro and in silico strategiesBakułaZofia
2148Vaccine-induced population restructuring alters the prevalence of pneumococcal bacteriocins in Icelandic and Kenyan genomic datasetsButlerMadeleine E B
2311Genomic analysis of Cutibacterium acnes strains isolated from prosthetic joint infections and healthy skinSalar VidalLlanos
2431Investigation of multiple copies of 16S rRNA genes with intragenomic heterogeneity in four clinical strains representing a proposed novel species of the genus AlloprevotellaBuhlMichael
2589Description of Eikenella glucosivorans sp. nov. with glucose metabolisation ability and emended descripition of the genus Eikenella to include species which are saccharolyticBuhlMichael
3255Evaluation of direct whole-genome sequencing from diagnostic samples in high-burden tuberculosis countriesMariner-LlicerCarla
3292Proposal of Parvimonas parva sp. nov., a second species in the hitherto monotypic genus ParvimonasBuhlMichael
3323Prediction of antimicrobial resistance in clinical isolates of enterococci by whole-genome sequencingCattoirVincent
3329Accelerating contact tracing investigations using targeted sequencingDümckeSebastian
4203A novel deep sequencing platform for genotyping and drug resistance detection of Mycobacterium lepraeBraetSofie
4265Defining publicly available whole-genome multilocus sequence typing schemas: the example of Streptococcus pyogenesRamirezMario
4444First description of in-host excision of the pathogenicity island harboring the toxic shock syndrome toxin-1-encoding gene in a methicillin-resistant Staphylococcus aureus from Cystic Fibrosis patientsBoudetAgathe
4542Genomic characterisation of Neisseria meningitis from the Russian FederationGostevVladimir
4673PulseNet international: integrating pulsed-field gel electrophoresis and whole genome sequencing for bacterial disease surveillance and outbreak investigations by means of suggested image analysis, bioinformatics database and simulation algorithmsAdamIbrahim El-Khalil
4709Genomic characteristics of clinical Brucella melitensis (Bm) isolates from Southern IsraelZilbermanBar
4787Comprehensive pathogen identification, antibiotic resistance and virulence genes prediction directly from simulated blood samples and positive blood cultures by nanopore metagenomic sequencingZhouMenglan
4819Genomic analysis of clinical multidrug-resistant Staphylococcus epidermidis isolated from bloodstream in the Kwazulu-Natal province, South AfricaAsanteJonathan
521Subtyping Escherichia coli in spontaneous bacterial peritonitis with use of Bruker Infrared (IR) Spectroscopy Biotyper and whole genome sequencingTanJaclyn Yizhen
98Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001–2018JevericaSamo
Abstract NumAbstract titleLast nameFirst name
1114Small intestinal bacterial overgrowth and gut microbiota composition following one anastomosis gastric bypass (OAGB)KanielOsnat
1183Alterations in the gut microbiome of golden jackal (GJ, Canis aureus) in different rabies hot-spots in IsraelLapidRoi
1376Increased colonisation by Candida tropicalis in children with active Crohn's diseaseKrawczykAgnieszka
1449Relationship between carbapenem-resistant Enterobacterales carriage and gut microbiome after liver transplantation: a longitudinal prospective cohort studyRinaldiMatteo
1467The role of the microbiome in the periodontal, peri-implant and healthy sitesSantagatiMaria
1489Microbiological aspects of Pseudomonas aeruginosa infection in children with cystic fibrosisIshchenkoOksana
2161Group B Streptococcus and methicilin-resistant Staphylococcus colonisation among pregnant women before and after the onset of COVID-19 pandemic in BrazilPintoTatiana
2204An innovative approach to the prevention of diabetes mellitus based on the composition of the intestinal microbiotaZagainovaAngelica
2245Pan-genome of urogenital Prevotella corporis and Prevotella brunnea: unexplored species among human microbiomeKsiezarekMagdalena
2255Environmental microbiota: identifying the hidden hell of a hospital roomVan Der SchoorAdriënne S.
2687Culture-free discovery and host-attribution of viruses, plasmids, and ARGs in metagenomes using proximity ligation (Hi-C) technologyLiachkoIvan
3025Analysis of gut colonisation by yeast in children with newly diagnosed coeliac disease and assessment of changes after a 6-month period on a gluten-free dietKrawczykAgnieszka
3082Distinct microbiota in patients diagnosed with colorectal cancer compared to healthy individuals   OlaussonAnne Mari
3124The most powerful hypervariable regions of 16S rRNA for taxa identification in sputumLopez-AladidRuben
3270Evaluation of the occurrence of methanogenic Archaea among children with Crohn's diseaseKrawczykAgnieszka
3301Occurrence and diversity of Gardnerella spp. in the midstream urine and vaginal swabs of asymptomatic womenRocha De SousaMárcia Daniela
3673Fungal diversity in the gut microbiome of young South African childrenNel Van ZylKristien
383Vaginal microbiome in the third trimester of pregnancy among women at Rahima Moosa Mother and Child Hospital (RMMCH)EmvulaSimon
3838Insights into Corynebacterium species diversity and stability in healthy urogenital microbiomeCappelliElisabete Alves
4308Quantitative investigation of treatment-related changes of Bacteroides fragilis, Prevotella copri, Bifidobacterium bifidum and Lactobacillus salivarius species in gut microbiota in patients with rheumatoid arthritisYazici OzçelikEda
4779Molecular analysis of the vaginal microbiome applying the Femoflor®16 test system in women with non-specific colpitisPurkathoferSandra
4837Akkermansia muciniphila in multiple sclerosisTarasovaElena
Abstract NumAbstract titleLast nameFirst name
1374Microbiome in celiac disease: changes in microbial profile along the gastrointestinal tract revealed by 16S rRNA high-throughput gene sequencingMarcos ZambranoLaura Judith
2960Unveiling the great mimicker: rapid diagnosis of spinal brucellosis by next-generation sequencing in a low incidence rate areaYaoYumeng
3153Metagenomic technique to identify Sudanese females’ vaginal microbiota and microbiota associated with bacterial vaginosisMohamedDeena
4486Ecology and phylogeny of the genus Elizabethkingia in the hospital environmentD. FernanDez-De-BobadillaMiguel
Abstract NumAbstract titleLast nameFirst name
1423In silico analysis of mechanisms underlying Porphyromonas gingivalis-triggered rheumatoid arthritisMaKevin Sheng- Kai
1475Bioinformatic analysis of the association between gastrointestinal dysbiosis and chronic fatigue syndromeMaKevin Sheng- Kai
1812Effect of mutation on AmpC promoter in multidrug-resistant isolates of diarrhoeagenic Escherichia coli in childrenSinghTaru
2029Evaluation of the accuracy of bioinformatics tools for genotypic species identification of clinical Klebsiella spp. isolatesTilevikDiana
2048Simplified phage identification from clinical sequencing dataMarquetMike
4175Fast, faster, fastest: improving an allele calling algorithm for whole-genome multilocus sequence typing (wgMLST)RamirezMario
4508Bacterial Taxonomic Identifier (BACTAX-ID): a new method for plasmid, viral and bacterial classificationD. FernanDez-De-BobadillaMiguel
Abstract NumAbstract titleLast nameFirst name
1002In vivo efficacy of BV100 in mouse models of Acinetobacter baumannii infectionLociuroSergio
1003Comparison of the pharmacokinetics of oral rifabutin and intravenous BV100 in ratsLociuroSergio
1007Rifabutin synergy / antagonism with Standard of Care (SoC) antibiotics in Acinetobacter baumanniiLociuroSergio
1139Pharmacodynamics of piperacillin/tazobactam-amikacin combination therapy versus meropenem monotherapy against piperacillin/tazobactam-resistant ESBL-producing Escherichia coli clinical isolates in a dynamic hollow-fibre infection model (HFIM)IslamKamrul
1140Phage/antibiotic combinations to eradicate Pseudomonas/Candida multi-infectionsManoharPrasanth
1254Pharmacodynamics of meropenem, cefepime and aztreonam in combination with a novel β-lactam, nacubactam against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae with murine pneumonia modelMaoHagihara
1256Novel β-lactamase inhibitor, nacubactam enhanced meropenem, cefepime and aztreonam activity against carbapenem-resistant and/or carbapenemase-producing Enterobacter cloacae in murine pneumonia modelMaoHagihara
1393The polyamino-isoprenyl compound NV716 resensitises old disused antibiotics against Pseudomonas aeruginosa (PA) by inhibiting efflux and disturbing outer membrane permeabilityWangGang
1395Adaptation of a lytic mutant phage for the generation of an antibiofilm phage cocktail with potential use in phage therapyBlascoBlasco
1510Activity of KBP-7072, a novel aminomethylcycline antibacterial, and tetracycline class comparators against 1,057 bacterial pathogens collected worldwide during 2019HubandMichael D.
1522In vitro activity of sulbactam/durlobactam against recent global clinical Acinetobacter baumannii-calcoaceticus complex isolatesMcleodSarah
1602In Vitro activity of nacubactam in combination with aztreonam or cefepime against ß-lactamase-positive Enterobacterales isolatesMorrisseyIan
1634Evaluation of vancomycin and flucloxacillin nephrotoxicity in comparison with vancomycin in a rat modelPaisGwendolyn M.
1638Evaluation of vancomycin slow and continuous infusion on nephrotoxicity in a rat modelPaisGwendolyn M.
1727Preventive effect of prebiotic inulin against intestinal colonisation by carbapenem-resistant Escherichia coli in a mouse modelIshnaiwerMurad
1732Targeting coagulase-negative staphylococci causing prosthetic infections with bacteriophages: can we use polyvalent anti-Staphylococcus phages?Kolendacamille
1733Revival of an old anti-alcoholic drug to fight biofilm infections on hernia meshesKaulLaurine
1792Phage discovery: isolation and characterisation of sixteen novel anti-Staphylococcus aureus bacteriophagesKolendacamille
1829HF-App, a R-Shiny web application to streamline calculations involved single-drug and combination hollow-fiber experimental setupAranzana-ClimentVincent
1881Double-carbapenem combinations against KPC-2-, OXA-48- and NDM-producing Escherichia coli and Klebsiella pneumoniaeAllanderLisa
2014Aminoglycoside susceptibilities of carbapenem-resistant Acinetobacter baumannii (CRAB)HaldimannKlara
2120Virulence factor quenching antibodies as a therapeutic strategy to treat Pseudomonas aeruginosa infectionsVilaplanaLluïsa
2128Cefepime/taniborbactam (formerly cefepime/VNRX-5133) demonstrates potent activity versus Enterobacterales with blaOXA-48ZeiserElise T.
2144Examining the antimicrobial activity of cefepime/taniborbactam (formerly cefepime/VNRX-5133) against Burkholderia species isolated from cystic fibrosis patients in the United StatesZeiserElise T.
2189In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072) against clinical isolates with molecularly-characterised tetracycline resistance mechanismsMendesRodrigo E.
2234The penicillin-sulfone inhibitor LN-1-255 restores in vitro β-lactam efficacy against a contemporary Spanish collection of Acinetobacter spp. clinical isolatesLasarte MonterrubioCristina
2249Isolation and characterisation of a novel JUMBO phage active against the emerging ST307 carbapenemase-producing Klebsiella pneumoniae cloneKolendacamille
2296Combination activity of azidothymidine and colistin against colistin-resistant Klebsiella pneumoniae in a murine model of urinary tract infectionThommesPia
2299Zidovudine plus fosfomycin: synergistic effect against clinical isolates of multidrug-resistant Enterobacterales - in vitro and in vivo evidenceAntonelloRoberta Maria
2301Uncovering novel antimicrobial agents for the treatment of wound infectionsAlves FerreiraDaniela
2465Simulating the use of phages by inhalation for respiratory tract infectionsGelmanDaniel
2544Metal-free antibacterial additives based on graphene materials and salicylic acid: from the bench to fabrics applications CacaciMargherita
2563In vitro antimicrobial activity of liposomal ceftriaxone against clinical strains isolated from companion animals with urinary tract infectionsAguiarSandra
2577In vitro activity of delafloxacin against resistant Gram-positive isolates from clinical samples in a tertiary hospitalDíaz De La TorreIrene
2586Antibacterial compounds targeting the DNA polymerase III holoenzymeCaputoAlessia
2613Antimicrobial efficacy and kinetics of bacteriophages in a murine model of disseminated carbapenemase-producing Klebsiella pneumoniae (KPC) infectionZagaliotisPanagiotis
2635Influence of pH on the antimicrobial activity of probiotics against carbapenemase-producing Klebsiella pneumoniae (KPC)Freire GasparettoIsabella
2660Development of DNA aptamers against multidrug-resistant Acinetobacter baumanniiCôrtesMarina Farrel
2732Assessment of antimicrobial molecules and bacteriocins isolated from Pseudomonas species for activity against multi-drug resistant bacteriaAdufa-AppeagyeiSandra
2891Failure of intravesical bacteriophages for treating a recurrent urinary tract infection (rUTI)MccallinShawna
2892Antibiotic-derived fluorescent probes to interrogate bacteria-antibiotic interactionsBlaskovichMark A. T.
2923Discovery of sub-micromolar inhibitors of the virulence factor LasB from Pseudomonas aeruginosa using rational designKieferAlexander Felix
2957Ketone- and cyano-selenoesters as potent antibacterial and anti-cancer agentsSzemerédiNikoletta
2977Bactericidal activity of sodium bituminosulfonate against Staphylococcus aureusIdelevichEvgeny A.
3083Antimicrobial thin coatings for functional implantable devicesGrumezescuValentina
3147Interaction of the new diazabicyclooctane (DBO)-β-lactamase inhibitor ANT3310 with clinically relevant β-lactamases: a biochemical studySannioFilomena
3150Azithromycin possesses biofilm–inhibitory activity and potentiates non-bactericidal colistin methanesulfonate against Klebsiella pneumoniaMoshynetsOlena
3205Activity of cefepime in combination with the new β-lactamase inhibitors enmetazobactam, zidebactam and taniborbactam against a Spanish nationwide collection of carbapenemase-producing EnterobacteralesVazquez-UchaJuan Carlos
3211Pharmacodynamic drug-drug interactions of antimicrobial combinations for treatment of Gram-negative infections SadoukiZahra
3219In vitro bacteriophage-host dynamics and their potential application against multidrug-resistant clinical Klebsiella pneumoniae solatesLiNa
3228Laser modified antimicrobial wound dressings coated with core/shell and zinc oxide (ZnO) nanoparticlesGrumezescuValentina
325In-vitro activity of lytic phages against Klebsiella pneumoniae clinical isolates: characterisation of phage vB_KpM-VAC13Pacios SantamaríaOlga
3257Activity of the β-lactamase inhibitor LN-1-255, a 6-(2-pyridyl)methylene penicillin-based sulfone, against a Spanish nationwide collection of OXA-48-producing EnterobacteralesVazquez-UchaJuan Carlos
3285Assessment of activity of a novel orally bioavailable β-lactam/β-lactamase inhibitor combination, ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) against Enteroactberales carrying blaOXA-48ZeiserElise T.
3404Identification of the mechanism of action for ridinilazole, a phase III antibiotic for treatment of Clostridioides difficileAvisTim
3413The spectrum of infection of phages against Klebsiella pneumoniae is highly variable being the bacterial capsule their main targetBeamudBeatriz
3426New antibacterial treatment strategies for Acinetobacter baumannii infectionsGarcia TorresSara
3694In vitro microdialysis of gepotidacin and suitable internal standards for in vivo calibrationLufAnton
3718Validation and improvement of a computational model of lipopolysaccharides' synthesis pathway with potential for identification of novel antimicrobial drug targetsGeorgeJohn
3785Rifabutin liposomes as a powerful duo for the treatment of Staphylococcus aureus infectionsFerreiraMagda
379Pharmacokinetic-pharmacodynamic target attainment analysis to support dose selection for nacubactam in combination with aztreonamBhavnaniSujata M.
384Pharmacokinetic-pharmacodynamic arget attainment analyses to support dose selection for nacubactam in combination with cefepimeBhavnaniSujata M.
385Characterization of nacubactam pharmacokinetics-pharmacodynamics (PK-PD) for efficacy in combination with aztreonam against carbapenemase-producing Enterobacterales in a one compartment in vitro infection modelVanscoyBrian D.
386Determination of nacubactam exposure in combination with aztreonam, required to orevent the emergence of on-therapy resistance utilising an in vitro hollow fiber infection modelVanscoyBrian D.
388Determination of nacubactam exposure in combination with cefepime, required to prevent the emergence of on-therapy resistance utilising an in vitro hollow fiber infection modelVanscoyBrian D.
3969CF-370, a systemically administered lysin with in vivo efficacy against a carbapenem-resistant Pseudomonas aeruginosa strain in a rabbit pulmonary infection modelLehouxDario
4164Efficacy of new promising di(heteroaryl)ethenes derivatives on Gram-positive bacteria in vitro and in an infection modelStracquadanioStefano
418Therapeutic antimicrobial polymers: the polycationic oligoethyleneimine killing performance against KPC- and OXA-48-producing Klebsiella pneumoniae clinical isolatesPintoSandra N.
4210Influence of chemical composition on the antichlamydial effect of liposome encapsulated azithromycinVarga-BogdanovAnita
4296The use of bacteriophages against root canal infection caused by Enterococcus faecalis VoitMarie Luise
4304Synthesis and characterisation of doxycyline-loaded amorphous calcium phosphate nanoparticles for antibacterial applicationsDe Lama-OdríaMaría Del Carmen
4372Structural and biochemical characterisation of ANT3273, a novel antivirulence compound, with Pseudomonas aeruginosa LasB elastaseEverettMartin
4481Bacteriophage therapy in orthopedic and cardiovascular surgery: clinical experience in six patients with difficult-to-treat infectionsMorovicPaula
4530Increased antibacterial properties of indoline-derived phenol Mannich bases CaladoRita
4659Guanidino lipoglycopeptides: novel glycopeptide antibiotics with potent in vitro and in vivo activityVan GroesenEmma
481Octenidine: novel insights into the detailed killing mechanism of Gram-positive bacteria at a cellular and molecular levelMalanovicNermina
498Surface-functionalised liposomes to deliver therapeutic nucleic acids in Escherichia coliMoreiraLuís
533Evaluation of pharmacokinetics/pharmacodynamics relationship of nacubactam in combination with cefepime against β-lactamase-producing Enterobacterales in murine thigh and lung infection modelsNagiraYu
534Evaluation of pharmacokinetics/pharmacodynamics relationship of nacubactam in combination with aztreonam against β-lactamase-producing Enterobacterales in murine thigh and lung infection modelsNagiraYu
577In vitro synergism of penicillin/ceftriaxone against Enterococcus faecalisThiemeLara
600Development of a phage cocktail for antibiofilm feature of Proteus mirabilis catheter-associated urinary tract infectionsMirzaeiArezoo
688Novel in vitro synergistic combinations in the treatment of nontuberculous mycobacteriaGómara LomeroMarta María
722Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by infection type, 2019-2020SaderHelio S.
787Antibacterial activity of gepotidacin against Stenotrophomonas maltophiliaKirchhoffLisa
863Therapeutic efficacy of ethionamide boosted with BVL-GSK098 in an acute murine model of tuberculosisRullásJoaquín
893Antimicrobial activities of cefepime, meropenem, aztreonam, and piperacillin combined with nacubactam against molecularly-characterised Enterobacterales collected worldwideSaderHelio S.
997Identification of new drugs for Neisseria gonorrhoeae using an in silico repurposing strategyRodriguesLiliana
998Efficacy of BV100 against Staphylococcus aureus in neutropenic thigh and lung infection mouse modelsLociuroSergio
Abstract NumAbstract titleLast nameFirst name
1013A translational rat model to assess kidney function changes with the addition of piperacillin/tazobactam to vancomycinChangJack
1069Therapeutic drug monitoring is necessary for patients receiving posaconazole tabletsZhouYvonne
1073Electronic cell counting facilitates quantification of persister formation of Escherichia coli under levofloxacin exposure in static and dynamic in vitro infection model experimentsSeegerJohanna
1094Reduced vancomycin exposure following a switch from trough to area under the curve (AUC) -based therapeutic drug monitoring (TDM)NgRong Xiang Kevin
1207Comparison of fixed-based and exposure-matched-based dosing of aminoglycosides in adult patients with cystic fibrosisRohaniRoxane
1236Initial vancomycin dosing protocol for haemodialysis patients and the revised 2020 consensus guidelines on monitoring vancomycin for serious methicillin-resistant Staphylococcus aureus (MRSA) infectionsZelenitskySheryl
1244Evaluation of cefiderocol exposure based on pharmacokinetic and pharmacokinetic/pharmacodynamic parameters in critically-ill patientsKatsubeTakayuki
1251Aminoglycosides in the intensive care unit: what's new in population PK modeling?DuongAlexandre
1295Determining levels of polymyxin B components B1, B2, B3 and isoleucine-B1 in plasma, urine and bacteria growth media: a simple and rapid 3-in-1 LCMS assayTohWilson Ghim Hon
1300Higher meropenem concentrations in brain tissue compared to cerebrospinal fluid in neurointensive care patientsSanz CodinaMaria
1316Gepotidacin (GSK2140944) demonstrates similar safety and pharmacokinetics in adults and adolescents (12 to 18 years)BarthAline
1382Pharmacokinetics and pharmacodynamics of the odilorhabdin NOSO-502 in a thigh infection model in neutropenic miceVan Den BergSanne
1497A lockdown literature review of antimicrobial extended stability in elastomeric infusersJenkinsAbi
1505VancoEasy: a mobile app for vancomycin dosing and dose adjustment in daily practiceChiriacUte
1506A physiologically-based pharmacokinetic model to explore the blood-milk barrier in lactating species: case study with oxytetracyclineTardiveauJennifer
1508A pharmacokinetic/pharmacodynamic analysis of high-dose, once-daily ceftriaxone for outpatient treatment of methicillin-susceptible Staphylococcus aureus (MSSA) infectionsZelenitskySheryl
1517Do intensive care unit (ICU) patients with severe infection reach target attainments during the important first days of treatment with β-lactams?SmekalAnna-Karin
1585Cefiderocol in critically ill patients with multi-drug resistant pathogens: real-life data on pharmacokinetics and microbiological surveillanceKönigChristina
1655In Vivo activity of novel siderophore-monobactam conjugates XNW801101 and XNW801102 against Pseudomonas aeruginosaAbdelraoufKamilia
1657In vitro susceptibility of ceftazidime/avibactam (CZA) and comparator antimicrobial agents against carbapenem-resistant Enterobacterales (CRE) from a large tertiary hospital in SingaporeLimTze Peng
1766Ciprofloxacin pharmacokinetics in morbidly obese individuals and healthy volunteers: a prospective clinical studyVan RheeKoen Patrick
1803Caspofungin population PK analysis in plasma and peritoneal fluid in septic patients with intra-abdominal infectionsGarbezNicolas
1805A PK/PD model-based analysis of tedizolid against E. faecalis in a hollow fibre infection modelIqbalKhalid
1856Population pharmacokinetics and dosing simulations of vancomycin administered by continuous infusion in critically ill patientsGarreauRomain
1929Vancomycin and the AUC threshold for nephrotoxicityLeeWee Boon
1953Activities of omadacycline alone and in combination with rifampin against Staphylococcus aureus and Staphylococcus epidermidis in biofilm time-kill analyses and a novel in vitro biofilm pharmacokinetic/pharmacodynamic modelMorrisetteTaylor
2024Population pharmacokinetic/pharmacodynamic study of ceftaroline after multiple doses administration in critical care patients with early-onset pneumonia and normal or augmented renal clearanceGrégoireNicolas
2136Pharmacometric analysis to evaluate dose adjustments of amoxicillin in hospitalised patients with impaired kidney functionSenSwapnoleena
2154In vitro PK/PD analysis of the impact of the size of the inoculum of Acinetobacter baumannii on polymyxin BAkrongGrace
2173Pharmacokinetic/pharmacodynamic modeling of gepotidacin against Escherichia coli and Neisseria gonorrhoeae in an in vitro hollow fiber infection modelMarchandSandrine
2177In vivo PK/PD analysis of the impact of the size of the inoculum of Acinetobacter baumannii on polymyxin BAkrongGrace
2240The in vitro effect of dual carbapenems on killing over time on carbapenemase producing Klebsiella pneumoniae isolates using clinical dosage based pharmacokineticsIyerCaitlin
2252Exposure to liposomal amphotericin B in critically ill patients: a prospective observational pharmacokinetic studyVan DaeleRuth
2257Height is predictive of tobramycin pharmacokinetics in adult cystic fibrosis patientsKoloskoffKevin
2268A Monte Carlo PK/PD simulation of the cumulative fraction of response for cefiderocol versus other antibacterial agents against suspected multidrug-resistant Gram-negative bacteriaJensenKlaus Skovbo
233Prescribing practices of intravenous vancomycin by French infectious disease specialistsLemaitreMarine
2524Probenecid, an old beta-lactamines pharmacokinetic enhancer for a renewed use?: a retrospective studyHuriezPauline
2592Pharmacokinetic study of colistin in patients with pneumonia caused by extensively drug-resistant Pseudomonas aeruginosaSorlíLuisa
2616Rationally optimising therapeutic combination therapies against multiple clinical Klebsiella pneumoniae isolates co-expressing New Delhi metallo-β-lactamase (NDM) and CTX-MSmithNicholas M
2713Synergistic killing of Klebsiella pneumoniae by double β-lactam combinations assessed via flow cytometry and quantitative systems pharmacologyShinEunjeong
272Pharmacokinetic/pharmacodynamic analyses of meropenem against major Gram-negative bacterial pathogens collected in Vietnam from June to December 2019TaniShunsuke
2744Thermal stability of β-lactam antibiotics in broth, agar and water: precisely achieving target concentrations in vitro by supplement-dosing algorithm that offset thermal degradationZhouJieqiang
2821Outer membrane (OM) permeability of six β-lactams in New Delhi metallo-β-lactamase (NDM) and CTX-M-co-producing Klebsiella pneumoniae (KP)YinzhiLang
2883Daptomycin pharmacokinetics and pharmacodynamics in critically ill patients undergoing extracorporeal membrane oxygenation (ECMO)WangHaofei
291Comparative bactericidal activity of representative beta-lactams against Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosaMacgowanAlasdair
3105Impact of individual ascitic fluids on growth of Escherichia coli and antimicrobial effect of ceftriaxoneVan OsWisse
3177A neonatal population pharmacokinetic model of flomoxef and assessment of neonatal flomoxef regimensDarlowChristopher
3189Synergistic effect of fosfomycin with flucloxacillin against Staphylococcus aureus in vitroNussbaumer-PröllAlina Karoline
3229Cefiderocol therapeutic drugmMonitoring (TDM) in a patient on dialysis, infected with imipenem-resistant Acinetobacter baumanii (IRAB) in the intensive care unit (ICU)CappeArnaud
3284Evaluation of gentamicin therapeutic drug monitoring in cardiac surgery, using population pharmacokineticsBashirNadhia
3503Effect of albumin on protein binding and pharmacokinetics of piperacillin/tazobactam in patients with severe burn injuryBergmannFelix
3697Impact of cytokine adsorber on clearance of several antibiotics in a critically ill patientFallerJonas Joseph
378Population pharmacokinetic analysis for nacubactam using data from Phase 1 studiesTrangMichael
3818Pharmacokinetics and pharmacodynamics of BV100 in neutropenic mouse lung infection modelsDaleGlenn E.
3976Pharmacokinetics of dalbavancin using 1g every 2 weeks for bone and joint infectionsMorata RuizLaura
4002Pharmacometric evaluation of fosfomycin/sulbactam combination against carbapenem-resistant Acinetobacter baumanniiMohd Sazlly LimSazlyna
4022Pharmacodynamic evaluation of meropenem and sulbactam in combination against carbapenem-resistant Acinetobacter baumanniiMohd Sazlly LimSazlyna
4103Optimal PK/PD target, efficacy and safety of daptomycin: a therapeutic drug monitoring retrospective monocentric analysisRío NoLaura
4411Setting up of a model for the study of antibiotic protein binding and prediction of interferences by other drugs: application with temocillinNgougni PokemPerrin
4732Cerebrospinal fluid pharmacokinetics of ceftobiprole in neurosurgical patients with external ventricular drainChavanetPascal
478Dose selection for phase III studies evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urinary tract infectionsScangarella-OmanNicole E.
479Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of gonorrhoeaScangarella-OmanNicole E.
4805Variable exposure to bedaquiline in multidrug-resistant tuberculosis treatment and its impact on treatment responseZhengXubin
4946Pharmacokinetics and pharmacodynamics of minocycline against Burkholderia cenocepacia in bronchopulmonary infectionVermaSalony
638Distribution and exposure of gepotidacin (GSK2140944) in tissues and body fluids of healthy and infected participantsBarthAline
660Pharmacokinetics of oral tebipenem pivoxil hydrobromide in subjects with varying degrees of renal impairmentGuptaVipul
678Therapeutic drug monitoring of β-lactam antibiotics: deviations in documentation and its impact on dose decisionsSwartlingMaria
693Relationship between pharmacokinetic/pharmacodynamic target attainment of meropenem and change in inflammatory biomarkers in critically ill patients: a prospective observational studyTroisiCarla
700Emesis is not associated with substantive changes in the pharmacokinetics of the novel antibiotic gepotidacin (GSK2140944)BarthAline
812Continuous infusion of tigecycline as an improved treatment option? Insights from a hollow-fibre studyAmannLisa F.
833A pharmacokinetically-based approach to predict anti-mutant efficacy of combined doripenem and levofloxacin therapy in in vitro model studies with Pseudomonas aeruginosaZinnerStephen H.
848Determination of recovery and optimal calibration technique for piperacillin-tazobactam and meropenem: an in vitro microdialysis studyHermansEline
933A population pharmacokinetic model of cefotaxime in intensive care patients can provide support for individual dosingSwartlingMaria
Abstract NumAbstract titleLast nameFirst name
1451Microbiological characterisation of Enterobacterales baseline qualifying pathogens obtained from adult patients participating in the ALLIUM Phase 3 study comparing cefepime/enmetazobactam to piperacillin/tazobactam for the treatment of complicated urinary tract infections/acute pyelonephritis (cUTI/AP)BelleyAdam
2507Real-world, multi-centre experience with eravacycline for complicated infectionsAlosaimySara
2973Fosfomycin use in the treatment of periprosthetic joint infection (PJI): a first impression in the NetherlandsTelgtDenise
3231Drug repurposing as an effective strategy to treat multidrug-resistant infections: “Teaching old drugs new tricks”Alves FerreiraDaniela
3523Influence of tedizolid on circulating cytokines in the human lipopolysaccharide challenge       JordaAnselm
3717Bacteriocin production in CoNS and CoPS isolates with antimicrobial activity against relevant pathogensFernández FernándezRosa
3899Meropenem/fosfomycin combination: an effective treatment for carbapenem-resistant complicated urinary tract infections from both in vitro evaluation and clinical case studyMoreira Netoluiz jorge
4507Cefiderocol as rescue therapy for carbapenem-resistant Gram-negative infections in ICU patients: early single-centre experience, Pisa, Italy (2020)TiseoGiusy
655Imipenem/cilastatin/relebactam efficacy, safety, and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia and renal impairment or augmented renal clearanceChenLuke
793Determining the location of Burkholderia pseudomallei in vivo following cessation of antibiotic treatmentHardingSarah
940Post hoc analysis of a subgroup of patients with carbapenem-resistant infections receiving rescue antibiotic therapy in the CREDIBLE-CR studyLongshawChristopher
Abstract NumAbstract titleLast nameFirst name
100Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhoea in Japan from 2013 to 2018OnoAkane
1000Determinants of antimicrobial resistance among the different European countries: more than antimicrobial consumptionPaivaJose Artur
1098Healthcare costs of target attainment of β-lactam antibiotics in critically ill patients: a retrospective analysis of the EXPAT studyEwoldtTim
1175Antibiotic-related online queries by the Hungarian population: an infodemiological and thematic analysis using Google TrendsGajdácsMárió
1209Pattern of surgical antibiotic prophylaxis in 18 Nigerian hospitals: a need for urgent interventionIregbuKenneth
1240Impact of a nationwide cefazolin shortage on antimicrobial supply in JapanKoizumiRyuji
1270Impact of multidisciplinary antimicrobial stewardship care bundle in the management of Staphylococcus aureus bacteraemia in an adult tertiary hospital in SingaporeShafiHumaira
1313Systematic review of antimicrobial stewardship programmes in long-term care facilitiesCrespo-RivasJuan Carlos
1406Mortality predictors in patients from whom blood cultures are obtained: the NO-BACT projectGirón OrtegaJose Antonio
1518Global Antimicrobial Resistance and Use Surveillance System (GLASS) in the African continent: early implementation 2017-2019Pessoa Da SilvaCarmem Lucia
1710Adherence to the 2019 national CAP guidelines at an American academic centre: did we change our practice?  SunBo
2026C-reactive protein testing and antibiotic use in medicine departmentsIgawaMay
2067Impact of implementing a multidisciplinary sepsis bundle in a community, non-teaching hospitalPolisettyRadhika
2224Noncompliance with microbiology culture report: opportunities to fill the gap for improved antibiotic stewardshipAl-HamadArif M.
2225Antibiotic stewardship attitudes and beliefs among frontline staff nurses: impact of virtual education in the COVID-19 eraPolisettyRadhika
2306Establishing antimicrobial stewardship programs in two provincial-level hospitals in Vietnam through an implementation research approach: an interim evaluation of the impact on prescribing practicesVuThi Lan Huong
2348Adherence to empirical antimicrobial stewardship guidelines in outpatients: point prevalence surveyNicolasJordi
238Evaluation of (in)appropriate antibiotic prescription in the emergency department: a single-centre retrospective studyOomenPatrick G.a.
2436What does antimicrobial stewardship look like where you are? Global narratives of clinical, academic and lay learners participating in a massive open online learning course on antimicrobial resistanceBonaconsaCandice
2449Impact of an Antimicrobial Stewardship Programme (ASP) on hospital-acquired candidaemia in a tertiary care Spanish hospitalEspinosa PerezMaria
2541Low antibiotic consumption despite doubled number of positive blood cultures in COVID-19LaszloffyBeata
2633Real-life economic impact of dalbavancinBeraudGuillaume
2729Antimicrobial stewardship bundle since the creation of a COVID-19 patients' non-invasive ventilation unit: a stitch in time saves nineFavierPatricio
2763An artificial intelligence system for antimicrobial prescription supportPillonettoMarcelo
2807Prospective audit and feedback implementation in two provincial hospitals in Vietnam: a pilot studyNguyen Thi CamTu
2833Development of antimicrobial stewardship program (ASP) and determination of its economic impact in seven Latin American hospitalsPorras GuzmanJessica Alejandra
2846The Global Point Prevalence Survey of antimicrobial consumption and resistance (Global-PPS): 2020 results of antimicrobial prescribing in Cote d’Ivoire Kacou N'doubaAdele
2864Effectiveness of a new antibiotic stewardship programme amongst adult patients in a tertiary hospital in VietnamNguyenHoa Quoc
2874Profile analysis of the antimicrobial pharmacotherapy optimisation strategies bundle in an antimicrobial stewardship program (ASP): rationalising with interdisciplinarityLopEs Campos E rEisHenry Pablo
3012Azithromycin consumption during the COVID-19 pandemic in Croatia in 2020MocibobLoris
3018Implementation of an antimicrobial stewardship dashboard in the ambulatory settingShabaniDania
3048Extending an antimicrobial stewardship hand of friendship: successful use of handshake stewardship with vascular surgery patientsShafiHumaira
3212Repeated point prevalence surveys of inpatient antimicrobial use in Sanandaj hospitals, Iran: an implication for antibiotic stewardshipVersportenAnn
3216Beyond consumption: a qualitative investigation of hospital clinician attitudes to receiving feedback on antimicrobial prescribing quality HughesGerry
3240A comparison of healthcare resource use and costs among female patients with antibiotic-sensitive versus -resistant uncomplicated urinary tract infection from an integrated delivery network databaseShafrinShafrin
326Empowering hospital pharmacists with antimicrobial stewardship interventions to improve day three reviews in a large teaching hospital: a model for improvement approachOlusogaAbimbola
3414Complexity as an antimicrobial stewardship theoretical framework: a scoping reviewHughesGerry
3466Exploring the role of patients as potential antimicrobial stewards in hospital: a qualitative studyHughesGerry
3480Using formulation to estimate country level relative patterns of primary health care AWaRe oral antibiotic useNguyenHoa Quoc
3496Is the delayed antibiotic prescribing strategy effective for reducing the use of antibiotics?LlorCarl
3628Patient engagement in infection-related care across surgical pathways: a scoping reviewMbamaluOluchi Nneka
3668Rationalising irrational prescribing: infection-related attitudes and practices across paediatric surgery specialties in a hospital in South IndiaSurendranSurya
3678Carbapenem-sparing strategy, carbapenem consumption, and Acinetobacter colonisation pressure in a tertiary care center in BeirutRizkNesrine
3699Impact of increased COVID‑19 hospitalised patients on antimicrobial use and exemplar high-profile infections in a large provincial English hospitalMacgowanAlasdair
3808Analysis of predictors for positive blood cultures among patients with blood cultures obtained: a cohort study (NOBACT project)Fernandez GuerreroRaquel
3832Applicability of quality indicators for appropriate antibiotic use in outpatient parenteral antimicrobial therapy (OPAT): a point prevalence surveyCalboEsther
3849Description of patients with negative blood culture: identification of a potential target population for antimicrobial stewardship activities (NOBACT project)Fernandez GuerreroRaquel
3936Effect of antimicrobial stewardship program on antibiotic consumption in primary care setting in Romagna local healt unit between 2018-2020 and during COVID-19 pandemic ContadiniIlaria
4107The resistance threshold and the criteria used for adjusting the guideline recommended empiric antibiotic therapy: a scoping reviewAuzinAli Masih
4143Economic impact of inappropriate antibiotic use: the example of upper respiratory tract infections in GhanaAfari-AsieduSamuel
4202Tracking the emergence of resistance at global level in newly approved antibacterial agentsArietiFabiana
4237Antibiotics used in lower respiratory tract infections: before and after COVID-19 diseaseGarcía SolerJuana Inés
429The impact of antibiotic stewardship ward rounds on antibiotic prescribing and its sustainability in a visceral surgery departmentGruberMagdalena
4317Using “standardised courses” as a simple metric to estimate country level relative patterns of AWaRe antibiotic useNguyenNga Thi-Quynh
4318A pilot study of a novel reimbursement model to ensure access to critical antibioticsHellmanJenny
4389Evaluation of the compliance with local and international guidelines for surgical antimicrobial prophylaxis prior to the implementation of an antimicrobial stewardship programme at a tertiary care university hospital: an observational pilot studyRodeFran
4497Development and multidisciplinary implementation of an intravenous to oral antimicrobial therapy protocol: optimising safety and minimising costsReisHenry Pablo
465Infections and patterns of antibiotic utilisation in support and comfort care patients: a tertiary care centre experienceAlawadEman
4684Antimicrobial stewardship innovative strategies during pandemics: COVID-19 in the acute care settings, a systematic reviewElshenawyRasha Abdelsalam
4740Intelligent and versatile IT support for antimicrobial stewardshipAdlassnigKlaus-Peter
4800Barriers and facilitators to the implementation of a clinical decision support system for antimicrobial prescribing in West AfricaPeiffer-SmadjaNathan
4936Staggered versus simultaneous administration of meropenem and amikacin in combined therapy against extensively drug-resistant Pseudomonas aeruginosa. May dosing schedule influence the initial decrease in the bacterial load?PrimNúria
4979Antimicrobial stewardship programes in 13 Belgian hospitals: a survey from the French association of Belgian hospital pharmacistsVerchevalChristelle
4992Antibiotic stewardship during the COVID-19 pandemicEvansTerry John
578Monotherapy versus combination therapy against carbapenem-resistant Gram-negative bacterial infections: a retrospective observational multi-centre studyAbdulGhafur K
631Quality indicators for the appropriateness of diagnosis and anti-infective therapy in patients with suspected bacterial meningitisMessiaenPeter
671Knowledge levels and attitudes of Hungarian pharmacists toward infectious diseases and antimicrobial resistance: questionnaire development and a quantitative, cross-sectional studyGajdácsMárió
771Opportunities for nurse involvement in surgical antimicrobial stewardship strategiesIeranoCourtney
925Reducing exposure to unnecessary antibiotics in the emergency department through early prediction of bacteriuria: development of a risk prediction model using electronic health records at an English tertiary hospitalRockenschaubPatrick
928Systematic review of the effects of antimicrobial cycling on bacterial resistance rates within hospitalsChatzopoulouMarianneta
Abstract NumAbstract titleLast nameFirst name
1121Influence of nisin-biogel at subinhibitory concentrations on virulence expression by Staphylococcus aureus isolates from diabetic foot infectionsOliveiraManuela
133Evaluation of the incidence and management of creatine kinase elevations and myalgias in Outpatient Parenteral Antimicrobial Therapy (OPAT) patients receiving daptomycinHardyMegan
1653The safety and efficacy of allergy assessment in sulfonamide allergyRoseMorgan
1662Association between thrombocytopenia and plasma concentrations of linezolid and metabolite PNU142586 in patients with renal impairmentHsuTing-Hsuan
1994Dual β-lactam therapy: should we do it?BleibtreuAlexandre
2009Frequency and outcomes of patients with documented penicillin allergies who receive β-lactams in the emergency departmentKingMadeline
2028Analysis of Clostridium difficile infection from patients receiving ceftaroline at a large academic medical centreKingMadeline
2890Incidence and characteristics of skin reactions to intravenous antibiotics in a tertiary care OPAT serviceO HigginsLisa
2961Results of the non-invasive in-hospital Delabeling of Wrong Antibiotic Allergy Labels (DWAAL) studySprietIsabel Els Katrien
3638No, he is not on diuretic!MBhavesh
829Model-based analysis of colistin’s impact on creatinine in critically ill patientsRognasViktor
Abstract NumAbstract titleLast nameFirst name
102Vulvovaginal candidiasis in women of reproductive age attending a clinic in Bafoussam, a town in the western region of CameroonKuate NgouanomKuate Ngouanom
1142Clinical features and outcomes of candidaemia origination in the urinary tractElbazmeital
1187Subacute invasive pulmonary aspergillosis arises in moderate immunosuppressionPocinhoSara
1190Severe pulmonary Mucorales superinfection in three influenza patients with and without influenza-associated aspergillosisWaldeckFrederike
1205Cellulitis with corresponding lymphatic dispersion caused by Sporothrix sp. in an immunocompromised patientPyrpasopoulouAthina
1363Impact of domestic mould exposure on Aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary diseaseFréalleEmilie
1704Occurrence of Prototheca spp. in aquatic environments in PolandIskraMateusz
1734Human microsporidiosis in France between 2018 and 2020: data from the French microsporidiosis networkPoirierPhilippe
1868Environmental screening for Cryptococcus neoformans sensu lato in SloveniaTomazinRok
188Mixed invasive mycoses in adult haematologic patients with invasive aspergillosisKlimkoNikolai
2000Prosthetic valve endocarditis (PVE) due to Candida parapsilosis: a retrospective review of 11-year data from a quarternary cardiac referral centre in IndiaKorol PonnambathDinoop
210COVID-19-associated pulmonary aspergillosis in a Russian medical centreKlimkoNikolai
2170Study for the ecology of Candida aurisXessImmaculata
2444Cryptococcosis: an upcoming diagnosis with novel therapeutic challengesEliadiIrene
2566Epidemiology and predictive factors of early and late mortality in candidaemia over 18 years in a tertiary hospitalGioiaFrancesca
2584Endocarditis caused by Trichosporon inkin: report of a clinical case  Pérez-GarcíaFelipe
2621Clinical characteristics of children with Trichosporon sp. infection in a paediatric tertiary hospital: a 13-year reviewNaduaKaren Donceras
2658Cryptococcoma and meningoencephalitis by Cryptococcus gattii: an uncommon diagnosis in a non-endemic countryBarbosa NevesSara
2667Investigation of diversity, co-occurrence and pathogenic implication of fungal communities in a wastewater treatment plant, using next-generation sequencing technologyYousfiHanane
2816A multi-centre pharmacoepidemiologic evaluation of echinocandin useJoJinhee
2870The emergence of multidrug-resistant Candida haemulonii: using whole genome sequencing to describe the population structure of Candida haemuloniiChenXin Fei
2918Characteristics and cumulative incidence of Candida auris candidaemia in colonised patients during a Candida auris outbreak: experience from an Italian tertiary hospitalMagnascoLaura
3060Clinical characteristics of 150 cases of Trichosporon infections: a joint analysis of FungiScope® and the French Society of Medical Mycology (SFMM)BrockhoffRonja
3439Impact of COVID-19 population-level restrictions on advanced HIV and cryptococcal disease diagnosis in South Africa GreeneGreg
3516Genomic epidemiology of Candida auris in Qatar reveals hospital transmission dynamicsTsuiKin Ming (Clement)
3786Epidemiology of superficial cutaneous fungal infections in the university hospital of Nice, FranceHasseineLilia
3883Invasive fungal diseases in children with systemic rheumatic diseasesKlimkoNikolay
3931The challenge of Candida meningitis/ventriculitis over ten yearsWalshJennifer
4015Prevalence of Candida species identified by MALDI-TOF mass spectrometry from 2013 to 2019 in a hospital from a south region of BrazilCarneiroMaiara
4120The emergence of multidrug-resistant Candida auris: using whole-genome sequencing to describe the population structureChenXin Fei
4172Factors associated with compliance of ESCMID recommendations in candidaemia: a single-centre retrospective cohort studyMaurilleCharles
4267Occurrence and densities of fungi in a central Greek coastal sand beachBeredakiMaria-Ioanna
4440Optimising antifungal stewardship during the COVID-19 pandemic: an evaluation of antifungal use in intensive careCottomLaura
4653Clinical and biological characteristics of Candida catenulata isolated (2010-2018) in China Hospital Invasive Fungal Surveillance Net (CHIF-NET)ZhangWei
556A multi-centre case series of Candida Famata bloodstream infection in Saudi Arabia and United Arab EmiratesBasemAlraddadi
629A high mortality rate in children with candidaemia due to Candida parapsilosis: a three-year studyZarrinfarHossein
759Candidemia caused by Yarrowia lipolytica in a patient with parenteral nutritionMartinez PerezRocio
801The incidence and risk factors of invasive fungal infection in acute lymphoblastic leukaemia or acute myelogenous leukaemia in the era of anti-mould prophylaxisOhSang-Min
903A nine-year review of candidaemia in a large Canadian health regionBourassa-BlachetteSamuel
905Disseminated histoplasmosis (DH) in non-HIV patients: experience of a Peruvian hospitalChinchaomayra
Abstract NumAbstract titleLast nameFirst name
1237Pulmonary mucormycosis, haemophagocytic lymphohistiocytis (HLH) and cytomegalovirus (CMV) pneumonitis in a B-cell acute lymphoblastic leukemia (B-ALL) patient receiving consolidation chemotherapyBapatAnjaneya
1242A novel rapid test for Aspergillus GalactomannanWangHe
1247A novel Point-of-Care testing automation of fungus (1-3)-β-D-glucan assayWangHe
1555The impact of readily available serum (1,3)-β-D-glucan on antifungal prescribingBrownLi-An
1651Full-automatic chemiluminescence immunoassay system for Aspergillus galactomannan detectionZhangQiangqiang
1852MALDI-TOF MS for the identification of dermatophytesTomazinRok
1906Comparison of two β-D-glucan assays in a tertiary care centre for diagnosing invasive fungal infectionsPeradottoMarco
1918Optimising the diagnosis and management of patients with invasive mold infections: effect of online education on physician knowledge and confidenceDuffeyJulia
2468Prognostic value of cytomegalovirus reactivation in non-AIDS and AIDS patients with lung Pneumocystis jirovecii infectionEpaulardOlivier
2505Comparison of 21-plex PCR with PCR-RFLP and rDNA sequencing for identification of clinical yeast isolatesKhodavaisySadegh
2871Levels of pentraxin 3 (PTX3) are elevated in bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosisVasilyevaNatalya
2900Cutaneous phaeohyphomycosis of the right hand caused by Exophiala Jeanselmei: a case report and literature reviewChongyangwu
3021Clinical utility of serum ß-D-glucanTsuiRachel
3041Lower levels of β-D-Glucan in Candida auris supernatant: implication for clinical use?FurfaroElisa
3174Iterative samples in patients with Pneumocystis jirovecii pneumonia: a 10-year prospective studyAlanioAlexandre
3207Analytical performance of the commercial MucorGenius® assays as compared to an in-house qPCR assay to detect Mucorales DNA on serum specimensGhelfenstein-FerreiraThéo
3383Central nervous system aspergillosis complicating ibrutinib chemotherapy: a series of three cases at a UK NHS teaching hospitalKeeleyAlexander
3387Discrimination of cryptic species within the Aspergillus fumigatus complex by OrbitrapTM high-resolution mass spectrometryBuilJochem B.
3507Application of the novel AcrionTM System for fast and accurate identification of yeasts isolated from patients with hematological malignancies in January 2021BuilJochem B.
3565The proteome bridges functional association of genetically unrelated highly pathogenic fungi: A case study in dimorphic and dematiaceous clinical fungiDe HoogG. Sybren
3603The comparison of three different protocols to identify filamentous fungi and dermatophytes by MALDI-TOF MSErcibengoaMaria
3725Diagnosis and follow-up of allergic bronchopulmonary aspergillosis: interest in new diagnostic tests?ChassagneClaire
3759Rhodosporidiobolus fluvialis as a newly emerging yeast causing fungemiaHuangJing Jing
4088An evaluation to assess the clinical performance of the Fungiplex Pneumocystis IVD real-time PCR KitGreenJulie
4141Laboratory diagnosis of invasive aspergillosis among haematological patients with combined use of Galactomannan Antigen and Aspergillus DNA real-time PCR detection: routine data collection 2012-2020VrioniGeorgia
4256Comparative evaluation of two immunoassays for galactomannan detection in bronchoalveolar lavage (BAL) and serum samplesIglesias CabezasManuel Jesús
4415New molecular automated method for diagnosis of invasive aspergillosis in haematological patients: preliminary resultsLo CascioGiuliana
4438Preliminary evaluation of T2Candida Panel® for the diagnosis of invasive candidiasis in critically ill patients FrançoisNadine
452The significance of basophil activation test in cystic fibrosis patients with Aspergillus sensitisation and allergic bronchopulmonary aspergillosisKlimkoNikolai
4527Chronic pulmonary aspergillosis among GeneXpert negative patients in BeninSissinto Savi De ToveYolande
4878Fast and simple MALDI-TOF mass-spectrometry-based method for filamentous fungi identification in clinical microbiology laboratoryCamaggiAnna
4921A fatal case of Syncephalastrum species pneumonia post COVID-19AhmedAneera
4981MALDI TOF mass-spectrometry-based identification of filamentous fungi: the strengths of the direct transfer method from plateVossgroeneKatharina
931The role of diagnostics-driven antifungal stewardship in the management of invasive fungal infections: a systematic literature reviewCapparellaMaria Rita
Abstract NumAbstract titleLast nameFirst name
1507Audit for antifungal treatment usage in adults with invasive fungal infections (IFI)GuptaAnkesh
1630In vitro post-antifungal effect of amphotericin B, fluconazole, and micafungin against Candida albicans, Candida glabrata and Candida parapsilosisCarvalhaesCecilia G.
1672Analysis of safety from STRIVE phase II Trial of rezafungin treatment of candidemia and/or invasive candidiasis: assessment of adverse events and laboratory valuesThompsonGeorge R.
1772Value-based antifungal treatments across EuropeVuvuFiston
2318Immunomodulatory effects of amphotericin B formulations and voriconazole on human neutrophils exposed to mature biofilms of Scedosporium apiospermumSimitsopoulouMaria
2473Screening of a small molecule library of synthesized heterocyclic compounds and amino acid derivatives against triazole-resistant Aspergillus fumigatusKavaliauskasPovilas
2607Allergic bronchopulmonary aspergillosis (ABPA) complicating chronic obstructive pulmonary disease (COPD) without asthma: responses to antifungal therapyAggarwalSunil
2641Long-term use of olorofim in the treatment of a Scedosporium apiospermum chest wall infectionMorrisseyOrla
2670A single-centre experience of OPAT amphotericin B for aspergillosisPowerNick
2815Improvement of Aspergillus udagawae infection with olorofim therapy in the setting of chronic granulomatous diseaseZerbeChrista
2928The impact of implementing an evidence-based package of measures (bundle) on the quality of care and outcomes of candidaemia in a tertiary hospitalEscudero SánchezRosa
3019A population pharmacokinetic model of voriconazole in patients undergoing renal replacement therapy with and without acute-on chronic liver failurePfaffendorfChristoph
3515Efficacy of voriconazole and anidulafungin combination against azole-resistant Aspergillus fumigatus in a neutropenic animal model of invasive aspergillosisGeorgiouPanagiota-Christina
3763Does previous exposure to antibiotics alter fluconazole MICs of Candida spp. found in the peritoneal fluid of patients with nosocomial intra-abdominal candidiasis (IAC)?DupontHervé
3817Safety and efficacy of intravenous itraconazole as primary antifungal prophylaxis in patients with haematological malignancies: a retrospective multi-centre studyRentziouGianna
4038Therapeutic drug monitoring of voriconazole for the treatment or prevention of invasive fungal infections in a medical centre (2009-2017)LiuYu-Ling
4049Treatment of Scedosporium mycetoma refractory to voriconazole with olorofimWalshThomas
4407Cellular apoptosis and cell cycle arrest as therapeutic targets for novel piperidine based 1,2,3-triazolylacetamide derivatives in Candida aurisSrivastavaVartika
4473Isavuconazole TDM: results from a reference laboratoryGomez LopezAlicia
4706Fluconazole versus posaconazole prophylaxis for prevention of invasive fungal infection in adult acute myeloid leukaemia patients in a tertiary referral hospital in the United Kingdom: cost benefit analysisElhefnawyNahed
490Systemic antifungal therapy evaluation in a hospital settingZavaletaEsteban
524Effects of type II diabetes mellitus on pharmacokinetics of liposomal amphotericin B in serum and tissues of uninfected MiceSlarveIelyzaveta
64Voriconazole concentrations in cerebrospinal fluid for cryptococcal meningitisTangGuangmin
709Two new aromatic compounds have antifungal properties against Candida albicansCharletRogatien
756Comparative outcomes of Candida auris candidaemia: a retrospective case-control studySimonSamuel
3941Serum fungicidal activity in patients treated with micafungin against Candida isolatesBeredakiMaria-Ioanna
3779T cells of invasive candidiasis patients show patterns of T cell exhaustion suggesting checkpoint blockade as treatment optionMellinghoffSibylle
1797Economic evaluation of diagnostic-driven versus empirical treatment strategies in high-risk immunocompromised patients with suspected Aspergillus infectionBryanAndrew
1307Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins versus other antifungal agents: a systematic review and meta-analysisGattiMilo
587Interaction of antifungal agents with pulmonary surfactant in vitroRauwolfKerstin Katharina
Abstract NumAbstract titleLast nameFirst name
1398Establishing a German national candidaemia surveillance network: one year of data acquisition and management by the NRZMykAldejohannAlexander Maximilian
1419Increase of fluconazole-resistant Candida parapsilosis strains during the SARS-CoV-2 pandemic in a Northern Italy hospitalZappavignaAndrea
1501Identification of off-patent compounds that present antifungal activity against azole-resistant Aspergillus fumigatusLucio VicenteJose
203European Confederation of Medical Mycology Candida III: species distribution and susceptibility of European candidaemia isolates from 13 countriesArendrupMaiken Cavling
2123Saprochaete clavata associated with paediatric patient infection in Brazil: identification, morphological description, antifungal susceptibility, biofilm characterisation and evaluationTuonFelipe
2265Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpressionCastanheiraMariana
2342Additive and synergistic effects of human neutrophils in combination with amphotericin B formulations or posaconazole against Lictheimia corymbifera biofilmsRoilidesEmmanuel
2560First detection of TR34/L98H alteration in cyp51A associated with pan-azole resistance in clinical Aspergillus fumigatus isolates in GreeceSiopiMaria
2574Azole resistance screening in Aspergillus fumigatus clinical isolates using azole-containing agar plates (EUCAST E.Def 10.1): low impact of plastic trays used and poor performance in cryptic speciesSerrano-LoboJulia
2700Delineation of the direct contribution of mutations in Candida auris ERG11 and TAC1B to triazole resistance alone and in combinationRybakJeffrey
3172Analysis of a geographically diverse collection of Diutina catenulata strains from different sources provides evidence for acquired resistance to azoles and some genetic clusteringMorioFlorent
3275In vitro comparative activity of systemic and topical azoles against Candida isolates from women with vulvovaginal candidiasisMeletiadisJoseph
3357In vitro antifungal activity of boric acid against azole-susceptible and -resistant yeast isolates from women with vulvovaginal candidiasis: uniform activity across species and against azole resistant isolatesAntonopoulouStavroula
3577Emerging azole resistance in Candida parapsilosis candidemia isolates: evaluation of Y132F mutations in ERG11 geneCanFusun
3704Antifungal activity of octenidine against emerging echinocandin-, azole- and multidrug-resistant Candida albicans and Candida glabrataBumbergerDominik
Abstract NumAbstract titleLast nameFirst name
1596Detection of ocular parasites during the period 2015-2020 in a tertiary hospital in Athens, GreeceKontotezaIfigeneia Vasiliki
1896Ascariasis case by Ascaris suum in non-endemic country (Italy)PeradottoMarco
2090Laboratory diagnosis of parasites causing gastrointestinal diseases by microscopy and real-time PCR in Lleida (Spain)LopezEric
2217Association between baseline iron status and post-treatment liver enzyme elevations in Plasmodium falciparum malaria volunteer infection studiesWoolleyStephen
2415Molecular identification of Toxocara isolated from jackal in Guilan and Mazandaran provinces, northern IranMikaeiliFattaneh
3289Performance and cost benefit improvement of multiplex real-time PCR  platform for the routine diagnosis of intestinal protozoonosisPerez TanoiraRamón
3724Visceral Leishmaniasis and laboratory findings in patient with feverMaisiMaria
3970Myiasis of wounds caused by Lucilia sericata: first report in TunisiaBoufaresSiwar
Abstract NumAbstract titleLast nameFirst name
4325Ex vivo antimalarial drugs susceptibility and molecular markers of resistance of Plasmodium falciparum in the southeast of GabonVoumbo-MatoumonaDominique Fatima
Abstract NumAbstract titleLast nameFirst name
1050Ivermectin for Strongyloides stercoralis infection in immunocompromised patients: a single dose or a 2+2 regimen?ChiesaAnnacarla
1265Study of gas chromatography-mass spectrometry (GC-MS) and antileishmanial activity of  the extract from Ficus racemosa leavesKumarRamesh
1572A case of imported tropical malaria with a complicated course in ArmeniaMirabyanSevak
2275Combined therapy in relapsing visceral leishmaniasis in co-infected HIV patientsRodrigues BorralhoJOAO MIGUEL
2620Complicated cutaneous leishmaniasis in a complex immunosuppressed hostBarreira CarujoAntónio Pedro
2715Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysisCrespillo-AndújarClara
2887Interest of metronidazole in the treatment of cutaneous leishmaniasisAbdeljelilMeriam
337Doxycycline prophylaxis in endemic hyper-reactive malarial splenomegaly in rural western Uganda: a retrospective cohort studyDaviesPeter
3594Treatment of Schistosomiasis in Pregnancy: A Systematic Review of Maternal OutcomesWatsonChelsia
4032Treatment of intestinalp rotozoa in pregnancy: a systematic review of maternal, fetal and infant outcomesIgboanugoSonia
4472Plasmodium ovale: should we prevent relapse?BarosaMariana
748Safety and tolerability of mebendazole in infants under one year of ageTasherDiana
817Toxoplasmosis after allogeneic haematopoietic cell transplantation: a matched case-control studyAertsRobina
Abstract NumAbstract titleLast nameFirst name
1348Malaria cases in the region of Crete during five-year periodMaisiMaria
1388Molecular typing of Belgian Echinococcus multilocularis specimens from alveolar echinococcosis human lesions using EmsB microsatellites analysisHayetteMarie-Pierre
154New intermediate host of Angiostrongylus cantonensis reported on Tenerife, Canary Islands (Spain)Izquierdo RodríguezElena Mercedes
2178Outbreak of cutaneous leishmaniasis among soldiers in French Guiana, 2020: clinical, behavioural, phylogenetic and environmental aspectsHenryKim
2317Blastocystosis: clinical features, routine practice diagnostics, and treatment outcomesBalen TopicMirjana
2840Intercurrent flaviviral viraemia and Plasmodium vivax and Plasmodium ovale infections in ill returned travelers to OntarioMahmoodRaesham
3193Clinical and epidemiological characteristics of cystic echinococcosis among children in Almaty region (2014-2019)DoszhanovaGaukhar
3409Cryptosporidiasis: molecular epidemiology in Northern SpainPascual Del Riquelme BabéAlfonso José
3428Usefulness of nested PCR in Leishmania typingRemadiLatifa
3619Evolution of genetic diversity of Plasmodium falciparum in isolates collected from asymptomatic children in Brazzaville between 2010 and 2018Voumbo-MatoumonaDominique Fatima
367Toxoplasma seroprevalence in the Netherlands: preliminary results from the PIENTER-3 studyStanoevaKamelia
4544Pregnancy complications in Venezuelan women with malariaForero-PeñaDavid A.
4617An association between Blastocystis subtypes and colorectal cancer patients: a significant different profile from non-cancer individualsElbadryAyman
4912The epiCrypt study: investigating transmission of Cryptosporidium in the homeMckerrCaoimhe
Abstract NumAbstract titleLast nameFirst name
1169Is being a refugee associated with increased 30-day mortality after visiting the emergency department?StorgaardSigne Freja
2452Not all is COVID-19: a case of severe imported malariaGonçalvesInês
2704Case report: differential diagnosis of liver abscess in a migrantSilvaCarolina
4601Visceral leishmaniasis in adults from southern Turkey: evaluation of epidemiologic, clinical, laboratory and treatment outcome characteristics of 26 casesInalSeza A.
4609Loiasis of importation among two tunisian soldiersAbidRym
4835Travellers’ diarrhoea incidence and impact during overseas military exercises: a location comparisonToriroRomeo
4959Cost effectiveness analysis of Chagas disease screening in Latin American migrants in Ireland: a Markov model analysisReidyPaul
512Schistosomiasis in the non-endemic setting: a retrospective review in a large centre in the United KingdomMcguireEmma
526Going through the bridge: medical doctors awareness of travel medicine in TurkeyTunaliVarol
Abstract NumAbstract titleLast nameFirst name
3544Impact of water chlorination on faecal carriage of ESBL-producing Escherichia coli in Bangladeshi children: results from a randomised controlled trialGreenwoodEsther Elizabeth
Abstract NumAbstract titleLast nameFirst name
1564Infectious diseases response in prisons: the experience from a Portuguese centreVieira AzevedoTelma Susana
1759Migrant patient experiences of TB treatment within a UK tertiary care hospitalRustageKieran
263Development of guidelines for spreading awareness in an epidemic or a pandemic using Delphi methodSharmaAkash
4219The AMR travel tool: an interactive evidence-based educational tool to limit antimicrobial resistance spread across bordersArietiFabiana
501An integrated hospital district performance evaluation for communicable diseases care pathways in low-and middle-income countries: evidence from three sub-Saharan countriesMazzilliSara
83Infographics about antibiotics: making facts accessible Van HeckeOliver
Abstract NumAbstract titleLast nameFirst name
1402Retrospective review of effectiveness of line-lock therapy for catheter-related blood stream infections in a cohort of haematology patientsMccarthyPierre
3408Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for controlPerez-GrandaMaria Jesus
3433Parenteral nutrition-related infections: a systematic review and meta-analysisSlonimShirly
4212An outbreak investigation of Central Line-Associated Blood Stream Infections (CLABSI) caused by Candida parapsilosis at the paediatric haematology/oncology centreSolopovaGalina
837Molecular genetic characteristics of the virulent properties of Klebsiella pneumoniae strains isolated from blood and cerebrospinal fluid of childrenNovikovaIrina
Abstract NumAbstract titleLast nameFirst name
1034 Multidisciplinary approach revealed succesful management of a difficult-to-treat left ventricular assist device (LVAD) infectionErolÇigdem
1042Delayed infection following buttock augmentation surgery SiobhanQuirke
109Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?KherabiYousra
1399In vitro study of Cutibacterium acnes behavior in bone and prosthesis infections contextReffuveilleFany
1468Profiles of LPXTG protein expression in Staphylococcus aureus clonal complexes isolated from periprosthetic joint infections and woundsMorales-LaverdeLiliana Andrea
1519Staphylococcus lugdunensis prosthetic joint infection: a multicentric retrospective cohort studyValourFlorent
1589Biofilm formation and antimicrobial susceptibility of Staphylococcus spp. from sonication fluid cultures of orthopaedic implant-associated infections: phenotypic and genotypic analysisSallesMauro Jose
1645Outcome and risk factors in prosthetic joint infections by multidrug-resistant Gram-negative bacteria: a retrospective cohort studySallesMauro Jose Costa
1646Non-elective and revision arthroplasty are independently associated with prosthetic joint infection caused by Acinetobacter baumannii: a retrospective single-centre cohort studySallesMauro Jose Costa
1726In-host evolution of a Staphylococcus fleurettii strain cause of a recalcitrant elbow prosthetic joint infection selects for defective AgrA pathotypeBidossiAlessandro
1867Risk factors for hip/knee prosthetic joint infections due to Gram-negative bacilli: a case-case-control studyLeroyAnne-Gaëlle
2030Diagnostic accuracy of synovial cell counts before reimplantation in patients with peri-prosthetic knee infections undergoing two-stage exchange proceduresAscioneTiziana
2113Description of etiology associated with prosthetic joint infection in a tertiary university hospital in MadridEstebanJaime
2286Antimicrobial susceptibility of Cutibacterium acnes isolated from prosthetic joint infections: differences between biofilms and planktonic bacteriaSalar VidalLlanos
2310Alpha defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infectionChisariEmanuele
2326One-stage exchange in late-chronic infection after instrumented posterior spinal fusion for scoliosisCoboJavier
2346Leukocyte esterase versus 2018 International Consensus Meeting (ICM) criteria in the diagnosis of periprosthetic joint infectionChisariEmanuele
2384Metal-on-polyethylene implants are associated with a higher risk of prostehetic joint infection (PJI) compared to ceramic-on-polyethyleneChisariEmanuele
2402Emergence of antibiotic resistance across two-stage revision for periprosthetic joint infectionChisariEmanuele
2462Prosthetic joint infections with Candida spp.: about 21 casesFourcadeCamille
2880If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections: a multicentre observational studyWouthuyzen-BakkerMarjan
2932Should all patients diagnosed with a culture-negative periprosthetic joint infection be treated with antibiotics?Wouthuyzen-BakkerMarjan
330Diagnostic value of new inflammatory markers in prosthetic joint synovial fluidShneiderOlga
332Impact of multidisciplinary management on prosthetic vascular graft infections prognosisPugesMathilde
3624Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devicesGoehringerFrançois
3892Prosthetic joint infection after the oral versus intravenous antibiotics trial: experience from oral treatment in a referral centre cohortYoungBernadette
3957Dalbavancin in combination with a broad-spectrum ß-lactam for probabilistic treatment of infection or suspected periprosthetic hip or knee infectionBonnetEric
398Fibrinolytic and antibiotic treatment of prosthetic vascular graft infections in a novel rat modelJohansenMikkel Illemann
401Exhaustive diagnosis of breast implants with capsular contracture: the microbiology laboratory as a major supportGuembeMaría
4459Comparative plasma pharmacokinetics and pharmacodynamics of different surgical antimicrobial prophylactic regimens in patients undergoing total knee and hip arthroplasty (TKA/THA) against bacteria isolated from patients with TKA/THA prosthetic joint infectionsLuqueSonia
4580Optimising the microbiological diagnosis of prosthetic joint infection: a 6-year evaluationCottomLaura
4977Peri-operative hypoalbuminaemia is associated with aortic graft infection: a case-control studyMendes PedroDiogo
566Staphylococcus aureus biofilm formation and structure are influenced by bone microenvironmentLamretFabien
659Staphylococcus epidermidis small colony variants: clinically significant threats for patients with prosthetic joint infectionFernandez RodriguezDiana
990Debridement, antibiotics and implant retention (DAIR): an effective treatment option for early prosthetic joint infectionsTatarelliPaola
Abstract NumAbstract titleLast nameFirst name
1027Should wound swab culture keep being ignored? A retrospective analysis based on ten years of experience managing sternal surgical site infection after sternotomy in children with congenital heart diseaseAbboudCely
1178Safety of tedizolid as suppressive antimicrobial therapy for patients with complex implant-associated bone and joint infection due to multidrug-resistant Gram-positive pathogens: results from the TediSAT cohort studyFerryTristan
1306Incidence and outcome of surgical site infections in thoracic-organ transplant recipients registered in the Swiss Transplant Cohort Study (STCS)SchreiberPeter W.
1635Comparing patients who received Chronic Antibiotic Suppression (CAS) to those who did not for non-staphylococcal prosthetic joint infectionsSekarPoorani
1658A single-centre retrospective study on the impact of reducing surgical prophylaxis from 48-hours to 24-hours in cardiovascular surgeryChungShimin Jasmine
2051Plasma-activated water as a new weapon in the fight against multidrug-resistant bacteriaRichterKatharina
2194Implementation of a phage therapy centre in France dedicated to complex bone and joint infection: 4-year experience of multidisciplinarity and multistep interactionsFerryTristan
2339Treatment of orthopeadic implants infection due to Enterococcus spp. between 2013 and 2020 in a French tertiary-care university hospitalMaurilleCharles
253Single dose antibiotic prophylaxis is sufficient in uncomplicated colorectal surgeriesChungShimin Jasmine
319Does antimicrobial prophylaxis with double-dose cefuroxime reduce surgical site infection in patients above 80kg?SommersteinRami
34Artificial neural networks and medicine: an interdisciplinary approach to surgical site infection in cholecystectomyCoutoBráulio
372The impact of a COVID-19 total lockdown on deep surgical site infections and other non-infectious complications after orthopedic surgeryUçkayIlker Hasan
4280Transmission rate of fungal and bacterial pathogens during lung transplantation from the donor to the recipient: also keep an eye on moldJungJette
4592Airborne antibiotic-resistant Staphylococcus epidermidis in inpatient wards linked with deep surgical site infectionsJohanssonAnders F
721Surgical site infection after cholecystectomy: a small risk that defines life and death of patientsCoutoBráulio
904Nosocomial meningitis in a hospital specialised in neurosurgery between 2014 and 2020CastroEduardo
Abstract NumAbstract titleLast nameFirst name
1045Ventilator-associated pneumonia in the SARS Coronavirus 2 (SARS-CoV-2) age: a new entity?PazMaria Veronica
1210Occurrence of Pseudomonas aeruginosa ICU pneumonia in relation to P. aeruginosa carriageRecanatiniClaudia
1261Epidemiology and microbiological profile of common health-associated infections among patients in the intensive care unit of a general hospital in Kuwait: a retrospective observational studyDharRita
1559Epidemiology and outcomes of non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2014-2019ZilberbergMarya
1567Microbiology of non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2014-2019ZilberbergMarya
167Assessment of knowledge and self-reported adherence to guidelines on ventilator-associated pneumonia (VAP) prevention among healthcare providers in critical care units of a tertiary government hospitalCruzMarie Gene
1949Impact of molecular syndromic diagnosis in the management of pneumonia in the intensive care unit (ICU) of a university hospital in GreeceStafylakiDimitra
2571Comparison between hospital and community-acquired Legionnaires’ disease: a large retrospective multicenter case seriesMorettiMarco
4159Prospective evalution of hospital-acquired pneumonia due to Corynebacterium striatum in a tertiary care educational university hospital: a series of 50 cases  SipahiOguz Resat
4361Temporal impact of risk factors for non-ventilator-associated hospital-acquired pneumonia (nvHAP) in patients outside the intensive care unitKachalovViacheslav
454Early lower respiratory tract Staphylococcus aureus screening could help detect ventilator-associated pneumonia in intensive care unit (ICU) patients VlaeminckJelle
4712Drug resistance in pneumonia (DRIP) score as a predictor of drug-resistant organism and clinical outcomes in hospital-acquired pneumonia (HAP) in a tertiary private hospital in the PhilippinesTibayanChristoper John
643Imipenem/cilastatin (IMI)/relebactam (REL) for treatment of Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia (HABP/VABP) caused by imipenem-nonsusceptible pathogens: subgroup analysis of the RESTORE-IMI 2 trialChenLuke
803Cost-effectiveness analysis of introducing 23-valent pneumococcal polysaccharide vaccine (PPSV23) in healthy French adults aged  ≥ 65 for the prevention of pneumococcal infectionLeleuHenri
Abstract NumAbstract titleLast nameFirst name
1008Validating post-discharge surveillance for surgical site infection by using WhatsApp technologyCoutoBráulio
1049Impact of selective decolonisation of critically ill extreme elderly patients using chlorhexidine 2% daily bathing on healthcare-associated infection ratesDelgado CorrealJulio Cesar
1150Needlestick still on the stage: lessons from 444 occupational injuries in a university hospitalSaltogluNese
1303Estimating the excess bed-days and economic burden of healthcare-associated infections in Singapore public acute-care hospitalsKwaAndrea Lay Hoon
1369Environmental contamination with highly-resistant microorganisms two years after relocating to a new hospital building with 100% single-occupancy roomsVan Der SchoorAdriënne S.
1378Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae ST48 in a German university hospital over a period of more than 5 yearsMaechlerFriederike
139Lessons learnt from OXA-48 producing Enterobacteriaceae outbreakLingMoi Lin
1392Molecular genetic analysis and risk factors of outbreak strains caused by vancomycin-resistant Enterococcus (VRE)KitagawaDaisuke
1394Dehydration tolerance in epidemic versus non-epidemic MRSA illustrated by isothermal microcalorimetryBaedeValérie O.
1433Carbapenem-resistant Klebsiella pneumoniae (CRKP) colonisation: dynamics of acquisition in a Neonatal Intensive Care Unit (NICU)IosifidisElias
1493Epidemiology and control of a carbapenem-resistant Enterobacteriaceae (CRE) outbreak in a skilled-nursing facility in southeast MichiganJoshiSeema
1500Simplified acute physiology score (SAPS2), Acute physiology and chronic health evaluation (APACHE2), sequential organ failure assessment (SOFA) and simplified therapetic intervention scoring system (TISS28) upon admission as risk indicators for ICU-acquired infections: a retrospective cohort studyGinterKatharina
1617Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit during the COVID-19 pandemicCasolariStefania
1691Impact of COVID-19 pandemic on availability of isolation facilities for patients with carbapenemase-producing organismsHuanXiaowei
1774Transmission of Enterobacteriaceae in neonatal intensive care unit (NICU) in family-centred careParmÜlle
1800Unravelling the drivers of the intra-clonal diversity of vancomycin-resistant Enterococcus faecium ST80 cloneRubinIngrid Maria Cecilia
1888Emergence and dissemination of a teicoplanin-resistant Staphylococcus epidermidis clone in a tertiary care hospital during SARS-CoV-2 pandemicSerrano-TomásMaría Isabel
1944Nosocomial influenza - a four-year observational study: not the patient is the highest riskScheithauerSimone
1987Stability of viral RNA in an environmental sampling kit and its detection with molecular biology techniquesBeffaMatteo
2096The spread of multidrug-resistant bacteria in tertiary level university hospitals: an emerging crisisTriguiMaroua
2151BugWatcher: a novel superbug detection system combining an information and communication technology platform, an air monitoring device and a rapid diagnostic test to control the spread of healthcare-associated infectionsRubio-MonterdeAna
2216Influence of previous detection of Gram-negative Enterobacterales with resistance to third-generation cephalosporins (3GCRE) in screening swabs on duration of antibiotic treatment in a neonatal intensive care unitKaaseMartin
2266Surgical helmets harbour common pathogens that can be distributed to the sterile fieldChisariEmanuele
228Length of stay, hospitalisation cost, and in-hospital fatalities from methicillin-susceptible and -resistant Staphylococcus aureus bacteraemia in a Japanese tertiary care hospitalTsuzukiShinya
2486The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case-control studyKlaukePaula
2537The prevention of urinary tract infections in healthcare settings in Belgium: there is still much room for improvementVersportenAnn
2622Risk factors of infections associated with antibiotic-resistant Gram-positive bacteria in patients with high-risk neutropaenia in a French haematology centreDelapierre MoisdonBaptiste
2675Predicting the risk of carbapenem-resistant Enterobacteriaceae colonisation in long-term care units using environmental samples and machine learning for graphsMarquesCatarina dos Santos
2712Clinical utility of methicillin-resistant Staphylococcus aureus nasal surveillance swabs in skin and skin structure infections  BurgoonRachel
2814Prevalence of device use, multidrug-resistant organisms and transmission-based precautions in nineteen large Australian acute care public hospitals: secondary outcomes from a national healthcare-associated infection point prevalence surveyRussoPhilip
2839Effect of timely lactate measurement on in-hospital mortality among adults with hypotension and hyperlactataemia: an observational study in two cohortsHuWenhan
2842Toxigenic Clostridioides difficile and vancomycin-resistant enterococci: new mode of transmission by shoes of healthcare workers? A prospective cohort studyBüchlerAndrea C.
2852Shifting of infection control personnel to COVID-19 areas and repercussions on an antimicrobial stewardship programmeAguirre-GarciaGloria Mayela
3006Reducing the infectious risk related to the use of bronchoscopes: the role of microbiological surveillanceTuvoBenedetta
3022Sequencing-independent approach for characterisation of Staphylococcus aureus population structureDufkovaKristyna
3049Performing a baseline measurement and developing an e-learning based on a newly developed simplified protocol for hand hygiene observations in the operating roomVan DijkManon Derkje
311Descriptive analysis of carbapenem-resistant Acinetobacter baumanni tested in the Antibiotic Resistance Laboratory Network, 2017–2019 SabourSarah
3135Outbreak with methicillin-resistant Staphylococcus aureus isolates lacking mec determinants on a neonatal ICU of a German hospitalSommerAnna
3144Contact investigations for highly-resistant microorganisms (HRMO): a mixed-methods analysis of patients’ comprehension of and self-reported compliance with (self-)sampling requests post-dischargeVan VeenAnneloes
3244Nosocomial transmission of multidrug-resistant Pseudomonas aeruginosa via the nozzles of electric toiletsNakamuraItaru
3253MRSA and MDRO screening positivity rates among high-risk patients in a Dutch academic hospital: evaluating the ‘screening-at-the-gate’ policyTostmannAlma
3263Awareness of healthcare workers with appropriate infection control practices related to multi-patient use of a closed loop medication administration deviceAlshamraniMajid
3273Antimicrobial resistance survey at Ospedale Policlinico San Martino IRCCS, Genoa, Liguria, Northwest Italy, 2014-2020CostaElisabetta
331Unraveling a nosocomial outbreak of COVID-19: the role of whole genome sequence analysisMeijerSuzy
3506Increasing detection of carbapenemase genes directly on rectal swabs: a way of improving surveillancePrim BoschNURIA
356Clinical and epidemiological features of patients colonized by different types of carbapenemase-producing EnterobacteralesAdlerAmos
3562Effect of UV supplementation on clonal recovery of Acinetobacter in a real hospital settingChatterjeePiyali
3605Molecular genomics of carbapenem-resistant Enterobacterales colonisation in an intensive care unit in the Umgungundlovu District, South AfricaEssackSabiha
3620Local Epidemiology of nosocomial Staphylococcus aureus infection in a resource-limited settingAdeyanjuAdeniran
3653Risk of infection in oncologycal patients colonised by extended-expectrum ß-lactamases- and carbapenem-producing EnterobacteriaceaeHoyos PulgarinJulián Andrés
3712Effect of the intensive care unit design on bacterial ecology and antimicrobial susceptibilityThabetLamia
3742Comparison of FT-IR spectroscopy analysis and molecular typing (PFGE) in evaluation of nosocomial transmission of vancomycin-resistant Enterococcus faeciumOgrinKatarina
3923Modelling antimicrobial resistance transmission to guide personalised antimicrobial stewardship interventions and infection control policies in healthcare settingPezzanimaria diletta
4155Comparison of FT-IR spectroscopy analysis and molecular typing (PFGE) in evaluation of nosocomial transmission in an oligoclonal outbreak of carbapenemase-producing Klebsiella pneumoniae.OgrinKatarina
4236Improvent of hand hygiene practices in hospitals after implementation of the German hand hygiene campaign "Aktion Saubere Hände": evaluation of results from a self-assessment tool between 2014 and 2020KramerTobias
4250Carbapenemase-producing Enterobacteriaceae (CPE) in hospital wastewater: a pilot study looking for the presence of CPE isolates, their species and involved genesHansenDennis Schröder
4270Environmental dissemination of Enterobacterales compared to digestive carriage in hospitalised patientsToulemondePierre-Etienne
4292Bacterial colonisation of neonates in a neonatal intensive care unit at a tertiary care hospital in Greece NikolakopoulouAngeliki
4332Unbiased prevalence- versus risk-adapted admission screening for multidrug-resistant pathogens: a comparative evaluation of screening strategies and their detection effectivenessHormelIna
4370Influence of the "built environment (BE)" in the epidemiology of antibiotic resistance in high-risk nosocomial areasAracil-GisbertSonia
4450Molecular characterisation of a nosocomial outbreak of Serratia marcescens in tertiary neonatal and paediatric intensive care unitsTürkAyşe Hande
446Risk of multidrug-resistant bacteria acquisition in patients with declared β-lactam allergy during hospitalisation in intensive care unit: a retrospective cohort study (2007-2018)StrazzullaAlessio
4506Epidemiology of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE) in Tuscany (Italy) during the COVID-19 pandemicPorrettaAndrea Davide
4851Clinical, microbiologic and genomic characterisation of dual carbapenemase-producing Gram-negative bacteriaMushtaqAmmara
564Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitalsSommersteinRami
57A point prevalence survey of healthcare-associated infections and antimicrobial use in Tunisian paediatric inpatientsBen JmaaMaissa
628Prospective surveillance of colonisation and disease by methicillin-resistant Staphylococcus aureus (MRSA) in a european paediatric cancer centreGrollAndreas H.
800Survival of nosocomially relevant bacteria on different inanimate surfacesKatzenbergerRuth Hanna
929The transmission of a multidrug-resistant epidemic Escherichia coli ST1193 clone carrying mcr-1-mediated colistin resistance in a paediatric surgery intensive care unit.KrutovaMarcela
965Critical points and potential pitfalls in a persistent outbreak of carbapenem-resistant, IMP-1-producing Pseudomonas aeruginosa among kidney transplant recipients: a case-control studyFreireMaristela P.
974Surveillance of Enterobacter cloacae complex colonisation and comparative analysis of different typing methods on a neonatal intensive care unit in GermanyWendelAndreas Friedrich
991Evaluation of causative microorganisms in healthcare-associated infections in the pre-COVID-19 and during COVID-19 era.  What has changed in the pandemic?AbboudCely
Abstract NumAbstract titleLast nameFirst name
1021Risk factors associated with a Clostridioides difficile infection in geriatric patientsDohrendorfCarla Maria
1029Impact of an antimicrobial stewardship programme focused on Clostridioides difficile infectionMerchante GutiérrezNicolás
1067Carbapenem-resistant versus non-carbapenem resistant Gram-negative bacterial nosocomial meningitis: results of the multi-centre EPHESUS-2 retrospective cohort studyAkyolDeniz
1082Faecal calprotectin could be useful to avoid unnecessary treatment in patients with detection of toxigenic Clostridioides difficileSuárez CarantoñaCecilia
1096Diarrhoea associated with Clostridium difficile in hospitalised cancer patients: a two-year studyKlyuchnikovaIrina
119A prospective study on incidence, risk factors and outcome of recurrent Clostridioides difficile infection: the ReCloDi studyGranataGuido
1266Prevalence of healthcare-associated infections and antimicrobial use in "Ryoyo" wards, stratified long-term care beds in Japanese long-term care facilitiese: a point prevalence surveySuzukiKumiko
1350Liver steatosis as a risk factor for recurrent Clostridioides difficile associated disease  PapicNeven
1377Trends in Clostridioides difficile testing and infections at a tertiary African hospital, 2017 - 2020NanaTrusha
1424Higher incidence rates of Clostridioides difficile infection in the lower-income elderly population in the USDubberkeErik
1534Pseudomonas aeruginosa infections after CT-guided spinal injectionsPaulGregor
1583What are the specificities of healthcare-associated infections in paediatric inpatients?KetataNouha
1619Applications of Clostridioides difficile EntericBio® PCR cycle threshold in predicting toxin positivity and clinical outcomesRickmanHannah
1648The burden of healthcare-acquired infections in Australian public hospitalsLydeamoreMichael
1747Short- and long-term mortality risk factors in Gram-negative bacteraemia: a retrospective cohort study from an English district general hospitalBaltasIoannis
1778Cycle threshold values of Clostridioides difficile PCR in asymptomatic carriers as a predictor of clinical diseaseMeltzerEyal
1909Healthcare-associated urinary tract infections: prevalence, risk factors and microbiological profileBen HmidaMariem
2202Surveillance of Clostridioides difficile infections in Austrian acute care hospitalsVan Den NestMiriam
2215Healthcare workers’ knowledge, attitude and practice survey of bacterial contamination of blood for transfusion in the Democratic Republic of the CongoHeroesAnne-Sophie
2278Aspergillus fumigatus outbreak possibly caused by construction work on the corridor of an intensive care unit: analysis using whole-genome sequencingHielStephan J.p.
2361Impact of the COVID-19 pandemic on Clostridioides difficile infection epidemiology among hospitalised veterans in South Texas, USAYoungEric
2371Hospitalisation costs and charges associated with primary Clostridioides difficile infection encounters and rehospitalisations in a national cohort of United States community hospitalsYoungEric
2958Using the international nosocomial infection control consortium data to estimate device-associated healthcare associated infection in children: an analysis of 38 countriesRosenthalVictor
2990Association between long-term care facility (LTCF) characteristics and incidence of infectionsHaenenAnja
3096Multidrug-resistant Gram-negatives in a burn unit in TunisiaPerez PalaciosPatricia
3206Delftia acidovorans bloodstream infection (BSI) outbreak in ICU COVID-19 patientsMondinoSara
3268Clostridioides difficile incidence increase related to a temporary ceftobiprole unavailabilityPaciniGiovanni
3339Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in a tertiary hospitalConceicaoEdwin
3351Emergence of multiresistant Enterobacterales from septicemic neonates at intensive care unit in Marrakech: resistome and nosocomial transmissionPerez PalaciosPatricia
344Clostridioides difficile infection after ceftolozane-tazobactam and ceftazidime-avibactam treatment: single-centre experienceGodefroyNagisa
3573Elizabethkingia meningoseptica infection in an intensive care unit of a tertiary care centre in Eastern India: a case seriesSamalSamir
3574Nasal carriage of panton-valentine leukocidin-positive Staphylococcus aureus in a tertiary hospital in Selangor, MalaysiaAl-TalibHassanain
3595A systematic review and meta-analysis of fidaxomicin and vancomycin for Clostridioides difficile infectionLiaoJ. Xin
3679Non inferiority of metronidazole for the treatment of first nonsevere episode of Clostridioides difficile infection: a retrospective cohort studyNajjar DebbinyRonza
374Outbreak of a toxic shock syndrome toxin carrying methicillin-susceptible Staphylococcus aureus on a neonatal unit and its controlMarekAleksandra
4246Safety and tolerance of different approaches of faecal microbiota transplantation for recurrent Clostridioides difficile infection in a reference centre in SpainOlmedo Samperiomaria
4314Hospital-aquired Clostridioides difficile infection (HA-CDI) during the COVID-19 pandemiaVázquez-CuestaSilvia Noemi
4331Ralstonia pickettii related outbreak associated with contaminated distilled waterAlp CavusSema
4374The role of the microbiome as a prediction biomarker of Clostridioides difficile infectionVázquez-CuestaSilvia Noemi
438Dissemination and pathogenesis of toxigenic Clostridium perfringens strains linked to neonatal intensive care units and Necrotising EnterocolitisKiuRaymond
4461Incidence of Clostridioides difficile infection during the COVID-19 PandemicLopez SanchezMaria
4496Clostridium difficile infection comes out of hospitalMickusRytis
4678Outbreak of invasive infections caused by Rhodotorula mucilaginosa in a tertiary hospitalHuangJing Jing
4714Convergence of two serotypes within the epidemic ST11 KPC-producing Klebsiella pneumoniae creates the “perfect storm” in a teaching hospitalChaoLiu
4922An outbreak of Pseudomonas aeruginosa in a critical care unit: VNTR typing reveals complex and multiple transmission events during COVID-19 pressuresBhattacharjeedeepannita
547Efficacy and safety of bezlotoxumab for the prevention of recurrence of Clostridioides difficile infection in real-life practiceMerchante GutiérrezNicolás
672Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) strains of diverse sequence types causing sepsis in neonates: the double-edged swordBasuSulagna
744Antibiotic resistance pattern, biofilm formation, phylogroups and pathogenicity islands in Escherichia coli causing catheter-associated urinary tract infectionEl-MahdyRasha
917Clonal clustering of Clostridioides difficile ribotype 176 in neighbouring eastern European countries suggests cross-border spreadKinrossPete
Abstract NumAbstract titleLast nameFirst name
1309Investigation on the status quo of full-time personnel of hospital infection control and their work, physical and mental health during the COVID-19 pandemicYongfangLiu
1420Prolonged exposure to open pulmonary tuberculosis in a neonatal unit: secondary attack rates among neonates, primary contacts and healthcare workersPopRoxana
158Nudging for hand hygiene: the effect of hand hygiene zones on 7 emergency departments' compliance rates in Riyadh, Saudi ArabiaSairafiBetule
223The effects of a virtual, real-time, antibiotic team on antibiotic prescribing behaviour of elderly care physicians in eight Dutch nursing homes Van EwijkCatharina Else
2352No increase of invasive aspergillosis during and after demolition work with simple prevention measures: a 5-year prospective study in a tertiary care centreD'incauStéphanie
2731Effect of UV supplementation on clonal dispersion of Klebsiella pneumoniae in a real hospital settingChoiHosoon
2879Carbapenem-resistant Enterobacterales: a 8-year surveillance at Keimyung University Dongsan Hospital and changes after moving to a new locationParkSunggyun
4154Efficacy of hollow-fibre shower filter units against Pseudomonas aeruginosa in an augmented care ward for safe patient useYetişÖzge
4286Faecal microbiota transplantation decreases intestinal carriership of multidrug-resistant microorganismsVendrikKaruna
705The experience of European hospital-based healthcare workers on following infection prevention and control procedures for COVID-19Van HoutDenise
947Consumption of alcohol-based hand rubs in French nursing homes during the pre-COVID-19 era: results from a nation-wide surveillance, 2018-2019BirgandGabriel
968A year of guidelines on respiratory protection for healthcare professionals in the era of COVID-19 pandemicBirgandGabriel
Abstract NumAbstract titleLast nameFirst name
1794Long-term antimicrobial effectiveness of a silver-impregnated foil on high-touch hospital surfaces in patient roomsWidmerAndreas F.
2097The interactions of bacterial contamination with healthcare mattress textiles specifically designed to repel microorganismsAdkinOsaretin Pat
2196Virucidal activity of alcohol-based hand rub against norovirus after 15 secondsKramerTobias
2437Effectiveness of a training intervention about healthcare waste management on the knowledge and practical skills of healthcare professionals in a teaching hospital of southern TunisiaBen JmaaMaissa
2642Effect of cold atmospheric-pressure plasma jet on biofilm and planktonic Staphylococcus epidermidis bacterial cellsSpiliopoulouAnastasia
3241Disinfecting handheld electronic devices with UV-C light in a healthcare setting: practicalities and implementationVan RossumCarsten
3372Validation of a mobile autonomous ultraviolet C (UV-C) robotic for disinfection of high touch surfaces in hospital critical areasBelliFilippo
4785Impact of chlorhexidine gluconate (CHG) on the skin microbiome in nursing home residentsGussinGabrielle
523Subinhibitory concentrations of mupirocin stimulate Staphylococcus aureus niofilm formation by upregulating cidAJinYe
Abstract NumAbstract titleLast nameFirst name
1163The effect of chitosan nanoparticles loaded with of mesenchymal stem cells supernatant on biofilm formation and bap1, rbmC genes expression of Vibrio choleraeShamsSaeed
123Hydrolytic activity and biofilm formation in Candida albicans: the effect of temperature and pH changeSidi Mohammed LahbibSeddiki
1387Development and validation of a high-content screening assay for inhibitors of enteropathogenic Escherichia coli adhesionPylkköTuomas
1801mRNA expression of ESBL genes of diarrhoeagenic Escherichia coli isolates from childrenSinghTaru
1861Oral streptococci can inhibit growth of Gram-negative respiratory pathogensLavigne-QuilichiniVincent
2043Infectivity of Cryptosporidium parvum can be altered by free-living amoebaeCostaDamien
2065Antibiotic sensitivity and biofilm formation in enterococcal urinary infections: a comparison between strains from Spain and UgandaCarrascoFélix
2143Virulence in third-generation cephalosporin-resistant and susceptible Klebsiella pneumoniae bloodstream isolates obtained from a German multi-centre surveillance studyLucassenKai
2598Resistance is futile: profiling the in vivo response of New Delhi metallo-β-lactamase (NDM)- and CTX-M-co-producing Klebsiella pneumoniae to antibiotic combinationsSmithNicholas M
261Can we minimize the risk of staphylococcal biofilm associated infections? An in vitro studyWójcik-BojekUrszula
2748Regulation of Toxoplasma gondii proliferation by protein PRAS40Cortès MollinedoValeria Ailyn
2975Dalbavancin activity against biofilm-growing MRSA isolated from patients with complicated skin and soft tissue infectionsDi DomenicoEnea Gino
3055The relationship between gastroduodenal pathologies and Helicobacter pylori CagL (Cytotoxin associated gene L) polymorphismOzbeyDogukan
3081Interaction between Mycobacterium abscessus and the fungus Exophiala dermatitidis in multi-species biofilmsLewinAstrid
3213Revealing the region-specific prevalence and expression of virulence factors present in enterotoxigenic Escherichia coliMondalIndranil
3283A new P-type ATPase inhibitor as a non-antibiotic bactericidal agentRayShilpa
3502Genomic characterisation on virulence and antibiotic resistance of Klebsiella pneumoniae and Klebsiella quasipneumoniae isolated from clinical samplesCruz BoettgerBruno
3556Bacillus cereus virulence and mortality in invasive infections in preterm neonateRuimyRaymond
3661Differential expression levels of heat shock proteins (Hsp70 and Hsp90) in Anopheles culicifacies adults in response to heat shockSinghTaru
4053Freeing the Aspergillus fumigatus of the polymycovirus makes it more resistant in the competition with Pseudomonas due to the altered iron-acquiring tacticsPatilRutuja Hiraji
4148Persisting and relapsing Staphylococcus aureus prosthetic joint infection managed with Debridement, Antibiotics and Implant Retention (DAIR): microbiological and molecular adaptationMuñoz GallegoIrene
4152Expression and structure of BrpA produced by Streptococcus dysgalactiae subsp. dysgalactiaeAlves BarrocoCinthia
4160Acinetobacter baumannii pneumonia alters the levels of lung surfactant proteins SP-A, SP-B, SP-C, and SP-DSirmatelFatma
4227Characterisation of Toll-like receptors-mediated signaling by symptomatic and asymptomatic Trichomonas vaginalis infection in mouse modelYadavSonal
4369Carbapenem resistance in Acinetobacter baumannii: insights from whole-genome sequencingBeirão AntunesJessica
4515Phenotypic and genotypic differences in clinical isolates of Pseudomonas aeruginosa acquired from adult CF treated in the National Institute of Tuberculosis and Lung Diseases in PolandMinkiewicz-ZochniakAnna
4620Genetic characterisation of the locus for streptolysin S from Streptococcus dysgalactiaeAlves BarrocoCinthia
4795Subpopulations of Moraxella catarrhalis with diverse backgrounds demonstrate various abilities to adhere and invade human respiratory epithelial cellsYa-LiLiu
712Analysing the fibronectin binding properties of Bartonella henselae adhesin A ThibauArno
818I3A ameliorates Shigella infectious colitis by inhibiting Shigella and regulating the immune responseYangHuan
844Characteristic of virulence profiles of Klebsiella pneumoniae isolated in an intensive care unit in MoscowNovikovaIrina
967Correlation between colibactin and biofilm formation in extraintestinal pathogenic Escherichia coli clinical strains isolated from Catalonia, SpainBallén TorresVictoria Del Pilar
Abstract NumAbstract titleLast nameFirst name
1262Longitudinal characterisation of the fungal skin microbiota in healthy subjects over the period of one yearBosshardPhilipp
1761Development of gut microbiome and acquisition of resistome in the gut of children from 0 to 15 years of agePaiHyunjoo
1969Inorganic nanoparticles modulate antipathogenic effects of microbiota isolates with impact on the infectious processHolbanAlina Maria
214Deletion of oprD enhances invasion of Pseudomonas aeruginosa PAO1 in cell culture modelFelipe-LlópezAlfonso
2383The associations between bacteria, biofilm production and antibacterial susceptibility in patients with recurrent tonsillitis and healthy controlsKlagisaRenata
3405Diversity of oral bacteria behaviour under antibiotic use in third molar surgery and advice for a personalised dentistryAlvesCarlos Henrique
3535Different modulatory effects of two different methicillin‐resistant Staphylococcus aureus clones on MG-63 cellsBongiornoDafne
3688Impact of acute colitis and repeated rectal flushing on the murine gut microbiomeKehrmannJan
4799Impact of rifampicin levofloxacin on gut microbiome and short-chain fatty acid production in mice with bone fracture: consequences for bone healthWallimannAlexandra
63Comprehensive integration of genome-wide association and gene expression studies reveals novel gene signatures and potential therapeutic targets for Helicobacter pylori-induced gastric disease BadrMohamed Tarek
774Lytic spectrum expansion of bacteriophages against carbapenem-resistant Acinetobacter baumanniiVuThao Nguyen
Abstract NumAbstract titleLast nameFirst name
108Combination of helium cold atmospheric plasma (CAP) and lysostaphin effectively eradicates Staphylococcus aureus biofilmsEhsaniParastoo
1097Experimental 3D-printed microfluidic device for dynamic in vitro study of biofilm formation using optical coherence tomography (OCT)TocDan-Alexandru
1435Antimicrobial efficacy of XF-73 and antibiotic comparators against clinically relevant Gram-positive microorganisms in biofilm mode of growthRomeo-MelodyIsabella
1964Development of a protocol for in vitro polymicrobial biofilm productionBottinoPaolo
2410Antibiotic strategies to combat biofilm resistance in a simulated prosthetic joint infectionLaplanteKerry
2531Characterisation and biofilm production of Pseudomonas aeruginosa strains associated with keratitis infectionsRaqiouiHanane
2573Effect of sub-inhibitory concentrations of antibiotics in biofilm cells of Staphylococcus hominis clinical isolatesVillarreal-SalazarVeronica
2661Study of the biofilm formation capacity in enterococci and their related genesCarrascoFélix
2701Eradication of biofilm-mediated methicillin-resistant Staphylococcus aureus infections using bacteriophage-antibiotic combinationsMorrisetteTaylor
3385Antibiofilm activity of phage ΦM in combination with fosfomycin against a rifampicin-resistant Staphylococcus aureus strainPonce-BenaventeLuis Alberto Juan
3442Strain-to-strain variations in the in vitro efficacy of a tri-enzymatic cocktail to prevent and disperse biofilms of bacterial species commonly associated with prosthetic joint infectionFontaineLaetitia
3610Massively parallel transposon mutagenesis identifies temporally essential genes for biofilm formation in Escherichia coliHoldenemma
3859Effectiveness of hybrid films comprising photosensitizer phloxine B embedded in saponite on polyurethane surface against methicillin-resistant Staphylococcus aureus (MRSA) biofilmDadiNitin chandra teja
4084In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with haematological malignanciesKlyasovaGalina
4316Polysaccharide intercellular-adhesin-dependent biofilm formation modulates antibiotic susceptibility in sessile Staphylococcus epidermidis populationsRohdeHolger
4362Characterisation of novel Staphylococcus epidermidis bacteriophages isolated from nasal samples as potential antibiofilm agentsInnocentAnna Jorina
4746The effect of cyclic di-GMP on Pseudomonas aeruginosa biofilm formation in a rabbit model for septic knee arthritisWeiQingjun
4816Tannic acid-stabilized silver nanoparticles: antibacterial and antibiofilm activity against clinical isolates from patients with chronic rhinosinusitisGibalaAgnieszka
640Identification of diorcinols and rubrolides as new antibiofilm compounds against Stenotrophomonas maltophilia biofilmsGudzuhnMirja
797Dynamics of biofilm formation of Streptococcus mutans, Streptococcus oralis and Veilonella parvula on saliva coated d-PTFE membranesBegićGabrijela
963Biocompatible and inhalable antimicrobial colistin-loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infectionsBugliFrancesca
Abstract NumAbstract titleLast nameFirst name
115Catalase protects staphylococcal biofilm against daptomycin activity El HajCristina
1263Evaluating a library of sortase A inhibitors (SrtAIs) loaded protein nanoparticles and their combination with antimicrobial peptides, for synergy against various bacterial strains and effects on in-vitro cell viabilityAlharthiSitah
1830Characterisation of a novel pneumococcal endolysin with therapeutic potential in experimental pneumococcal meningitisValenteLuca Gabriele
1905Development of enhanced sensitivity tools to monitor Leishmania infantum infectionMajoorAlissa
2242Evaluation of the heteroresistance to carbapenems in Escherichia coli strains with SOS system suppression and harbouring OXA-48 plasmidsRecachaEsther
2751Comparison of amphotericin B lipid complex, conventional amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidaemiaTuonFelipe
2791Different concentrations of vancomycin with gentamicin loaded polymethylmethacrylate (PMMA) to inhibit biofilm formation of Staphylococcus aureus and their implications TuonFelipe
2813Evaluation of Staphylococcus aureus and Candida albicans biofilms adherence to polyether-ether-ketone (PEEK) and titanium alloy prosthetic spine devicesStadler Tasca RibeiroVictoria
3389Experimental study of antimicrobial activity of non-woven polymeric material impregnated with copper and silver nanoparticlesHoptaOlena
4117Study of the inflammatory response of co-cultured murine macrophages and lung epithelial cells following exposure to cigarette smoke extract (CSE) and/or Aspergillus fumigatus sporesBouyssiAlexandra
4789Phosphorylcholine esterase plays a critical role in Dolichos biflorus agglutinin and Helix pomatia agglutinin binding to pneumococcal teichoic acidZhouMenglan
567Yeast cell wall mannan-rich fraction modulates bacterial cellular respirationSmithHelen
568Yeast cell wall mannan-rich fraction modulates reactive oxygen species (ROS) production of antibiotic susceptible and resistant Escherichia coliSmithHelen
697Epigenetic resistance modulation divergence in resistant phenotypic profiles of Staphylococcus aureusRibeiroEdna
Abstract NumAbstract titleLast nameFirst name
1065Impact of human genetic variants on C-reactive protein levels and acute appendicitisPeetersToon
1504Chronic granulomatous disease: infectious manifestations and management experience of a hospital centreGranadoJoana
Abstract NumAbstract titleLast nameFirst name
1498Bacterial infections in patients with large B cell lymphoma treated with chimeric antigen receptor T cell therapyRuiz-CampsIsabel
1516Non-bacterial infections in patients with large B cell lymphoma treated with chimeric antigen receptor T cell therapyRuiz-CampsIsabel
1869Faecal microbiota transplant (FMT) prior to allogeneic haematopoietic cell transplantation (HCT) in patients colonised with multidrug-resistant organisms (MDRO) results in improved survivalGhaniRohma
1975Infections in small bowel and multivisceral transplant recipients in a UK centreKohSamantha
2391Predictors of mortality and infection management during checkpoint inhibitor immunotherapy in patients with advanced lung cancer: a retrospective cohort studyBavaroDavide Fiore
2588Bloodstream infections and patterns of resistance in febrile patients with haematological malignancies at a tertiary care center in LebanonS. KanjSouha
2639Service evaluation of a new national febrile neutropaenia protocol using the AUS-rule for risk stratification within the UKNapperRachel
2737Home-based care of low-risk febrile neutropaenia in children: a national implementation studyHaeuslerGabrielle M
2738Increasing cefepime infusion time in febrile neutropaenia decreases time to defervescencePerkinsNicholson
2943Cost-effectiveness analysis of a home-based febrile neutropaenia programme for children with cancerHaeuslerGabrielle M
3162Predictors of mortality in neutropenic enterocolitis among children with haematological malignanciesKhedrReham
3325The tetanus antibody levels in the people living with HIV in a Turkish HIV care centreNazliArzu
3513Bacteremias in paediatric patients with acute lymphoblastic leukemia: our experience over a 5-year period of timeBangeasAthanasios
3926Prospective evaluation of febrile neutropenic patients in a tertiary care educational university hospital: a series of 671 casesSipahiOguz Resat
4313Infectious complications in haematological patients receiving CAR-T cell therapyGarcía-PoutonNicole
4607Should we do allogeneic haematopoietic stem cell transplantation in patient with pre-existing mucormycosis: why not?RogachevaYuliya
4848Characteristic features of patients with adult-onset immunodeficiency due to anti-interferon gamma antibodiesWeihaoHe
493A prospective study of plasma and bronchoalveolar lavage fluid cytomegalovirus (CMV) DNA load quantification for the diagnosis and outcome of CMV pneumonitis in immunocompromised hostsSaksirisampantGasit
Abstract NumAbstract titleLast nameFirst name
1908Comparison between age groups for antibody response after mRNA vaccines against SARS-CoV-2BelgiovineCristina
3233Incidence trends of type 1 diabetes in two European countries with different rotavirus vaccination policiesZurlChristoph
3702Invasive pneumococcal disease (IPD) among elderly in nordic countries: different needs for broader protectionPalmborgAndreas
Abstract NumAbstract titleLast nameFirst name
1104Lymphocyte proliferative and cytokine response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsHarrisonNicole
1967The determined response to vaccination with B/lineages in trivalent influenza vaccinesSanchez De PradaLaura
2345Persistence of vaccine-induced protection against hepatitis B in solid organ transplantation recipientsLejeuneSophie
3059The use of an electronic prescribing system to identify high priority inpatients for influenza vaccination at an Irish teaching hospitalO' ConnorRoisin
3609Development and characterisation of an aerodynamic system for pulmonary delivery of influenza vaccineBhargavaSaurabh
3781Live vaccine based on probiotic Enterococcus L3 strain containing epitopes of SARS-Cov-2 S protein stimulates specific immune response in miceSuvorovAlexander
3862Retrospective evaluation of hepatitis B virus exposure of those who had a diagnosis of rheumatological disease and applied to the Adult Vaccination Outpatient Clinic of Ege University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology between 2017-2020, Izmir, TurkeyTasbakanMeltem
623Protection against H9N2 influenza A virus induced by recombinant M2e-HA2 fusion proteinZeinolabedinMaryam
Abstract NumAbstract titleLast nameFirst name
1012Phase 3 trial to evaluate safety, tolerability and immunogenicity of V114 followed by 23‑valent pneumococcal polysaccharide vaccine 6 months later in at-risk adults (PNEU-DAY)BuchwaldUlrike K.
1315Distribution of serotypes and antimicrobial sensitivity of invasive Streptococcus pneumoniae infections in two district general hospitals in South-East EnglandRajaNadeem Sajjad
1835Immunogenicity of standard- versus double-dose of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in kidney transplant recipients and waiting list patients: a randomised controlled open-label trialLarsenLykke
1860Evaluation of the effectiveness of PCV13 immunisation among children 1 year of age in the Republic of KazakhstanBeissegulovaGulzhan
2450Elucidation of structural activity relationships of lipid A-based TLR4 mimetic adjuvants in a bacterial subunit vaccineIzacJerilyn
3421Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 Years and older with medical conditions and other factors that increase risk of pneumococcal diseaseSabharwalCharu
3483Audit of pneumococcal vaccination status in patients with invasive pneumococcal diseaseEnnisNiamh
3493Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults ≥65 years of age with prior pneumococcal vaccinationYoungMariano
3519Serotype 15C immune responses to a 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine–naive adultsYacisinKari
4017Safety and immunogenicity of a tetanus toxoid conjugated quadrivalent meningococcal vaccine (MenACYW-TT) in meningococcal vaccine-naïve older adults (≥56 Years of Age)DhingraMandeep Singh
4367Development of attenuated bovine herpesvirus 4 as a safe, inexpensive, single-dose vaccine to control Streptococcus suis infection in domestic pigsSealeyKatie
4463Pneumococcal nasopharyngeal carriage in preschool children after pneumococcal conjugate vaccine in PolandKielbikKarolina
4476The new quadrivalent meningococcal conjugate vaccine MenACYW-TT is well tolerated and immunogenic when administered as a single-dose in a broad age range (12 months of age and above)DhingraMandeep Singh
668Effectiveness of maternal pertussis vaccination in Singapore: a test-negative case-control studyChongChia Yin
724Rapid and effective protection of  Hla-MntC-SACOL0723 multi-epitope protein (HMS) recombinant vaccine formulated with alum and MPL adjuvants against Staphylococcus aureus sepsis infection in a mouse modelKhadijehAhmadi
742A phase III, randomised, double-blind, active comparator‑controlled, lot-to-lot consistency study to evaluate the safety and immunogenicity of V114 in healthy adults ≥50 years of age (PNEU-TRUE) SimonJakub K.
850Phase III trial to evaluate safety, tolerability and immunogenicity of V114 followed by 23‑valent pneumococcal polysaccharide vaccine 12 months later in healthy adults (PNEU-PATH)TuYingmei
Abstract NumAbstract titleLast nameFirst name
1923The interferon-gamma (IFN-γ) and interferon-alpha (IFN-α) levels in blood cell supernatants and vaginal samples of patients with recurrent vulvovaginal candidiasisKlimkoNikolay
236Blood dendritic cell and myeloid-derived suppressor cell subsets in patients with COVID-19 associated pneumoniaKniazevaVolha
2502Evaluation of novel synthetic lipid-A based molecules for use as vaccine adjuvantsErnstRobert
309Frequency of soil-transmitted infections in tuberculosis patients in the Peruvian Amazon and impact on mediators of lung tissue damageLoaderMaria Cristina
4226Streptococcus pyogenes colonisation and associated serological responses in a cohort of Gambian childrenKeeleyAlexander
4333Circulating sex steroids and Staphylococcus aureus nasal carriage in a general population in NorwayStensenDina B.
4520Complement C7: strong association with clusterin, but no indication for the presence of a modulating alternatively spliced C7-like proteinMassriMariam
4707Monoclonal antibody directed to the PilQ-PilA DSL region in Pseudomonas aeruginosa improves survival of infected mice in a model of sepsis caused by burn woundsZahedi BialvaeiAbed
701Effect of the capsular material of Cryptococcus neoformans on the interplay between microglial cells and neutrophilsBholaPrathna
Abstract NumAbstract titleLast nameFirst name
2503Contribution of weekly interdisciplinary rounds with a paediatric infectious disease specialist in a paediatric intensive care unitDe GregorioMarion
3173Aims and challenges of the creation of a national network of young clinical microbiologists: a French experienceGhelfenstein-FerreiraThéo
3266Survey of medical students on knowledge, attitudes and behaviour regarding the rational use of antibiotics and antimicrobial resistance in GermanyWiese-PosseltMiriam
3939Preparedness to prudent antimicrobial prescribing of final year medical students in CroatiaPalcevskiDora
4547A needs assessment for infectious diseases consultation at rural hospitalsHollingsheadCaitlyn
4630The most successful free smartphone applications for clinical microbiologyErcibengoaMaria
4822Establishing a Pan-European examination in medical microbiologyDoyleMaeve
Abstract NumAbstract titleLast nameFirst name
3833Mapping twenty years of antimicrobial resistances research trendsLuzChristian
Abstract NumAbstract titleLast nameFirst name
2038High faecal calprotectin levels correlate with SARS-CoV-2 intestinal shedding in COVID-19 patients  ZerbatoVerena
2052Importance of vitamin D levels in COVID-19 infectionKoksalIftihar
3130Genomic determinants associated with SARS-CoV-2 virulenceRuiz-RodriguezPaula
3504Cysteamine and its oxidised form, cystamine, reduces SARS-CoV-2 production in culture and cytokines release of CD4+ T cellsAlonziTonino
3563Characterisation of SARS-CoV-2 lineages during june 2020 in Aragon, SpainTristancho-BaróAlexander
3664Serological status and SARS-CoV-2 IgG persistence among infected healthcare workersKasztelewiczBeata
380 COVID-19 reinfection or relapse? A retrospective multicentre cohort study from IranSalehiMohammadreza
3971Role of systemic microbial translocation during COVID-19OlivaAlessandra
4108Oral bacteriotherapy effects on metabolic profile and fatigue score in SARS-CoV-2 infected subjectsInnocentiGiuseppe Pietro
4142Genetic diversity of SARS-CoV-2 strains on the basis of RdRp geneSiafakasNikolaos
42Identification of host factors that interact with the 5' end of the SARS-CoV-2 and MERS-CoV RNA genomesAlhatlaniBader Y.
4448SARS-CoV-2 clinically significant re-infection documented by PCR, serology, and full genome NGS analysisAlainSophie
4719Mechanical ventilation leads to tidal-volume dependent reduction of ACE2 in lungs of rodent models and blood of mechanically-ventilated patients's JongersBart
4737Belgian twins born with the Brazilian variant of SARS-CoV-2: transplacental versus intrapartum infectionDemuyserThomas
4762Functional activity of the complement system in hospitalized COVID-19 patients with a focus on the lectin and alternative pathwayCharitos FragkakisPanteleimon
4768Detailed epitope mapping of SARS-CoV-2 nucleoprotein reveals specific immunoresponse in cats and dogs housed with COVID-19 patientsScalasDaniela
4776Novel PIKfyve inhibitor has broad spectrum antiviral activity in preclinical experimentsMighdollMichelle I.
4780Mutations within the exonuclease proofreading system of SARS-CoV-2 as a driver of evolutionMackAndrew
4808Preclinical efficacy of BIO101 on respiratory function in SARS-CoV-2-infected Syrian hamstersLatilMathilde
4891Seropositivity for SARS-CoV-2 in cats and dogsBienzleDorothee
4907Viperin-derived ddhC as a novel serum biomarker for COVID-19 and other viral infectionsMehtaRavi
603SARS Coronavirus 2 (SARS-CoV-2) reinfection within the first 3 months of COVID-19 recovery in a referral hospital, Tehran, Iran GhiasvandFereshteh
971Identification of 12 Novel Mutations of SARS-CoV-2 from Turkey and Their Impact on Protein Dynamics: In silico AnalysisUnluSezin
Abstract NumAbstract titleLast nameFirst name
114Aetiology and antimicrobial resistance of secondary bacterial infections in patients hospitalised with COVID-19 in Moscow city hospitalKarnoukhKonstantin
1204COVID-19 readmission among immigrants in DenmarkMoussaAmar Ali
1232Factors associated with hospital admission and adverse outcome for COVID-19: role of social factors and medical careBeaumontAnne-Lise
1276Incidence of SARS Coronavirus 2 (SARS-CoV-2) infection in a large HIV clinic at the Tel Aviv Medical CentreHalperinTamar
1330The application of next-generation sequencing in the epidemiological investigation of nosocomial clusters of COVID-19: experience in a private hospital in Hong KongZeejonpaul sze tsing
1458Comparison of bacterial and fungal co- and secondary infection in COVID-19 patients in England by wave one and wave two of the pandemicSpringerAdelle
1611Molecular characterisation, phylogenetic and variation analyses of SARS-CoV-2 strains in TurkeyKarameseMurat
1683SARS‐CoV‐2 reinfection in patients recovered from COVID‐19 in the Republic of CyprusTsioutisConstantinos
1685COVID-19 status in a large population of healthcare workersMuñozPatricia
1895Dissemination of SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7) in Southern SpainDe Salazar GonzálezAdolfo
2072Evolution, virulence and immunogenicity of relevant SARS-CoV-2 spike mutantsCoscollaMireia
2094No evidence of SARS-CoV-2 in hospitalised patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020PanattoDonatella
2103SARS-CoV-2 antibodies profile in people with acute respiratory infections during 2020 in Castile and Leon, SpainSanzIván
2262Impact of social distancing measures on COVID-19 PCR positivity rates in the 2nd Health Region of GreecePournarasSpyros
2295Analysis of variations in the amplification curves of the “s” gene in the presence of SARS-CoV-2 variant B.1.1.7PascarellaMichela
2511Using A2B-COVID to understand SARS-CoV-2 transmission during an outbreak in a rehabilitation unitBlackabyJessica
2649Comparison of epidemiological and infection characteristics of patients with influenza and COVID-19: a retrospective study at single general district hospital in EoE, UKKandilHala
2756HDPCR™ data analytics offers unique opportunities for assay optimisation and COVID-19 surveillanceWangMimi
2787Tracking the D614G change in the SARS-CoV-2 spike protein during the early pandemic leveraging Principle Component Analysis (PCA)SchererChristiane
2834COVID-19 infection and mortality of healthcare workers from a multi-centre private healthcare system in MexicoLopez RomoALICIA ESTHELA
2882Prevalence of COVID-19 in BCG vaccinated vs unvaccinated population in MexicoSalcido MontenegroAlejandro
2885Clinical characteristics and mortality of COVID-19 patients in a tertiary care hospital in Mexico City: a one-year experienceCastañeda-MéndezPaulo Francisco
2909Co-infections of SARS-CoV-2 with other respiratory viruses were common after the second wave of the COVID-19 pandemicPérez San JoséDiana
296The burden of COVID-19 in HIV-1-infected patients in northern France after lifting of the domestic lockdownMeybeckAgnes
2983Risk of COVID-19 infection and outcomes among healthcare workers working in a large tertiary care hospitalAlshamraniMajid
3143Seroprevalence of SARS-CoV-2 antibodies among the general population in Romania: a cross-sectional studyGradisteanu PircalabioruGratiela
3199Using breakpoint modelling to explore the link between non-pharmaceutical COVID-19 interventions and infection incidence in the Republic of IrelandBoudouMartin
3220Clinical presentation and outcomes of hospitalised patients with COVID-19: a registry experience from a low-middle income countryNasirNosheen
3236Transmission profile of SARS COV2 in the V Health Region. Period July to October 2020AguilarGloria
3473Risk factors for bacterial co-infection in hospitalised patients with SARS-CoV-2 infection: single-centre retrospective studySolera HornaClara
3509A new SARS-CoV-2 lineage (B.1.411) is driving the recent large pandemic wave in Sri LankaJayathilakaDeshni
3527Seroprevalence of anti-SARS-CoV-2 IgG antibody in hospitalised patients: results of the first hospital-based serosurvey from IndiaSinghKomal
3532Virological surveillance of influenza and COVID-19 season 2019/2020 in Bavaria, Germany suggests no SARS-CoV-2 spread prior to the first German case in late January 2020SingAndreas
3629Microbiological characteristics of bacterial bactereamias among patients hospitalised with COVID-19 in a tertiary referral hospital in Northern Greece during the second epidemic waveTychalaAreti
3667Descriptive epidemiology of inbound international passengers at Islamabad airport (point of entry)Noreennadia
3681SARS-CoV-2 in wastewater: utilising wastewater surveillance to address testing disparities within IsraelCraddockHillary
3728A large SARS-CoV-2 outbreak in a long-term care facility: lessons learned from a molecular epidemiological analysisEscalas BordoyAntoni
3755Community-acquired respiratory tract co-infections in non-ICU patients hospitalized with COVID-19 pneumoniaMoraitouEleni
3775Comparison performance of two rapid antigen detection test for COVID-19Custódio MotaJóni Alexandre
3829Fungal superinfections in COVID-19 patients hospitalised in a tertiary referral hospital in Northern Greece during the second more intense epidemic waveTychalaAreti
3902Comorbidity as criteria of hospitalisation for patients with COVID-19PshenichnaiaNatalia
3925Predictive model of hospitalisation of patients with COVID-19PshenichnaiaNatalia
3952Tracking the spread of SARS-CoV-2 and variants in wastewater in Vienna and suburban areasMasseronAmandine
4074SARS-CoV-2 seropositivity among paediatric healthcare personnel just after  the first peak of pandemic: a nationwide surveillance OygarPembe Derin
4082Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of BahrainKamal Hasan Mohamed SaeedNermin
4096Investigation of the COVID-19 impact during pregnancyPerez TanoiraRamón
4097Active surveillance for early detection of SARS-CoV-2 infections across high-risk community key populationsDe NardoPasquale
4158Seroprevelance of antibodies against SARS-CoV-2 among healthcare workers between two waves of pandemicDiamantiIoanna
4193Increase in COVID-19 numbers in downwind regions following a wind changeHailwoodAlice
4214Exposure to SARS-CoV-2 of healthcare workers during two pandemic waves: a targeted population analysis from a major COVID-19 reference centreDi RuscioFederica
4279Different bacterial and fungal infections detected in SARS-CoV-2-positive and SARS-CoV-2-negative patients admitted to intensive care unitsMontecchiniSara
4556Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission and associated factorsSnellLuke Blagdon
4570Impact of COVID-19 pandemic in patients admitted to a reference Italian paediatric hospitalRussoCristina
4585Changes in antimicrobial resistance and antibiotic consumptions during COVID-19 epidemicMeschiariMarianna
4635Presence of COVID-19 antibodies IgG/IgM in Kinshasa (DRC) populationMukuku SifaCathy
4710Seasonal human Coronaviruses (sHCoVs) circulation among adults before COVID-19 pandemic at a tertiary care hospital in TurkeyDizmanGulcin
4739Epidemiology of potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in a paediatric cohort in KuwaitAl-HaddadFatemah
4828Prevalence and risk factors of SARS-CoV-2 antibody responses among a cohort of 1913 healthcare workers at the Consorci Sanitari del Maresme (CSdM), Catalonia, Spain during the first wave of COVID-19 pandemicClavéPere
488COVID-19 and flu/respiratory syncytial virus (RSV) adult hospitalisations in a Belgian tertiary referral centre: epidemiological, clinical and outcome data comparisonBourgeoisMarc
4926The Seroprevalence of COVID-19 in healthcare workers with and without prior infection: data from the SORTED StudyConnollyStephen P
4935The epidemiology of SARS-CoV-2 virus in Moscow region from January 2021 till April 2021CherkashinaAnna
606High prevalence of SARS-CoV-2 in dogs and cats living in COVID-19 positive householdsBroensEls M.
766Profile of COVID-19-positive patients admitted from March to June 2020 at the Sino- Congolese Friendship Hospital in N'djili from Kinshasa, Democratic Republic of CongoHassanMwana-Yile
879Excess mortality in nursing homes during COVID-19 pandemicBessisSimon
982Transmission of SARS Coronavirus 2 (SARS-CoV-2) within households: a prospective cohort study in the Netherlands and Belgium, interim resultsVerberkJanneke Doortje Maria
Abstract NumAbstract titleLast nameFirst name
1015Co-infection in patients hospitalised with COVID-19: a retrospective cohort study in a tertiary hospital in Madrid (Spain)Díaz PollánBeatriz
1059Mucormycosis in patients with COVID-19: a prospective multi-centre study from IranSalehiMohammadreza
1111Prophylactic and therapeutic low molecular weight heparin in COVID-19TunçerGülşah
1118National Early Warning Score 2 (NEWS2) and laboratory predictors correlated with clinical deterioration in hospitalised patients with COVID-19TunçerGülşah
1168Characteristics of haematologic patients with COVID-19 as compared to non-haematologicFernández-CruzAna
1170Secondary haemophagocytic lymphohistiocytosis in a COVID-19 patient with previously undiagnosed Hodgkin's lymphomaZambrano SánchezGabriela
1181Correlation between nasopharyngeal SARS-CoV-2 viral load and viremia in patients hospitalised for COVID-19HagmanKarl
1185SARS-CoV-2 disease in older hospitalised patients in Southern Italy by day-to-day follow-upDi CarloPaola
1195A retrospective cohort study of risk factors for readmission after hospitalisation for SARS-CoV-2 infectionFalcóAnna
1219Analysis of consecutive patients with active COVID-19 related suspected acute stroke: clinical, biochemical and outcome data of the first 63 patientsBen Abidfatma
1352Risk factors for mortality in adult COVID-19 patients who develop bloodstream infections: analysis at a large teaching hospital in ItalyDe AngelisGiulia
1422Symptomology of COVID-19 during the first 6 months after illness onset: a longitudinal cohort study of mild, moderate and severe cases of SARS-CoV-2 infectionWynbergElke
1443Changes of CT findings and laboratory characteristics in COVID-19 pneumonia patients during recovery phaseWangQingqing
1513Pulmonary function impairment and radiological improvement in COVID-19 patients after 10 weeks of follow-upPaternotteNienke
1514Outcomes for patients ‘not for intubation’ receiving CPAP and improvements in palliationReadAndrew
1526Comparing outcomes and factors that predict mortality for patients on CPAP for COVID-19 across two wavesJovaisaiteAgne
1541Bacterial and fungal co-infections in patients with COVID-19 related pneumonia: a retrospective cohort studyBediniAndrea
1556Rate and impact of infections in the outcome of COVID-19 hospitalised patientsMoreno-TorresVictor
1561A retrospective analysis of hepatitis B reactivation after treatment with tocilizumab in SARS-CoV-2 infectionFernández-CruzAna
1576Low intubation and mortality rates among patients with COVID-19 treated with high-flow nasal oxygen in the wardIoannouPetros
1631Acquired thrombotic thrombocytopenic purpura after COVID-19FioriAgustina
1743Risk factors for bacterial infections in patients with moderate to severe COVID-19: a case-control studyNasirNosheen
1795COVID-19 in outpatients: can we predict secondary hospital admission?: The CHAD studyDesgrangesFlorian
1859The utility of high-flow nasal oxygen for COVID-19 hypoxemic respiratory failurePerinpanathanTanaraj
1961Real-world evidence of the effectiveness of hydroxychloroquine treatment among hospitalised COVID-19 patientsKuranzSeth
2001Pre-existing chronic kidney disease (CKD) was not associated with a severe clinical presentation of hospitalised COVID-19: results of a case-control studyRussoAntonio
2046Herpes simplex virus reactivation in patients with SARS-CoV-2 pneumonia: a prospective, observational trialFranceschiniErica
2099Prospective study of the clinical and stewardship outcomes of serial measurements of procalcitonin levels in COVID-19 patientsKandilHala
2162The quantitative radiological Chung Score correlates with deterioration of respiratory function in patients with COVID-19 pneumoniaScottoRiccardo
2188A bedside predictive score of clinical outcome in patients hospitalised for SARS-CoV-2 infectionVolpicelliLorenzo
2221Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosisDe AngelisGiulia
2238Clinical features of candidaemia in COVID-19 patients and comparison between non-COVID-19 patientsMuñozPatricia
2335Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: a multi-centre observational studyMonariCaterina
2343Prolonged viral shedding does not impact outcome in hospitalised COVID-19 patientsNasirNosheen
2355Clinical impact and resources consumption in SARS-CoV-2 or influenza patients requiring hospital admission: a comparative analysisLopez-MontesinosInmaculada
2368Bacterial infections in intensive care unit adult patients with COVID-19: experience from a reference teaching hospital in San Jose, Costa RicaRamirez-CardoceManuel
2377Prevalence, characteristics and outcome of people with psychiatric disorders hospitalised for COVID-19PascaleRenato
2499A retrospective, monocentric study comparing co and secondary infections in critically ill COVID-19 and influenza patientsMarcouxDiane
2604Secondary bacterial pneumonia in patients with COVID-19: how can we improve the diagnosis? A retrospective approach in a university hospitalCarmoAnalia
2624Bloodstream infections in patients receiving extracorporeal membrane oxygenation for COVID-19 pneumonitisBanksTristan
2630The microbiology of Gram-negative and Gram-positive bacterial respiratory pathogens in the setting of COVID-19: impact on morbidity and mortalityPuzniakLaura
2636Acute abdominal pain: an emerging presentation of SARS-CoV-2?KayranJade
2684Quantification of T lymphocyte subpopulation as a prognostic marker in SARS-CoV-2 infectionCampogianiLaura
2709Characteristics of procalcitonin in hospitalised patients with COVID-19 based on bacterial co-infectionsSoWonhee
2736Long(est) COVID-19? A persistent SARS-CoV-2 infection in an immunocompromised host, 286 days and counting…HackettMark
2742Antibiotics on admission? A descriptive analysis of microbiological isolates from 174 first wave COVID-19 cases admitted to critical care at a large, metropolitan tertiary centre, aimed at refining antibiotic use in critically unwell patientsMcnultyMarie
2747Antimicrobial treatment patterns among patients with Gram-negative respiratory pathogens during the COVID-19 pandemic: a multi-centre evaluation in the USPuzniakLaura
2758Characteristics and mortality outcome among COVID-19 outpatients and inpatients in the United StatesPuenpatomAmy
2759Comparison of outcomes based on antibiotic use stratified by procalcitonin levels in hospitalised patients with COVID-19SoWonhee
2770Clinical characteristics and outcomes of hospitalised patients with COVID-19 in Argentina: results from the ECCOVID multi-centre prospective studyCordovaEzequiel
2831Effect of methylprednisolone treatment on COVID-19: an inverse probability of treatment weighting analysis of a binational cohort from Italy and ChinaMaKevin Sheng-Kai
2847Effect of pre-admission use of statins on prognosis of patients with COVID-19: a propensity score-matched binational cohort studyMaKevin Sheng-Kai
2865Real-time Ct values for SARS-COV-2 as prognostic marker for the clinical outcome in patients affected by COVID-19RavaniniPaolo
2906Impact of COVID-19 in patients awaiting liver transplantationKounisIlias
2911Mid-regional (MR)-proADM as a prognostic factor in COVID-19 patients: the experience of Udine University Hospital (Italy)TasciniCarlo
2914CMV and HSV viral loads in bronchoalveolar lavage fluid in critically ill patients with COVID-19: a retrospective single centre studyBrianoFederica
2968Epidemiology of nosocomial infections associated with COVID-19 in a Tunisian intensive care unitMnifBasma
3023Superinfections related to tocilizumab use in patients with COVID-19 pneumonia Mateu SubiràAina
3129Nosocomial infections in COVID-19 critically ill patientsMartinsAntónio
3163A real-life use of remdesivir in COVID-19 patients: a retrospective case-control studyCogliati DezzaFrancesco
3194COVID-19 in haemodialysis patients: what affects short- and long-term mortality?ErolCigdem
3214Differences between the waves in Northern Italy: how the type and outcome of COVID-19 infected patients admitted to the emergency room have changedBongiovanniMarco
3224COVID-19 maternal and perinatal outcomes: living systematic review and meta-analysisZhouDengyi
3333Risk factors for bacterial co-infection, antibiotic use and outcomes of hospitalised patients with COVID-19 pneumonia: a multi-centre case-control study (COVID-Metrosud)Abelenda AlonsoGabriela
3381Co-infections in patients with COVID-19Perez TanoiraRamón
3444Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multi-centere study (COVID-Metrosud)Abelenda AlonsoGabriela
3520Characteristics and clinical outcome of elderly adults admitted to intensive care unit with severe forms of COVID-19GkoufaAikaterini
3536CXCL-10 levels at hospital admission represent potential predictor of COVID-19 outcomeCirilloDaniela Maria
3539Lung sequelae in severe COVID-19 patients: assessment three months after cure of the acute diseaseSilva-PintoAndré
3637Role of procalcitonin in antibiotic prescription at admission of severe COVID-19 patients in intensive care unit: a prospective cohort studyCunhaFlávia
3641Low incidence of hospital-acquired bloodstream infections and association with severity of the disease and corticosteroid therapy in patients hospitalised with COVID-19ConaAndrea
3691The risk of vertical transmission in SARS-CoV-2OzcanGulin
3719Outcomes of ventilator-associated pneumonia in COVID-19 patientsMartinez-MartinezMaria
3723Smoking as a risk factor for intubation in hospitaliSed COVID-19 patientsNitsotolisThomas
3761Dynamics of SARS-CoV-2 genomic and sub-genomic RNA in patients receiving treatment with remdesivirAlonso NavarroRodrigo
3831Antibacterial treatment in complicated COVID-19: no beneficial effect on clinical outcome or course of diseaseSchonsMaximilian
3889Clinical features of patients with COVID-19 in home isolation versus hospitalised patients: a multi-centre retrospective experience in a COVID-19 group in Campania, Southern ItalyPisaturoMariantonietta
3901A possible role of asymmetric dimethylarginine (ADMA) during SARS-CoV-2 infection: the experience of Udine University Hospital, ItalyTasciniCarlo
3962SARS-CoV-2, a potential new virus implied in drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: case seriesMascittiHélène
3992Design of a mortality predictive model for COVID-19 using data mining techniquesAsencioMaria Angeles
4185Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19?SipahiOguz Resat
4239Migrant COVID-19 pneumonia in two patients with agammaglobulinemiaCrosatoVerena
4271Effect of two different high-dose methylprednisolone treatments on clinical outcomes in severe COVID-19 patientsHasanogluImran
4282Does immunosuppression increase the risk of secondary bacterial infection in critically ill SARS-CoV-2 patients?VirkHarjeet
4287Incidence of bloodstream infections in hospitalised patients with COVID-19 in a tertiary hospital in Athens, GreecePetrouEleni
4466Impact of timing on the outcome of patients with COVID-19 treated with remdesivirFalconeMarco
4475Incidence and severity of COVID-19 among patients with chronic hepatitis B in CroatiaVrsaljkoNina
4488The burden of ventilator-associated pneumonia in critically ill patients with severe COVID-19StufanoMonica
4509Long-term sequelae in a post-COVID-19 populationCiardiMaria Rosa
4531Pneumococcal infection in a cohort of 818 COVID-19 hospitalised patients: risk factors and outcomeTesoroDaniele
4643External validation of ten clinical scores for prediction of 90-day mortality in patients admitted with COVID-19VerscheldenGil
4649Increase in primary Enterococcus faecium bloodstream infections specific to the second COVID-19 pandemic wave across an expanded dual-site COVID-19 intensive care unit servicePayneLara
4652Co-infection and other features of COVID-19 in critical patientsGarcia PérezCristina
4657COVID-19 and candidaemia: high mortality in critically ill patientsCojuc-KonigsbergGabriel
4665Early experience from active screening of COVID-19-associated pulmonary aspergillosis in ICUPavonePaolo
4667[68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of endothelial activation in COVID-19 patientsAarntzenErik
4679Characteristics of paediatric multisystem inflammatory syndrome (PMIS) associated with COVID-19JiaXiaojiong
4681Tendencies of changes in respiratory microflora in patients suffering from community-acquired pneumonia during COVID-19PshenichnaiaNatalia
4687Characteristics of anxious-depressive disorders of patients after COVID-19Chichirelo-KonstantynovychKiarina
4688Early evaluation of antibacterial therapy in COVID-19 hospitalised patients as part of a COVID-19 antimicrobial stewardship programGalyAdrien
4694Association between early antibiotic therapy and in-hospital mortality among older patients with SARS-CoV-2 pneumoniaPrendkiVirginie
4729Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centres in West AfricaJaspardMarie
4738Clinical characteristics and outcome of patients affected or not by COVID-19 in emergency department (RESILIENCY study II)RussoAlessandro
4745Impact of SARS-CoV-2 viral load measured by cycle threshold and days from symptom onset to admission on the mortality of hospitalised patients with COVID-19RicoVeronica
4752Alveolar-arterial gradient as marker of severity among COVID-19 patientsPipitoneGiuseppe
4781The value of calprotectin in prediction of severe respiratory failure in COVID-19 patients: a multi-centre prospective studyDe Guadiana-RomualdoLuis García
4813Characteristics and outcomes of patients with COVID-19 at a Senegalese Treatment Center of EpidemicsLawsonAgbogbenkou Tevi Dela-Dem
4817Persistent asthenia after one year following acute ALS/SARS-CoV-2 infectionSampedroEva
4908Pulmonary function tests at 1 year following acute SARS-CoV-2 infectionFernandezMikel
4909Effectiveness of high flow nasal oxygen in the treatment of COVID-19: a systematic reviewMcgingRosa Maeve
4911One-year follow-up of COVID-19 long-haulers: a longitudinal study among non-hospitalised patientsSlamadorsaf
4913Persistent symptoms in a cohort of patients after acute COVID-19StupicaDasa
4925PIMS-TS: a one-year retrospective study in a Portuguese hospitalOliveiraRita
4929Development and validation of the RCOS prognostic index: a bedside multi-variable logistic regression model to predict hypoxaemia or death in patients with SARS-CoV-2 infectionAlvarez-UriaGerardo
4932Bacterial co-infection and superinfection in COVID-19 patients admitted in an ICUCampo RamosRainer
4942Physical capacity of individuals with long COVID: a cross-sectional studyMargalitIli
4964Prolonged SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: a tailored approachD'abramoAlessandra
4968Enterococcal and candida sp. abundance in the digestive tract is independently associated with death of Sars-Cov2 critically ill adults.PatrierJuliette
4971Silent hypoxia demonstrated early in the course of COVID-19 patients with the six-minute walking testMondragon EguiluzJaime Arturo
4984Use of SeptiCyte RAPID to assess the risk of ICU admission in COVID-19 patientsHardy-WerbinMax
4988Is COVID‐19-associated pulmonary aspergillosis a myth?HeldJürgen
506Intubation risk and mortality according to ROX index, biomarkers, type of corticosteroid boluses and ruxolitinibMora DelgadoJuan
593Incidence and impact outcome of hyperglycemia in COVID-19 patients requiring intensive care unit (ICU) admissionBahloulMabrouk
653Is there an increased risk of bloodstream infection in COVID-19 infection?OrellanaMª Angeles
663Impact of one or more comorbidities and the microbiome metabolic therapy (MMT) KB109 on symptom resolution in non-hospitalised patients with mild to moderate COVID-19HaranJohn
828COVID-19 reinfection in healthcare workers: a case seriesBongiovanniMarco
900Evaluation of positive blood cultures on patient outcomes with COVID-19ReboldNicholas
973Factors associated with admission to intensive care units in COVID-19 patients in Lyon, FranceSaadatian-ElahiMitra
977Tobacco smoking and severity of COVID-19: the experience from a hospital-based prospective cohort study in Lyon, FranceSaadatian-ElahiMitra
995Are there any clinical diferences between community-acquired and hospital-acquired COVID-19? Experience of a public tertiary cardiovascular disease specialised hospital in São Paulo, BrazilAbboudCely
Abstract NumAbstract titleLast nameFirst name
1057Comparison of two SARS Coronavirus 2 (SARS-CoV-2) IgM and IgG antibody detection assays in COVID-19   WangHe
107The role of neutrophil-to-lymphocyte ratio in predicting disease severity among COVID-19 patients in metropolitan medical centre: a prospective cohort studyTanEndymion Ervin
1141Comparison of a novel antigen detection test with reverse transcription PCR (RT-PCR) assay for laboratory diagnosis of SARS-CoV-2 infection CiritOsman Sezer
1199Evaluation of SARS-CoV-2 rapid diagnostic antigen test in COVID-19-suspected patients in CroatiaDakovic RodeOktavija
1216Lumipulse G SARS-CoV-2 Ag assay evaluation for SARS Coronavirus 2 (SARS-CoV-2) antigen detection using 594 nasopharyngeal swab samples from different testing groupsMenchinelliGiulia
125Prospective and comparative evaluation of STANDARD Q COVID-19 Ag test to detect SARS-CoV-2 from nasal cavity and nasopharyngeal swabsKimSunjoo
1375Development of a multi-parametric spot-immunoassay (SIA) for the detection of SARS-CoV-2 antibodies in COVID-19 patientsSternaPhilipp
1391The sensitivity of SARS-CoV-2 antigen detection in symptomatic patients, attending the collection site for preventive testingHurychJakub
1533An evaluation of Annexin-1, Annexin-2 and BMP-7 serum levels in COVID-19 patientsAktug DemirNazlim
1571Analysis of subgenomic RNA in SARS-CoV-2VinuelaLaura
1612Rising to the challenge of the COVID-19 pandemic: increasing capacity and reducing turnaround times in the first 10 months of the COVID-19 pandemic  CafferkeyJacqueline
1706Tracking SARS-CoV-2 genome in search of nucleotide polymorphisms affecting QIAstat-Dx® performancePeñarrubiaLuis
1728Estimation of the role of antibodies against SARS-CoV-2 as a diagnostic tool on hospital admission: experience of a tertiary care Greek hospitalPetinakiEfi
1744Analytical specificity of the SARS-CoV-2 transcription-mediated amplification (TMA) assayMuñozAlba
1765Assessment of false positive result rates with rapid testing for SARS-CoV-2 antigen reveals setting-dependent variabilityMenchinelliGiulia
1822Clinical performance of the rapid antigen test for the detection of SARS-CoV-2 virusKasztelewiczBeata
1842Nasal Swab Home Collection Kit for SARS-CoV-2 detectionShahJyotsna
1880Rapid COVID-19 antigenic tests: reliable for detecting high viral loadsSoleimaniReza
196Comparative study of rapid PCR SARS-CoV-2 versus conventional PCR in urgent patient carePalancaMatilde Maria
1989Extraction bottleneck in the diagnosis of SARS-CoV-2: evaluation of an alternative protocol derived from veterinary useBottinoPaolo
2053FluoroType® SARS-CoV-2 varID Q – quantitative identification of SARS-CoV-2 and detection of the most relevant mutations from swabs and salivaBufeThorsten
2059Correlation of emergency use authorisation (EUA) serological assays to an in-house SARS-CoV-2 serological assay and wild-type neutralisation assayTothDerek
2064Evaluation of two rapid antigenic tests for the detection of SARS-CoV-2 in nasopharyngeal swabsDescyJulie
2086Live or dead: a strategy to evaluate the SARS-CoV-2 integrity/infectivity in nasopharyngeal samples in clinical settingsFernández-NatalIsabel
2108Comparative quantitative analysis of positive results in asymptomatic subjects by SARS-CoV-2 antigen test with RT-PCR assayLeperaValentina
2145Implementation of a rapid antigen assay for SARS-CoV-2 in the hospital: results from a comparison with molecular testingLeperaValentina
2176Questionable positive predictive value of COVID-19 rapid antigen test: a real-life experienceThomaR
2211Comparison between two techniques for the detection of SARS-CoV-2 IgG: Alinity™ and AtellicaIM®Hernández-FeblesMelisa
2246Diagnostic accuracy of a rapid PCR test in lower respiratory tract specimensDe PaceVanessa
2260Sensitivity and specificity of OnSite® COVID-19 Ag rapid test in nasopharyngeal samplesGonzález DíazAida
2272Evaluation of a new lyophilized RT-PCR for the preliminary diagnosis of the variant B.1.1.7. by SARS-CoV-2De Salazar GonzálezAdolfo
2302Evaluation of the presence of neutralizing antibodies for SARS-CoV-2 in a cohort of hospital employees in relation to vaccination BioNTech/Fosun Pharma/PfizerPascarellaMichela
2379Evaluation of the BioFire® Respiratory 2.1 and 2.1 plus Panels for the detection of SARS-CoV-2 in nasopharyngeal swab samplesBuccambusoMaggie
2421A screening program for SARS-CoV-2 detection by RT-PCR in saliva in healthcare professionalsDe Salazar GonzálezAdolfo
2423Usefulness of a multiplex RT-PCR assay as a screening to detect SARS-CoV-2 variant B.1.1.7FontanLeticia
2467Evaluation of a rapid antigen test performed on nasal swabs for the detection of SARS-CoV-2LoukaChristina
2489Surveillance of SARS-CoV-2 sequences for in silico evaluation of the reactivity of the SARS-CoV-2 assays in the BIOFIRE® Respiratory 2.1 (RP2.1) and BIOFIRE® Respiratory 2.1plus (RP2.1plus) panelsSpauldingUsha
2506Gene expression in peripheral blood cells as early detection hyperinflammation and coagulation disorder in patients with COVID-19MelnichukNataliia
2562Performance comparison of TaqPath™ COVID-19 Combo CE-IVD kit and Lyra® SARS-CoV-2 assay for detecting SARS-CoV-2 in upper respiratory specimensGandhiManoj
2590Comparison of TaqPath™ COVID-19 Combo Kit and BGI Real-Time Fluorescent RT-PCR Kit for detecting SARS-CoV-2 in nasal swabsGandhiManoj
2680Clinical evaluation of a rapid sample-to-answer molecular assay for the detection of SARS-CoV-2ZarkotouOlympia
2699Dried blood spots: a robust sample material for detection of anti-SARS-CoV-2 antibodies: valuable tool in the context of seroprevalence and vaccination studiesWeisserHeike
2705Clinical performance of the Cobas® SARS-CoV-2, RealTime SARS-CoV-2 and TaqPath™ COVID-19 Combo Kit using the 2-out-of-3 infected-patient “gold standard”YoungStephen
2711Novel antigen assay for acute diagnostics of COVID-19 in the laboratoryDieckmannKersten
2719Novel PCR test to differentiate between infections with SARS-CoV-2, influenza A and BSchröderAnn-Kristin
2721Expansion of ChromaCode’s HDPCR™ SARS-CoV-2 assay EUA to increase access and throughputBrownBradley
2727Diagnostic screening method for detection of SARS-CoV-2 VOC 202012/01Sanchez CalvoJuan Manuel
2730Correlation between quantitative anti-SARS-CoV-2 IgG ELISA and neutralisation testsKlemensOliver
2762HUMASIS® SARS-CoV-2 antigenic rapid tests: the performance at an East Algiers hospitalBaghdadiImene
2830SARS-CoV-2 antibody repertoire related to disease severityObriadinaAnna
2835Design and performance of the Alinity m Resp-4-Plex assayKularRupinder
2889The association between SARS-CoV-2 RT-qPCR cycle threshold and clinical outcomes of hospitalised patients with COVID-19 in a Mexican cohortFlores-PerezRomulo Omar
2899Validation of a saliva-based test for the molecular detection of SARS-CoV-2 infectionTasciniCarlo
2944Monitoring of immune response progression in healthcare workers after administration of COVID-19 mRNA vaccine MazzuccoLaura
3014Evaluation of a RT-qPCR assay without extraction for SARS-CoV-2 detectionFenauxHonorine
3015SARS-CoV-2 antibodies rapid tests: a useful epidemiological tool in challenging settingsSaluzzoFrancesca
3032Utility of serial measurement of neutrophil-to-lymphocyte ratio to predict development of acute respiratory distress syndrome (ARDS) in hospitalised COVID-19 patients: a retrospective cohort studyBano MehdiKulsoom
3053Evaluation of the performance of SARS-CoV-2 immunoassays KirbasEkin
3079COVID-19 antibody-detecting rapid diagnostic tests show high false-positive rates among pre-pandemic serum and blood samples of patients with malaria, schistosomiasis and dengueVanroyeFien
3080Clinical validation of a freeze-dried multiplex one-step RT-qPCR assay for UK VUI 202012/01 variant of SARS-CoV-2 discrimination in clinical samplesMombelliBeatrice Nicole
3122Biomarkers for COVID-19 diagnostics and prognosticsGündischMargrit
3227Evaluation of different storage conditions of oropharyngeal swabs in viral transport medium and saliva samples for the detection of SARS-CoV-2EscolarCristina
3232Is the S gene dropout strategy a reliable tool for B.1.1.7 variant identification? New alternative for SARS-CoV-2 detection in combination with UK variant differentiationAlonsoHenar
3237SARS-CoV-2 community-based surveillance in the workplace by using pooled samples: when prevention pays offAlonsoHenar
3282Analysis of analytical performances of the new COVID-19 nucleic acid (RNA) POCT detection kit (AIGS realtime fluorescent PCR method) in comparison with a commercial real-time PCR COVID-19 kitThabetLamia
3307 Targeted virome enrichment and nanopore sequencing enables detection and genome assembly of unknown viruses: the example of SARS-CoV-2KaramitrosTimokratis
3322Ultrasound could represent a useful and safe tool for COVID-19 diagnosis and monitoringCatalanoMario
3546Clinical validation of a COVID-19 PCR kit and comparison with CE-IVD commercials assays on weak positive samplesOmiccioliEnrica
3557Evaluation of a real-time RT-PCR Point-of-Care testing (POCT) for laboratory diagnosis of SARS-CoV-2 in a tertiary hospital in GreeceKaragianniMarianna
3566Comparison of eight PCR methods for SARS-CoV-2 detection in clinical samplesDe BeerJessica Lilian
3625Performance characteristics and utilisation of a rapid antigen-based test for SARS-CoV-2 at the Clinical Center of the University of Sarajevo, November 2020–February 2021Dedeic LjubovicAmela
3740Comparative evaluation of two antigen rapid diagnostic tests to diagnose SARS-CoV-2 infectionPérez-GarcíaFelipe
3828Evaluation of saliva sample for diagnosis of SARS-CoV-2 in massive screeningsGual De Torrella BennasarAna
3860Low-efficiency amplification of gene N in the AllplexTM SARS-CoV-2/FluA/FluB/RSV assay as tool for screening SARS-CoV-2 VOC 202012/01Peñate-GarridoJuan Manuel
3881Prevention is better than cure: the importance of a good analysis in silico for verifying the correct detection of SARS-CoV-2 strains circulating worldwideEscolarCristina
4030Performance of an automated in vitro diagnostic PCR test for SARS-CoV-2 in upper respiratory swabs and saliva on the NeuMoDx™ molecular systemGongLijie
4089Evaluation of the EurobioPlex SARS-CoV-2 variants, detection and typing real-time RT-PCR kitAmoureuxMarie-Claude
4098Clinical and analytical validation of automated and rapid mariPOC® SARS-CoV-2 antigen testGoswamiMeghadipa
4123Evaluation of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage assayBoutolleauDavid
4124Rapid identification of the 501Y.V1/B.1.1.7 variant with the Allplex® SARS-CoV-2/FluA/FluB/RSV RT-PCR kitLaliSalah-Eddine
4281Diagnosis and monitoring of COVID-19 pneumonia: a comparison between lung ultrasound and high-resolution computed tomographyCatalanoMario
4284Clinical performance of the Celltrion DiaTrust™ COVID-19 Rapid Antigen Test: a prospective studyBlairMatthew
431Usability study of saliva samples for SARS Coronavirus 2 (SARS-CoV-2) real-time diagnosticsFarquharsonMaria Victoria
4358Evaluation of multiple SARS-CoV-2 rapid antigen tests in an emergency departmentGuedez LopezGLADYS VIRGINIA
4378Evaluation of a SARS-CoV-2 antigen assay in low risk populationScapaticciMargherita
4437Multiplexed and highly sensitive SARS-CoV-2 quantitative antibody testing using bead array technology HofnerManuela
4484Expanding SARS-CoV-2 sequencing to a regional laboratory network: proof-of-concept on Oxford Nanopore Technologies’ MinIONObbelsDagmar
4518SARS-CoV-2 salivary detection: new diagnostic and reliable toolPoletti De ChaurandValeria
4604A rapid and extraction-free methodology for detection of SARS-CoV-2 using the QuantuMDx lyophilised SARS-CoV-2 RT-PCR detection Assay for use in the screening of single/pooled saliva samplesCaffryJessica
4728Robust detection of SARS-CoV-2 in a multi-centre evaluation of clinical performance using the QuantuMDx SARS-CoV-2 RT-PCR Detection AssayScullyPhilip
4731Evaluation of LIAISON® SARS-CoV-2 TrimericS IgG assay and comparison with microneutralization titersJeulinHelene
4734Evaluation of the automated LIAISON®SARS-CoV-2 Ag test for the diagnosis of SARS-CoV-2 infection on nasopharyngeal swabsJeulinHelene
4788Meeting worldwide SARS-CoV-2 testing demands without extraction using XfreeTM COVID-19 direct RT-PCRMartinezRobert
4814An evaluation of the detection of SARS-CoV-2 antigen in a cohort of symptomatic and asymptomatic patients: report from the evaluation of SKUP (Report number 2021/124 www.SKUP.org)LehaneLucy
482Comparing the performance of two commercially available COVID-19 serological assaysSchwiebertRalph
4854Reducing ambiguous weakly positive SARS-CoV-2 PCR results caused by remnant RNA using RNaseNijhuisRoel H. T.
4858Evaluation of the SARS-CoV-2 Lentiviral Surrogate Neutralization Assay (SCLSNA) in the measurement of natural versus vaccine-induced immunityMerluzaJohn
4866A CRISPR-powered universal infectious disease assayBrownKeith
4917Performance of a microfluidic, immunofluorescence point-of-care SARS-CoV-2 Antigen Test for detection of COVID-19 infection in asymptomatic adults and childrenEllisJayne
4919SARS-CoV-2 detection: fast and cost-effective sample processing prior to RT-PCRSalvador-GarcíaCarme
4928Comparative evaluation of two commercial rapid molecular assays for the emerging SARS-CoV-2 in a tertiary care Greek hospitalGiannopoulouPanagiota
4947High-throughput, extraction-free detection of SARS-CoV-2 with SherlockTM CRISPR platformPenaJennifer
4955A commercially available SARS-CoV-2 antibody test is well suited for clinical useFriis-HansenLennart
4961SARS-CoV-2 viral RNA detection and sequencing in rectal samples collected from hospitalised patientsFiammamaura
4970Evaluation of RT-PCR-based typing of SARS-CoV-2 as a complementary approach to de novo  sequencing of SARS-CoV-2 genomes in Dutch public health surveillanceJanssensThierry Karl Suzanne
525Early prediction of COVID-19 ventilation requirement and mortality from routinely collected baseline chest radiographs, laboratory, and clinical data with machine learning at King Abdulaziz Medical City in RiyadhAlawadEman
530Evaluation of rapid antigen test for SARS Coronavirus 2 (SARS-CoV-2) compared with RT-PCR for testing received in symptomatic patients ZarrasCharalampos
539Evaluation of rapid antigen test for SARS Coronavirus 2 (SARS-CoV-2) compared with rapid RT-PCR for testing received in symptomatic patientsZarrasCharalampos
558Impact of implementing rapid point-of-care testing (POCT) with the ID NOW™ COVID-19 system in an emergency department (ED) during the second wave of the pandemicBaronAudrey
589Agreement between RT-PCR and chest CT for COVID-19 diagnosis during the first epidemic wave at the Rouen Normandie French hospitalAlessandri-GradtElodie
669Performance evaluation of Simplexa® COVID-19 direct for detection of SARS-CoV-2 on deep throat saliva and other upper respiratory tract specimensLamHoyin
702Isolated intracranial hypertension associated with COVID-19: a case reportBedewiMohamed
775Introduction of myCROBE® fully automated solution for routine SARS Coronavirus 2 (SARS‑CoV‑2) detectionZejdovaMichaela
84MALDI-TOF mass spectrometry and machine learning as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabsZintgraffJonathan
851It is All(plex) in the mix: the impact of SARS Coronavirus 2 (SARS-CoV-2) mutations on commercial diagnostic assaysCoessensMarie
882Novel neutralising anti-S1 SARS Coronavirus 2 (SARS-CoV-2) human monoclonal antibody formulation for use as a cross-platform external quality assessment (EQA) sample and prospective quality controlsZhelevPavel
Abstract NumAbstract titleLast nameFirst name
1203An investigation into the beneficial effects of high-dose interferon beta-1a compared to low-dose interferon beta-1a (the base therapeutic regimen) in moderate to severe COVID-19Alavi DarazamIlad
1283ESCAPE trial: preliminary data on the effect of vafidemstat treatment in the COVID-19 induced immune response in hospitalised patientsArévaloMabel
2085Efficacy of COVID-19 Human Immune Globulin (COVID-HIG) in animal models of SARS-CoV-2 infectionJhaAruni
2316Impact of glucocorticoid treatment in SARS-CoV-2 infection mortality: multi-centre database retrospective studyFernández-CruzAna
2558Safety of baricitinib in the treatment of severe-to-critical COVID-19 pneumonia: a retrospective analysisSireno LedezmaAngélica Lizbeth
262Metallodrug ranitidine bismuth citrate suppresses SARS Coronavirus 2 (SARS-CoV-2) replication and relieves virus-associated pneumonia in Syrian hamstersYuanShuofeng
3276A randomised, controlled, double-blind clinical trial to assess the efficacy of allogeneic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT Study)Martínez-MuñozMaría Esther
3294Identification of highly immunogenic epitopes in the SARS-CoV-2 spike protein to produce neutralising monoclonal antibodies for treatmentFernandez-BaratLaia
3363Toxicity of remdesivir as treatment of non-critically ill COVID-19 patientsQuesada-MuñozLucía
3649Inhaled pan-Janus kinase inhibitor TD-0903 in patients with COVID-19-associated acute lung injury: part 1 results of a two-part, phase II, randomised, double-blind, placebo-controlled studySinghDave
4337Vitamin D supplementation and recovery times in patients with SARS-CoV-2 in TunisiaAbrougHela
4443Cellular and animal model demonstration of the mitigation of SARS-CoV-2-induced mortality by massive polypharmacological interventionMayerPascal
464The efficacy of remdesivir as treatment of COVID-19 in real life Hidalgo-TenorioCarmen
4720Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rateShawe-Taylor.Marianne
4721IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regressionBuazonApril
4749Efficacy of remdesivir-containing therapy in hospitalized COVID-19 patients: a prospective clinical experienceRussoAlessandro
4771Dexamethasone with or without remdesivir for the treatment of COVID-19 in hospitalized patients receiving oxygenGressensSimon
4838Impact of remdesivir for the treatment of COVID-19 in SpainMontejanoRocío
4883Remdesivir vs. standard of care for severe COVID-19GoAlan S.
4985Significant SARS-CoV-2 RNA decay during remdesivir treatment in real-life COVID-19 hospitalised patientsCeccherini SilbersteinFrancesca
608Remdesivir versus Standard-of-Care for severe coronavirus disease 2019 infection OlenderSusan A
644Prophylactic administration of the monoclonal antibody ADG20 provides potent protection against SARS-CoV-2 in rodent and non-human primate models of COVID-19KakuChengzi
738Pharmacokinetics of lopinavir/ritonavir in hospitalised patients with COVID-19 not requiring critical careMacgowanAlasdair
Abstract NumAbstract titleLast nameFirst name
1417Immune profile of individuals who recover from mild/moderate COVID-19 is back to normal after a few weeksBulutOzlem
157Two encouraging favourable outcomes of SARS Coronavirus 2 (SARS-CoV-2) infection in patients days away from haematological stem cell transplantation for acute myeloid leukemiaVan UytvanckAlexandra
1640The state of local immunity of the oral cavity in patients after COVID-19KalchanavaNatallia
1682Specific antibodies levels to SARS-CoV-2 of doctors and patients before vaccinationBoroninaLiubov
1715Frequency of COVID-19 symptoms and of SARS-CoV-2 positive nasopharyngeal swabs among healthcare workers according to serostatus at baseline: a prospective multi-centre cohortKohlerPhilipp
1941Prospective close analysis of the serological response to SARS-CoV-2 in a cohort of patients admitted to our hospital for COVID-19 pneumonia: One-year follow-upGrau GómezGemma
2060Pseudotemporal whole-blood transcriptional profiling of COVID-19 patients stratified by clinical severity reveals differences in immune responsesBroderickClaire
2073The state of local immunity of the oral cavity in patients after COVID-19KalchanavaNatallia
2104Risk of SARS-CoV-2 infection in previously infected and non-infected cohorts of health workers at high risk of exposureSánchez-MontalváAdrián
2388Comparison of sensitivity of lateral flow immunoassay and chemiluminescence immunoassay for SARS-CoV-2 antibody detectionLecároz AgaraMaría Concepción
245Bloodstream infections in patients hospitalised with SARS Coronavirus 2 (SARS Cov-2) infection: association with immunosuppressive therapiesKhatriAkshay
2509Antibody status and incidence of SARS-CoV-2 infection in healthcare workers according with their workplace at a healthcare area in Spain during COVID-19 pandemicGrau GómezGemma
2617Cytokine profile associated with worse prognosis in Peruvian COVID-19 hospitalised cohortPons CasellasMaria Jesus
2811Use of COVID-19 convalescent plasma for the treatment of moderate to severe cases of SARS-CoV-2 infection does not inhibit natural production of specific antibody: a children’s hospital experienceArrietaAntonio
2849Anakinra to improve 28-day outcomes in patients with moderate-to-severe COVID-19: results of the SAVE open-label clinical trialGiamarellos-BourboulisEvangelos
2867IL-1α inhibition reduces COVID-19 hyperinflammation in a novel murine modelGiamarellos-BourboulisEvangelos
2901Metatranscriptomic analysis of host response and vaginal microbiome of female patients with severe COVID-19XiaoMeng
3165Detection of circulating galectins in patients with COVID-19: novel biomarkers for SARS-CoV-2 infectionGomez JunyentJoan
3252Preliminary analysis of the humoral and celullar immune response to the BNT162b2 mRNA COVID-19 vaccine in a cohort of healthcare workersMartinez Lacasaxavier
3280Serological response to COVID-19 in a community outbreakBragagnoloLuciana
3298A whole-blood assay to measure interferon (IFN)-γ response to SARS-CoV-2 peptides in COVID-19 patientsAielloAlessandra
3345In vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapyPetroneLinda
3347Antibody response after COVID-19 recovery and vaccinationNaaberPaul
3392SARS-CoV-2 sensing by TLR3 and TLR7 enhances immune response and hACE2 expressionRizzoSabrina
3416Comparation of four automated immunoassays for evaluation of umoral immunity after Pfizer/BioNtech BNT162b2 vaccineGibernaEliana
3475Early-onset encephalitis during SARS-CoV-2 infection: a case reportMastroianniClaudio
3581Persistence of neutralising antibodies and clinical protection up to nine months after SARS-CoV-2 infection in elderlyCollarinoRocco
3701Evaluation of the best immune biomarkers and SARS-CoV-2 antigens to discriminate between COVID-19 patients and non-COVID-19 individuals using a whole blood platform assayNajafi FardSaeid
3751Immunophenotype analysis in patients with SARS-CoV-2 infection admitted to the IRCCS Sacro Cuore-Don Calabria HospitalTibertiNatalia
3819A novel whole-blood immune functional assay uncovers long-lasting SARS-CoV-2-specific memory T cells in COVID-19 convalescent healthcare workers MoutonWilliam
3821Antibodies against type-I interferon: detection and association with clinical severe outcome in COVID-19 patientsTrouillet-AssantSophie
3861SARS-CoV-2 vaccination: autoimmune responsesMarinouIoanna
3954Method comparison for the detection of IgG anti-SARS-CoV-2 antibodies: all equal, all different?RibeiroRicardo Jorge
4036COVID-19 vaccination and detection of anti-spike antibodies MarinouIoanna
4125ABO blood group and SARS‐CoV‐2 antibody response in blood donorsAlakbarovaGumral
4134Association between pre-existing seasonal coronavirus antibodies and the immunological response against SARS-CoV-2LavellAyesha
4198Tocilizumab or anakinra in the treatment of COVID-19 systemic inflammation: a retrospective, observational studyFranzettiMarco
4221Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19TheobaldSebastian
4251Serosurveillance in healthcare workers: can we evolve a strategy to keep patients and healthcare workers safe? MurugesanMalathi
4341Outbreak of mild COVID-19 infections presenting with diarrhoea, in vaccinated residents of a Greek nursing homePournarasSpyros
4383High soluble TREM-1 (sTREM-1) plasma concentrations are associated with outcome in ICU patients with COVID-19: results from a pilot studyJollyLucie
4456Cominarty® inmune response can neutralise SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7)De Salazar GonzálezAdolfo
4715Increase of myeloid-derived suppressor cells and reduced production of cytokines by monocytic and dendritic cells in COVID-19 patientsSchrijverIrene T.
4716Clinical efficacy of bamlanivimab/etesevimab and casirivimab/imdevimab against SARS-CoV-2 variants of concernFalconeMarco
4742Overall survival after convalescent plasma transfusion in patients with hematological malignancies and COVID-19: the hemoplasm studyHuesoThomas
4764SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.ShamierMarc Conrad
4769Dose-ranging virology study of the combination COVID-19 antibodies casirivimab and imdevimab in the outpatient settingPortal-CelhayCynthia
4775Early treatment of SARS-CoV-2 infection with subcutaneous administration of casirivimab and imdevimabO'brienMeagan P.
4777COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimabO'brienMeagan P.
4794Assessment of anti-SARS‐CoV‐2 antibody avidity in patients with COVID-19BaranIrmak
4868Humoral immune response to SARS-CoV-2 8 months after the moderate to severe infectionAgüerosAdrián
4874Persistence of SARS-CoV-2 IgG in healthcare workers (HCWs) diagnosed with COVID-19 in the first wave of the pandemicMcgreal-BelloneAimee
4927Evolution of SARS-CoV-2 antibody responses (IgM+IgA versus IgG) during COVID-19 pandemic among healthcare workers at the Consorci Sanitari del Maresme (CSdM), Catalonia, SpainClavéPere
4965Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infectionBoussenInès
5006ELISpot COVID to explore the cellular immune response to SARS-CoV-2Trombert PaolantoniSabine
545Late-onset haemophagocytic lymphohistiocytosis after COVID-19 pneumoniaBasileGregorio
557Seroprevalence of anti-SARS-CoV-2 IgG antibodies among blood donors after first and second COVID-19 pandemic wave in AzerbaijanAlakbarovaGumral
605Immunological profiles in moderate and severe cases of COVID-19 patientsVasilyevaNatalya
824Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19De NooijerAline H.
Abstract NumAbstract titleLast nameFirst name
2796COVID-19 vaccination rate among healthcare workers in metropolitan DetroitSuleymanGeehan
3137VACCELERATE: European coronavirus vaccine trial accelerator platformSchumacherSofie
3430Evaluation of vaccination effectiveness against SARS-CoV-2 in healthcare professionalsTsalidouMaria
3753Demographic characteristics and COVID-19 risk factors of volunteers registered on COVIREIVAC, the French national platform for COVID-19 vaccine trialsSambourgJessica
4633Humoral immune response after two consecutive doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workersErdoganmerve
4923Antibody response to mRNA COVID-19 vaccine in elderly residents in a Greek nursing homeGiannopoulouPanagiota
4938Neutralising activity of BNT162b2 mRNA-induced antibodies against B.1.351 SARS-CoV-2 variantDe Salazar GonzálezAdolfo
4945Short-term impact of COVID-19 vaccine on COVID long-haulersSlamadorsaf
Abstract NumAbstract titleLast nameFirst name
1035Impact of an education intervention on knowledge of infection control practices among healthcare providers during COVID-19 pandemicKhanumiffat
1076Secondary infection in COVID-19 infected patients: incidence and impact outcomeBahloulMabrouk
1127Readmission, reinfection, and relapse: a mysterious story of COVID-19RabieiMohammad Mahdi
1259Can SARS-CoV-2 screening after exposure safely replace quarantine in healthcare workers?YakubovskyMichal
1274Evaluation of the personal protective equipment use of healthcare professionals working in pandemic hospitalsKeskinHavva
1554SARS-CoV-2 seroprevalence among healthcare workers of a Swiss tertiary care centre at the end of the first wave: an assessment of the efficacy of preventive measures to limit intrahospital transmissionMeylanSylvain
1609Antibiotic prescribing behaviour in patients hospitalised with COVID-19: lessons from the first waveO'kellyBrendan
1760Medical face masks offer self-protection against aerosols: an evaluation using a practical in vitro approach on a dummy headSterrChristian Maximilian
1809Definitions for classifying COVID-19 as community-acquired or hospital-acquired among hospitalised patients: experience from a large tertiary care centreVoor In 't HoltAnne F.
1899Preliminary data on the BNT162b2 COVID-19 vaccine efficacy against two different SARS-CoV-2 variantsPaceLorenzo
1930Effectiveness of contact tracing in a Greek university hospital with universal masking policyKofteridisDiamantis
1942Knowledge, attitudes and behaviours of UK healthcare workers towards uniform laundering polices during the COVID-19 pandemicOwenLucy
1965Serologic surveillance and phylogenetic analysis of SARS-CoV-2 infection in hospital healthcare workersBomersMarije
2209One original building organisation for COVID-19 patients: a resilient response to the pandemicBessisSimon
2357Personal protective equipment and SARS-CoV-2: factors associated with healthcare worker infectionPrestonRebecca
2401Impact and feasibility of mobile PCR-based surveillance for SARS-CoV-2 to prevent transmission and improve living conditions in nursing homes during the COVID-19 pandemic: a prospective, regional real-life pilot studyStemlerJannik
2549SARS-CoV-2 genome sequencing reveals cross-site infections in a UK hospital trustWenlockRhys
2552Secondary attack rate following isolation of patients with suspected SARS-CoV-2 infection in multiple-bed roomsRagozzinoSilvio
2565COVID-19 outbreak at the adult hemodialysis department of a tertiary care hospital in The NetherlandsHaanappelCynthia Paola
2570The epidemiology of hospital inpatient exposure to SARS-CoV-2: a retrospective cohort studyWenlockRhys
2648Comparing SARS-CoV-2 seroprevalence among healthcare workers in hospitals and nursing homes: a cross-sectional serosurveillance study in Bergen, NorwayKuwelkerKanika
2663High rates of rectal colonization by MDRO in hospitalized patients at a COVID-19 department during the second wave of the pandemic diseaseGiannitsiotiEfthymia
2765COVID-19 infection among healthcare workers in metropolitan DetroitSuleymanGeehan
2836Impact of the COVID-19 pandemic in the antimicrobial stewardship and infection prevention and control programmes during the first wave in a tertiary-care teaching hospitalQuirósRodolfo Ernesto
2859Changing landscape of paediatric respiratory infections in the year of COVID-19YeeRebecca
2881The holistic approach to implement infection prevention and control during an emergency: experience from COVID-19 response in KazakhstanStetsykVitalii
2924Enterococcal bloodstream infection in critically ill patients with COVID-19: a retrospective single center studyLabateLaura
3146Implementation of infection prevention and control measures for routine patient care during the COVID-19 pandemicEbnerJulia
322Hospitalisation of SARS Coronavirus 2 (SARS-CoV-2) paediatric patients within the general paediatrics ward: coping with a persistent pandemicTamariItamar
3326Comparing testing strategies for the detection of nosocomial cases of COVID-19 in English hospitalsEvansStephanie
3334Bloodstream infections in COVID19-patients in a Greek reference hospitalMoraitouEleni
3365When the mask slips: nosocomial transmission of COVID-19CreedonMargaret
3367COVID-19 transmission cluster within a Dutch hospital, involving patients and healthcare professionalsSandersLisanne
3368Healthcare workers are main driver for clusters of SARS-CoV-2 in the hospitalCadenauLaura
3491Sampling and analysis technique to detect SARS-CoV-2 on surfaces during self-control procedures: a case studySabelliCristiano
3558COVID-19 incidence in vaccinated healthcare workers (HCWs) in comparison to the general populationSánchez-ArcillaIgnacio
3612Healthcare workers’ experiences of infection prevention and control practices in South Africa and India during the SARS-CoV-2 pandemicMbamaluOluchi Nneka
3659Assessment of knowledge, attitude, and practices about COVID-19 of the frontline healthcare workers working on point of entries across PakistanNoreennadia
3758Nosocomial infections in critically ill patients with COVID-19ChtaraKamilia
3766A universal test strategy to prevent nosocomial transmission of SARS-CoV-2 at a tertiary hospitalFüszlAstrid
3823Antigenic rapid test for SARS-CoV-2 screening of individuals newly admitted to detention facilities: sensibility in an asymptomatic cohortCasiglianiVirginia
3836Co- and secondary infection in COVID-19 patients within intensive care units in England: a retrospective cohort study from the first wave of the pandemic ChudasamaDimple
3933Prevalence of nosocomial COVID-19 in hospitalised patients in Málaga (Spain)Martinez PerezRocio
3951Secondary infections in patients hospitalised with COVID-19SakkaVissaria
3961In-hospital contact tracing of COVID-19 exposed patients: is 48 hours enough? TausanMatija
4112Evaluation of COVID-19 status in a large population of healthcare workersMuñozPatricia
4127Clinical implications of exposure status of COVID-19 in healthcare workersErolÇigdem
4269COVID-19 transmission to healthcare workers: where is the risk?LomontAlexandra
4340Risk factors for seropositivity of SARS-CoV-2 among healthcare workers before vaccination eraPinarlikFatihan
4366Persistence of SARS-CoV-2 RNA on high touch surfaces at the COVID-19 Emergency Department of the referral tertiary care hospital in Northern GreeceTychalaAreti
4381Impact of COVID-19 pandemic on hospital-acquired infections: a single-centre analysisShbakloNour
4403SARS-CoV-2 isolation from an asymptomatic patient with follicular non-Hodgkin lymphoma treated with hyperimmune plasmaRondinoneValeria
4615Calculation of serial interval for symptomatic cases identified through contact tracing in the Republic of Ireland Contact Management ProgrammeBuckleyClaire
4693Effective use of UV-C irradiation as an inactivation tool for SARS-CoV-2 on porous and non-porous surfacesTomásAna Luísa
4825An unprecedented and large-scale departmental support mission to assist living facilities for elderly people facing the COVID-19 pandemicColasAnais
4904The impact of real-time whole genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaksFrancisRodric
706Community- and hospital-acquired SARS-CoV-2 infections among patients and healthcare workers in two medical centers in Cologne (Germany) from March to December 2020Montilva LudewigMaria Veronica
767SARS-CoV-2 testing in patients with low COVID-19 suspicion at hospital admission in a third-level hospital in StockholmRequena-MéndezAna
935Evaluation of single-use FFP3 mask decontamination efficacy and mask integrityBaileyClaire
Abstract NumAbstract titleLast nameFirst name
1485Quantifying social contact patterns in response to COVID-19 public health measures in CanadaBrankstonGabrielle
1551Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription driversVan LaethemJohan
1917Getting insight into COVID-19 vaccine hesitancy in health students in a Paris area universityLuytDomitille
2583Impact of remdesivir on hospital-bed resources and budget in COVID-19 time in FranceBeraudGuillaume
3208Transmission of SARS-CoV-2 by children attending school:  an observational, longitudinal sampling study of infected children, contacts and the environmentCorderyRebecca
3582Real-time reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID-19 in DenmarkDessauRam B.
3623Attitudes and awareness of SARS-CoV-2 related risks among the public in India and South AfricaMbamaluOluchi Nneka
3639Policies and use of therapies for COVID-19 disease amongst Australian health servicesSmithEmma, Louise
4352Unexpected reduction of rotavirus infections during SARS-CoV-2 pandemicRussoCristina
447Market surveillance study on hand gels and disinfectant efficiency during COVID-19 pandemics in CroatiaPileticKaca
4685Confirmed reinfection of SARS-CoV-2 by whole genome sequencingGutiérrez-FornésCristina
4741Influences of the altitudes on COVID-19 vaccine in GermanyFobiweJohn Paul
Abstract NumAbstract titleLast nameFirst name
1695Feasibility, efficiency and effectiveness of pooled sample testing strategy (Pooled NAAT) for molecular testing of COVID-19PrakashShantanu
2198SARS-CoV-2 outbreak on HMS Northumberland: key lessons for the maritime environmentWoolleyStephen
2516The impact of the COVID-19 pandemic on referrals to the Irish national OPAT programmeBrowneRobert
2728Best practice guidance for digital contact tracing apps: a cross-disciplinary review of the literatureO' ConnellJames
3152Establishment and state of affairs of the German National Pandemic Cohort Network (NAPKON)VehreschildJörg Janne
3494A preliminary report on SARS- CoV-2 infections in staff and patients in a non-COVID superspecialty hospital: strategies for surveillance and controlRajaKavita
3652Descriptive analysis of inbound international passengers at all the operational airports across Pakistan (points of entry)Noreennadia
4465An overview of the establishment of a national contact tracing programme: a quality improvement approach in a time of pandemicBuckleyClaire
4695Experiences and contributions of community pharmacists during the COVID-19 pandemic: a qualitative studyDurandClaire
4798Implementing a clinical decision support system for COVID-19 care management in West Africa: a contextual analysisPeiffer-SmadjaNathan
768What do people hospitalised with COVID-19 think about their care? Results of a patient satisfaction survey in LiverpoolAhmedMuhammad Shamsher
Abstract NumAbstract titleLast nameFirst name
1165The challenge of COVID-19 for a clinical microbiology departmentMuñozPatricia
129Factors affecting mental health outcomes of healthcare workers during the COVID-19 pandemic at a tertiary hospital in the PhilippinesApa-ApArchimedes
1607Impact of the COVID-19 infection in the perception of health status of the personnel at a tertiary care teaching hospitalQuirósRodolfo Ernesto
1749Effect of the COVID-19 pandemic on the seasonal profile of antibiotic consumption in primary care in Andalusia, SpainPeñalva MorenoGermán
1823Snapshot of parents’ opinions towards vaccines after the first COVID-19 pandemic wave: results from a survey across EuropeStahlJean-Paul
2129COVID-19 vaccine acceptance and refusal among Canadian healthcare workers: a multi-centre surveyDzieciolowskaStefania
2159“Coronaaah, what’s this?”: a French popular science comic about COVID-19PugesMathilde
3530Introduction of algorithm-based targets determination using GenMark Dx® ePlex blood culture identification system improves sepsis management, aids early antimicrobial stewardship (AMS) interventions, results in significant cost savings and reduces healthcare worker (HCW) patient interaction time allowing efficient use of HCW time in the era of COVID-19 pandemicBoyleBreida
4258The deep impact of the COVID-19 pandemic on medical students: an online cross-sectional study evaluating Turkish students’ anxiety TasbakanMeltem
4355Evaluation of social determinants among a cohort of patients of a post-COVID-19 care outpatient clinic at a referral hospital in Athens, Greece: implications for service uptake and design of care modelsKakalouEleni
4426SARS-CoV-2 transmission in a indoor large-scale live music event: a randomised clinical trialRevolloBoris